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Abstract
Despite being the principal bacterial cause of gastroenteritis world wide, the
epidemiology of Campylobacter jejuni is poorly understood. This is largely because
the proportion of human disease caused by different sources of infection is unknown.
In this study a diverse strain collection was selected comprising of 91C. jejuni isolates
from diverse animal and environmental ecological niches as well as clinical isolates
from patients representing a range of disease outcomes. Whole genome comparisons
were performed by DNA microarray analysis with the dual aim of identifying genetic
markers specific to strains from different ecological niches and identifying novel
virulence determinants.
A new phylogenomic technique for the analysis of DNA microarray data was
developed combining Bayesian algorithms to model phylogeny based on whole
genome data with parsimony based algorithms to identify the key genes contributing
to the clade formations. This method revealed a previously undetected C. jejuni
population structure comprising two main clades, a "chicken clade" and a "non-
chicken clade". These statistically supported clades differentiated strains from distinct
ecological niches with 94% of strains isolated from chickens and 41% of clinical
isolates contained within the "chicken clade". C. jejuni isolates from ovine, bovine
and sand isolates also formed distinct clades within the "non-chicken clade". Key
genes contributing to the distinction of strains from one ecological niche from another
were identified. In particular a putative glycosylation islet cj 1321-cj 1326 was found
to be present in strains within the "chicken clade" but absent or divergent from strains
in the "non-chicken clade', a result validated by peR screening. This locus represents
a potential genetic marker of C. jejuni strains of avian origin.
The DNA microarray data analysis method described in this study may be used to
study other bacterial pathogens facilitating the identification of bacterial phylogenies
and genetic markers associated with specific phenotypes.
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1.0 Introduction
1.1 The organism
Campy/obaeter cells are slender Gram-negative rods approximately 1.5-6 urn long
and 0.2-0.5 urn wide, with characteristic spiral morphology. The Campy/obaeter
genus contains sixteen species that are members of the delta-epsilon group of
proteobacteria, of which C. jejuni is most commonly associated with human disease.
C. jejuni is a microaerobic bacterium requiring an oxygen concentration in the range
of 3-15% and a carbon dioxide concentration of 3-5% for growth. The optimal growth
temperature of C. jejuni is 42°C, the gut temperature of avians, in which the
bacterium forms part of the commensal flora. The cells are flagellate with a
characteristic corkscrew-like motility mediated usually via a single, polar, unsheathed
flagellum (Guerry et ai, 1992). C. jejuni is oxidase positive and is unable to ferment
or oxidise sugars. The inability to ferment sugars means many routine biochemical
tests used in diagnostic microbiology laboratories to identify pathogens are redundant
for the identification of Campylobaeters. Many of the characteristics of
Campylobaeters, including the microaerobic growth and spiral morphology with polar
flagella mediating corkscrew motility, are shared with a second member of the delta-
epsilon group of proteobacteria, the genus He/ieobaeter of which Helieobaeter pylori
is the type species (Owen, 1998).
1.2 The disease
Human Campylobaeter strains were first documented in the 1940's and 1950's as a
thermophilic group of 'related vibrios' associated with human diarrhoeal disease
(King, 1957; Wheeler and Borchers, 1961). Although first cultured from blood
samples the organism was suspected to also be present in the human gut. However,
failure to successfully culture the organisms from stool samples due to overgrowth by
coliforms prevented this from being confirmed. The Greek word Campylobacter,
meaning a curved rod, was proposed by Sebald and Veron in 1963 to distinguish
microaerobic vibrios from classical cholera and halophilic groups in the genus Vibrio
(Sebald and Veron, 1963). Then, in the 1970's, following the development of a
selective culturing technique and successful cultures of the organism from human
stools (Butzler et al., 1973; Dekeyser et al., 1972) the status of Campy/obaeter as a
"new" human pathogen was confirmed (Skirrow, 1977). Since its identification in the
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1970's, C. jejuni has become the most commonly isolated human gastrointestinal
pathogen in the developed world with 44,832 Campy/obaeter cases (provisionally)
reported In England and Wales In 2003
(www.hpa.org.uk/infections/topics_azJcampy/data_ew.htm).This figure is thought to
be an underestimate with the actual number of cases per annum estimated to be
approximately half a million (Agency, 2000).
A feature of human C. jejuni infection (campylobacteriosis) is the wide spectrum of
clinical disease presentation and outcome. This ranges from asymptomatic carriage to
the most common presentation of self-limiting diarrhoea and rarely sequelae
including septicaemia and neuropathy such as Guillain-Barre syndrome (GBS).
1.2.1 Asymptomatic carriage
Asymptomatic carriage of C. jejuni in humans has rarely been documented. However,
several cases were identified by the Infectious Intestinal Diseases (lID) study carried
out by the Foods Standards Agency (Agency, 2000). This study was undertaken to
estimate the number of cases of gastroenteritis occurring in England and Wales.
Seventy general practice surgeries were recruited into the study and groups of people
from each practice were asked to report on a weekly basis for six months whether
they had suffered from gastroenteritis. All patients who presented to their GPs from
34 of the general practices over a twelve-month period were matched with controls
and asked to provide stool specimens. Information was also obtained from both cases
and controls regarding risk factors and personal characteristics. The definition of a
control in this study was ' ... persons who have been free of loose stools or significant
vomiting for three weeks prior to the onset of illness in the case.' In total over 6000
cases who developed gastroenteritis were matched with controls within the cohorts
and both provided stool specimens that underwent microbiological investigations.
Interestingly, some of the stool specimens from the control population tested positive
for C. jejuni. These control patients were the first well-characterised asymptomatic
human carriers of C. jejuni.
1.2.2 Diarrhoeal disease
The most common presentation of campy lobacteriosis is gastroenteritis following an
incubation period of 24-72 hours. The illness is characterised by fever, abdominal
cramps, headache and loose to bloody diarrhoea, lasting between 5 and 10 days and
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usually self -limiting (Blaser, 1997). The acute diarrhoeal illness has clinical
manifestations similar to salmonellosis or shigellosis and clinically cannot be
distinguished. Definitive diagnosis of campylobacter associated human disease is
made by the isolation of the organism from patients' faeces on selective media
containing vancomycin, polymyxin Band trimethoprim (Kaijser, 1992). The
Campylobacter Sentinel Surveillance Scheme, launched in 2000, has collected C.
jejuni epidemiological and microbiological typing data from twenty-two health
authorities in England and Wales (covering a population of about 12 million people).
Data from the first two years of the study has shown that diarrhoea (98%), abdominal
pain (92%) and fever (85%) were the most commonly reported symptoms associated
with C. jejuni human infection. However, vomiting (39%) and bloody diarrhoea
(33%), although reported less frequently, were still evident in a significant proportion
of the cases.
1.2.3 Post C. jejuni infection sequelae
Following C. jejuni infection, sequelae occasionally occur. These include
bacteraemias (occurring in around 1.5/1000 intestinal infections), endocarditis,
reactive arthritis, meningitis, post-dysenteric irritable bowel syndrome (PD-IBS),
GBS and the rare variant of GBS, Miller Fisher syndrome (MFS) (Kuroki et al., 1993;
Skirrow, 1991). GBS is an autoimmune disorder of the peripheral nervous system
characterised by weakness of limbs, respiratory muscles and loss of reflexes.
Recovery usually takes place over weeks or months but up to 20% of patients may
require mechanical ventilation and 15-20% are left with severe neurological defects
(Nachamkin et al., 1998).
1.3 Pathogenesis
The human host possesses a number of innate mechanisms, including a mucus layer,
an epithelial barrier, peristalsis and acidic pH, through which to protect itself from
gastrointestinal pathogens. Following ingestion, C. jejuni must first circumvent these
physical barriers. Gastric acid rapidly kills C. jejuni and ingestion of the pathogen
with food aids its survival in the stomach (Blaser et al., 1980; Walker et al., 1986).
Human volunteer studies have demonstrated an infectious dose as low as 500
organisms (Black et al., 1988) but variation in host susceptibility and! or virulence of
strains exists.
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Following ingestion, successful pathogens must penetrate the mucus layer and adhere
to the intestinal epithelium of the small intestine and occasionally of the colon. Most
campylobacters are found within deep caecal crypts, thus avoiding clearance by
peristalsis. The spiral shape and corkscrew-like motility of the bacterium is important
in its ability to colonise the mucus layer of the intestinal tract (Morooka et al., 1985)
and C. jejuni cells have been shown to adhere to and invade Caco-2 cells more
effectively in the presence of a chemical mimicking the viscosity of intestinal mucus
(Szymanski et al., 1995). Moreover, pre-treatment of Hep-2 cells with mucin resulted
in enhanced invasion of C. jejuni in four clinical strains (de Melo and Pechere, 1988).
Thus, intestinal mucus appears to promote cell adhesion and invasion of C. jejuni.
The mechanism of adherence to the intestinal epithelium used by C. jejuni is
unknown but several adhesins have been identified. CadF, an outer membrane protein
(OMP) of C. jejuni, promotes the binding of the pathogen to intestinal epithelial cells
(Konkel et al., 1999). Similarly, ajlpA mutant showed a marked decrease in adhesion
to Hep-2 cells (Jin et al., 2001). However, the most well characterised virulence factor
facilitating colonisation is the flagellum. Experimental evidence implicates flagella
and/or motility as requirements for successful colonisation of the chick intestinal tract
and to cross polarised epithelial cell mono layers (Doig et al., 1996; Grant et al., 1993;
Nachamkin et al., 1993; Wassenaar et al., 1993). Flagella are the locomotory
organelles of bacteria. In C. jejuni, flagellin is encoded by flaA and flaB and the
flagella filaments are composed predominantly of the FlaA flagellin interspersed with
the highly variable FlaB flagellin (Guerry et al., 1991). A defectiveflaA gene leads to
immotile bacteria (Wassenaar et al., 1991). However, mutations in geneflaB but not
flaA result in a motile phenotype, although both genes are required for maximum
motility (Kinsella et al., 1997). Non-motile mutants lose the ability to adhere to and
consequently invade cells in vitro and in vivo (Nachamkin et al., 1993; Wassenaar et
al., 1991). However, invasion was possible when non motile mutants were
centrifuged onto tissue culture cells, indicating that motility is not the only factor
involved in invasion (Wassenaar et al., 1991). The secretion of invasion proteins into
host cells to promote uptake is well documented in gastroenteric pathogens such as
Salmonel/a, Shigella, Yersinia and enteropathogenic E. coli (Zaharik et al., 2002).
Upon co-cultivation with host cells, C. jejuni expresses nine novel proteins against
which rabbit antisera has been raised. Treatment of C. jejuni with the rabbit antisera
reduced cell invasion by 98%, implicating the production of novel proteins in the role
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of host cell invasion (Konkel et al., 1993). It has been demonstrated that one of these
secreted proteins is a product of the Campylobaeter invasion gntigen B (ciaB) gene.
CiaB comprises 610 amino acids with has 40.6% to 45.4% sequence similarity to type
III secreted proteins associated with Salmonella SipB, Shigella IpaB and Yersinia
YopB proteins. Mutants in ciaB were non-invasive for INT -407 cells and using
immunofluorescence microscopy the CiaB protein has been shown to translocate into
INT-407 cells (Konkel et al., 1999). Similarly, FlaC identified in C. jejuni strain
ATCC43431, is found in the extracellular milieu of wild type cultures as a secreted
protein. Purified recombinant FIaC binds to Hep-2 cells and invasion of the cells by
flaC null mutants was reduced to 14% suggesting a role for FlaC in cell invasion
(Song et ai, 2004). Genes homologous with those encoding classical type III secretory
apparatus have not been identified in NCTC11168. However, Yersinia secretes
virulence factors through the flagellar apparatus and it has been speculated that C.
jejuni may secrete proteins using the same mechanism. Indeed, mutations in several
genes encoding the basal body, hook and filament structural components of the
flagellum indicated that CiaB export requires at least one of two structural filament
proteins (Konkel et ai, 2004). Furthermore, mutations in genes essential for flagellum
biosynthesis (jlgF andflgE) resulted in a phenotype that did not secrete FlaC (Song et
al, 2004). In H. pylori, the virulence factor CagA is transported directly into host
cells via a type IV secretion system (Christie and Vogel, 2000). Genes found on a
plasmid (pVir) identified in C. jejuni strain 81-176 have significant homology to type
IV secretion system genes and inactivation of four of these genes resulted in
decreased invasion on INT-407 cells (Bacon et al., 2001). However, the sequenced C.
jejuni strain NCTC 11168 which was isolated from a patient with gastroenteritis did
not possess any plasmids (Parkhill et al., 2000). Although the mechanism is not fully
understood, C. jejuni very clearly invade cells in the human intestinal tract as shown
in vivo in clinical intestinal biopsies (van Spreeuwel et al., 1985) as well as intestinal
biopsies of infected primates and other animal models (Babakhani et al., 1993;
Newell and Pearson, 1984; Russell et al., 1993). Eukaryotic cell invasion by C. jejuni
has also been shown in vitro, by the demonstration of the invasion of C. jejuni into
human epithelial cell lines (Ketley, 1997; Konkel et al., 1992). Damage to gut
epithelial cells may occur during invasion and! or by subsequent cytolethal distending
toxin activity. Disruption of the normal functioning of epithelial cells results in their
inability to absorb water and ions leading to the characteristic diarrhoeal disease
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associated with clinical C. jejuni infection. Attempts by the host's immune system to
combat the pathogen present in infected tissue results in common C. jejuni disease
symptoms such as fever and inflammation of the gut epithelium.
The mechanism of pathogenesis for the debilitating and often life-threatening
complications associated with C. jejuni also remains unclear. Following C. jejuni
infection in humans, increases in enteroendocrine cells (ECs), T lymphocytes and gut
permeability may persist for a year or more and are these are thought to be
contributory factors to PD-IBS. Furthermore, it has been hypothesised that the
peripheral neuropathy GBS may be caused by molecular mimicry between surface
components on the C. jejuni cell and human gangliosides. The C. jejuni surface
antigen, lipooligosaccharide (LOS), has a relatively conserved inner core with a
terminal outer core region that can vary in structure between strains and can mimic
human gangliosides, GM2 and GM3 and to a lesser degree, GD1b and GD2 (Guerry et
al., 2002). The generation of antibodies against LOS that cross-react with human
gangliosides is thought to be responsible for the nerve damage observed in GBS
(Yuki, 1997). Goodyear et al added weight to the molecular mimicry hypothesis by
raising monoclonal antibodies against C. jejuni ganglioside mimicking LOS that were
cross reactive with neural gangliosides and caused neurotransmission block in mice
(Goodyear et al., 1999). This molecular mimicry is due to the presence of N-acetyl
neuraminic acid (NANA), also known as sialic acid, in both LOS and human
gangliosides. NANA has been identified as a constituent sugar in the LOS of C. jejuni
and three genes, (neubl , neuB2, and neuB3), encoding NANA have been identified
(Linton et aI, 2000). Although compelling, molecular mimicry as the mechanism of
GBS pathogenesis, remains unproven.
After 30 years of research into C. jejuni, the full mechanism of pathogenesis is still
poorly understood. This is largely because there are no suitable animal models.
Several animal models have been tested including mice (Newell and Pearson, 1984),
colostrum deprived piglets (Babakhani et al., 1993) and monkeys (Russell et al.,
1993). A ferret diarrhoeal disease model (Bacon et al., 2001) and a rabbit ileal loop
model (Everest et al., 1993) have been used. However each of these animal models
are expensive and difficult to use. Chick colonisation models (Medema et al., 1992;
Nachamkin et al., 1993) have also been used to test mutants but since C. jejuni is a
gut commensal in chickens, this is not an appropriate disease model. Consequently,
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al., 1997). Birds also act as a reservoir which may account for the isolation of C.
jejuni from sand samples (Broman et al., 2002). The proportion of human disease
attributable to these different sources of infection is unknown. In addition, studies of
risk factors for human disease have consistently failed to identify an explanation for a
large proportion of cases (Rodrigues et al., 2001). Thus effective control strategies to
minimise or eliminate Campylobacter from the food chain are difficult to implement.
1.4.2 Typing Methods
Phenotypic and genotypic methods for differentiating between C. jejuni strains were
developed to aid surveillance and epidemiological studies. Traditionally Penner (heat-
stable) (Penner and Hennessy, 1980) and Lior (heat-labile) serotyping (Lior et al.,
1982) have been used to classify C. jejuni strains. Such analysis was introduced to
facilitate the tracing of routes and sources of C. jejuni infection and the identification
of serotypes associated with post-infection neuropathies has been particularly
noteworthy (Fujimoto et al., 1997; Kuroki et al., 1993).
More recently molecular techniques such as pulsed-field gel electrophoresis (PFGE)
and multi locus sequence typing (MLST) have been used to type strains at a genetic
level. Using PFGE the genome is cut into large fragments by rare cutting enzymes
(Sma! and Kpnl). DNA fragments are separated by coordinated application of pulsed
electric fields from different positions in the electrophoresis cell. Thus, DNA
fragments are orientated and separated according to size within agarose gel matrix.
Profiles are visualised by staining in ethidium bromide. The band profile of isolates
can then be compared and contrasted, with clonal strains identified as those
possessing identical profiles (On et ai, 1998).
MLST is a sequencing based technique that discriminates strains based on variations
in the nucleotide sequences (including single nucleotide polymorphisms or SNPs),
encoding seven housekeeping loci present in C. jejuni. These housekeeping loci were
chosen by screening the C. jejuni genome database
(www.sanger.ac.uklprojects/Cjejuni) for loci encoding enzymes responsible for
intermediary metabolism. Suitable genes were then chosen based on a number of
criteria including chromosomal location (a minimum distance of 70 kb suggests
coinheritance in the same recombination event to be unlikely), suitability for primer
design and sequence diversity (indicated from pilot studies). PCR products are
amplified with primer pairs and amplification products are purified and sequenced.
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Allele profiles are identified, described and then grouped into lineages or clonal
complexes using the program BURST (Dingle et 0/., 2001b). BURST is a heuristic
algorithm available within the program START (Jolley et al.,2001) used to identify
existing sequence types (STs) and automatically assign ST's to their clonal complex.
New ST's that do not belong to a previously identified clonal complex are recognised
by the fact the software does not automatically assign them. MLST has been used to
study the relationship between 814 Campylobacter strains from a variety of sources
(Dingle et al., 2002) indicating that C. jejuni strains are genetically highly diverse
with a weakly clonal population structure (Dingle et al., 2001a; Suerbaum et al.,
2001). These data also indicate that the population of C. jejuni strains exhibit
significant genetic plasticity. An independent study of 184 C. jejuni strains found an
unexpected association between strains isolated from cattle and humans suggesting a
common source of infection (Schouls et 0/.,2003). However, because of the carriage
of strains of multiple types and an extremely high diversity of strains in animals
current typing methods for Campylobacter strains is probably not useful for source
tracing and global epidemiology. Although many methods have been described for
typing C. jejuni, none have been shown to distinguish strains with phenotypic
characteristics associated with pathogenesis and / or different ecological habitats.
Thus the development of typing schemes to monitor human Campylobacter infections
through the identification of foodbome sources and routes of transmission has been
unsuccessful.
1.S Socioeconomic factors
The lID study (Agency, 2000) (Chapter 1.2.1) indicated that Campy/obaeter affects
haIfa million people in England and Wales annually, costing the economy of England
alone an estimated 69.5 million pounds each year. There are several areas where these
costs arise including the use of GP services such as consultations, microbiological
tests and treatment. Furthermore, an average of 6.5 days per annum are taken off
work by the adult working population resulting in lost revenue. Campy/obaeter
disease also results in the inability to conduct normal household duties by carers and
other non-working adults. Although hospital admittance due to Campy/obaeter
disease is rare costs do arise due to days spent in hospital, hospital outpatient and
accident and emergency visits. The estimated economic burden covers just the
primary infection and does not take into consideration the impact of sequelae such as
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GBS, MFS, bacteraemias and PD-IBS that have all been linked with C. jejuni
infection (Allos, 1998; Ang et al., 2001; Blaser, 1995; Thomley et al., 2001).
1.6 The C.jejuni genome
The C. jejuni genome sequence ofNCTCII168, an isolate from a patient with severe
gastroenteritis, was annotated and published in 2000 (Parkhill et al., 2000). The single
circular chromosome, comprising 1654 predicted protein coding sequences (CDSs)
(1,641,481 bp) had a GC content of 30.6% (Figure 1). Surprisingly there were very
few repeat gene sequences, no plasmids and no insertion sequences or phage
associated sequences revealing little about the mechanism of pathogenesis of this
poorly understood pathogen. However, many short homopolymeric tracts were found
in CDSs likely to encode surface structures. Such hypervariable sequences are
thought to contribute toward the high levels of variation in surface structures and may
be involved with survival of the organism in different ecological niches. More
recently, a second C. jejuni genome, strain RM1221, was sequenced (Fouts, 2005).
The single circular genome of this strain was larger than that of NCTC11168, at
1,777,831 bp with 1884 CDSs and a slightly lower GC content of 30.31%. As with
NCTCI1168 no plasmids were found to be associated with the genome but a high
proportion of predicted CDSs contained homopolymeric tracts. The average protein
sequence percentage identity was calculated for all proteins matching the reference
NCTC11168 strain. C. jejuni strains NCTCl1168 and RM1221 had a high level of
protein sequences in common with 1468 proteins averaging 98.41% identity. The
incomplete genomes of three further Carnpylobacter species that rarely cause human
disease, C. coli, C. lari and C. upsaliensis, were also recently published (Fouts, 2005).
C. coli is frequently isolated from pigs but has also been isolated from other animals
including cattle and dogs (Stephens et al, 1998). C. coli is responsible for 8% of
Campylobaeter infections reported to the PHLS each year making it the second most
common Campylobaeter species associated with human gastroenteritis (Tarn et al.,
2003). C. coli showed the highest percentage identity to C. jejuni with 1399 protein
sequences averaging 85.81% identity. C. upsaliensis showed the next highest level of
identity to C. jejuni (1261 protein sequences averaging 74.72% identity). The natural
host of this species is domestic cats and dogs where it may cause diarrhoea, indeed C.
upsaliensis was first isolated from canine faeces. However, this species has been also
associated with clinical disease, including rare outbreaks and septicaemia (Bourke et
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al., 1998). C. lari showed the lowest level of identity to C. jejuni (1251 protein
sequences with an average of 68.91% identity). This phenotypically, genotypically
and ecologically diverse species has been isolated from wild birds, poultry, cattle,
shellfish and water samples (Aarestrup et al., 1997; Endtz et al., 1997; Lastovica and
le Roux, 2000; Skirrow, 1994).
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Figure 1. Diagrammatic atlas of the genome of C. jejuni strain NCTCll168. From the outside, the first
circle (green) shows coding sequences transcribed in a clockwise direction. The next circle (also in
green) shows coding sequences transcribed in an anticlockwise direction. The putative origin of
replication is represented with a small vertical line at the top. Potentially phase variable genes
containing homopolymeric tracts are shown in blue. Genes involved with surface structures transcribed
in a clockwise direction are shown in red, those transcribed in an anticlockwise direction in pale red.
The innermost histogram shows the similarity of each gene to its Helicobacter pylori orthologue,
where the height of the bar and the intensity of colour are proportional to the degree of similarity.
Adapted from Parkhill et ai, 2000.
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1.7 Virulence determinants
The genome sequence ofNCTCll168 revealed distinct genetic loci for three major C.
jejuni surface antigens; the flagella biosynthesis locus and two major surface-located
glycolipids biosynthesised by C. jejuni, LOS and capsular polysaccharide (CPS)
(Figure 2). In addition, outer membrane proteins such as the major outer membrane
protein (MOMP) are important surface antigens allowing exchanges between the
bacterium and the environment (Zhang et aI, 2000).
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Figure 2. Schematic representation of the three major C. jejuni surface antigens, flagellum, LOS and
CPS. Adapted from Karlyshev et aI, 2005 in press.
27
1.7.1 Flagella
Flagella are the locomotory organelles of bacteria and are probably the best-
characterised virulence determinant for C. jejuni. Motility facilitates dispersal, allows
the cell to move towards and away from different environments and facilitates the
penetration of the mucus layer of the intestine. The flagella biosynthesis locus
contains over 50 genes (Figure 3) and it is therefore costly (in terms of energy) for the
cell to both synthesise components of the flagellum, and to subsequently propel the
bacterium. Consequently, flagella biosynthesis must be under tight control to prevent
the expenditure of wasted energy by the cell. In E. coli and S. typhimurium a
regulatory cascade determines the order in which flagella biosynthesis genes are
expressed (Aizawa, 1996; Harshey and Toguchi, 1996, Chilcott and Hughes, 2000).
Motility genes are organised into operons located in four regions of the genome. The
master operon comprises regulatory genes jlhC and jlhD that are controlled by global
cellular signals (cAMP, phosphorylated OmpR and heat shock proteins). The products
of jlhC and jlhD act as a signal for the cell to begin transcription of the second level
of flagellar genes, encoding the basal body and hook components. Two regulators are
synthesised at this point that act antagonistically; FliA encoding o", an alternative
sigma factor, and anti-sigma factor FlgM. FliA turns on the third and final set of
flagellar genes, but is rendered inactive by FlgM until the stage in flagellar assembly
where the final flagellum components are required (Harshey and Toguchi, 1996).
Upon completion of the hook and basal body structure, FlgM is exported through the
structure out of the cell, relieving inhibition of 028 thus genes required for late
flagellar assembly stages are expressed (Chilcott and Hughes, 2000). Some hierarchy
of flagellar gene expression has been observed in C. jejuni. Based on gene
homologies with NCTCII168, C. jejuni lacks the master operon genesjlhC andjlhD
and possesses three sigma factors, 070 (encoded by rpoD),d8 (encoded by jliA) and
d4 (encoded by rpoN) (Parkhill et al., 2000). Early flagellar genesjlgS,jlgR, RpoN
and FliA are regulated by 070 (Wosten et al, 2004). Insertional inactivation of jliA
encoding alternative sigma factor cJ28 resulted in truncated flagella whereas insertional
inactivation of rpoN encoding OS4 resulted in the complete absence of flagella
(Jagannathan et al., 2001). A C. jejuni homologue of FlgR found in H pylori, part of
the NtrC transcriptional activator family associated with d4 promoters, was also
insertionally inactivated and these mutants also lacked flagella (Jagannathan et al.,
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2001). Furthermore, despite the absence of anti sigma factor flgM based on gene
homologies with NCTC 11168, a flgM homologue identified in H pylori has since
been identified in C. jejuni (Colland et al, 2000; Hendrixson and DiRita 2003). The
flagellar filament in C. jejuni comprises flagellins FlaA and FlaB. Although adjacent
to one another flaA and flaB genes are under the control of different promoters (ds
and 054 promoters respectively) (Wassenaar et al., 1994). The complete lack of
flagella in rpoN andflgR mutants indicates thatjlaA, although under control of ads
promoter, is no longer transcribed. However, in H pylori, FlgR represses flaA
transcription and deletion of jlgR results in the upregulation of jlaA (Spohn and
Scarlato, 1999). In C. coli, inactivation of flhA, a member of the LcrDIFlbF family
whose members are all integral cytoplasmic membrane proteins involved with the
regulation of surface proteins results in a failure by the cell to synthesis flagellin
(Doig et al., 1996b; Miller et al., 1993). Inactivation ofjlhA can occur naturally via
slipped strand mispairing of a short poly T tract in the flhA gene leading to high
frequency phase variation of gene expression (Park et al., 2000). However, based on
gene homologies with NCTCll168, the jlhA gene in C. jejuni does not contain the
homopolymeric tract present in C. coli thus flagellin gene expression in C. jejuni is
not controlled by phase variation of flhA (Park et al., 2000). C. jejuni, therefore,
appears to have a different mechanism controlling the expression of flagellar
components to both the well-characterised mechanisms in place in S. typhimurium
and to its close relatives, C. coli and H pylori. A two-component signal transduction
system, FlgSlFlgR, is at the top of the hierarchy regulating the jla regulon in C. jejuni.
RpoN-dependent genes encoding the flagellar hook-basal body filament complex are
activated via the phosphorylation of FlgR (Wosten et al, 2004).
In C. jejuni, the construction of the flagellum begins with the basal body, containing
the flagellar motor and switch. This anchors the flagellum to the cell and is embedded
into the inner and outer membranes. The hook (encoded by jlgE) is then constructed
which acts as an axial coupling structure (Kinsella et al., 1997). Transcription ofjlgE
is under the control of d4 promoter activity (Luneberg, Glenn-calvo et al, 1998).
Finally, once the other components are in place, the filament is constructed. In C.
jejuni flagellin is encoded by jlaA and jlaB, genes that are 95% identical at the
nucleotide level (Nuijten et al., 1990). Flagella filaments are composed predominantly
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of the FlaA flagellin interspersed with the variable FlaB flagellin (Guerry et al.,
1991).
Rotation of the flagellum is driven by the motor in the cell envelope, mediated
through the flagella hook. A two component regulatory system, CheA and CheY,
regulates chemotaxis in response to attractant and repellent gradients. Phospho-Che Y
interacts with the flagellar motor to control swimming behaviour (Yao et al., 1997).
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Figure 3. Schematic representation of the flagellar locus including the O-linked glycosylation locus in
C. jejuni strains NCTC11168, 81-176 and C. coli strain VC 167. Adapted from (Szymanski et al., 2003)
Post-translational modification of flagella through O-linked glycosylation has been
identified in C. jejuni and C. coli (Doig et al., 1996b). Pseudaminic acid (Figure 4) is
O-linked to as many as 19 serine and threonine residues in the central, hydrophilic,
surface exposed region of the flagellin protein of C. jejuni strain 81 176 (Logan et al.,
2002; Thibault et al., 2001). Flagellin proteins are the only known O-linked
glycosylated molecules in C. jejuni and although biological significance for this
extensive modification is unknown, the modification appears to be important for
flagella assembly, as mutations in some genes involved in pseudaminic acid
biosynthesis (e.g. cj1293,pseB) may result in non-motile and aflagellate cells (Linton
et al., 2000). The intracellular accumulation of unmodified flagella subunits in these
mutants (Logan et al., 2002), suggests that glycosylation may be required for the
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recognition by flagella secretion/assembly apparatus (Thibault et al., 2001). However,
these studies were performed in 81-176 that has a truncated glycosylation locus
compared to the sequenced strain NCTClll68 (see Figure 3).
The flagellum is a highly antigenic target. Recognition of the flagellin monomers by
host cell receptors triggers proinflammatory and adaptive immune responses in
enteric pathogens such as S. typhimurium and E. coli (Berin et a!., 2002; Eaves-Pyles
et al., 2001). Variation in cell-surface exposed glycan structure may assist in bacterial
evasion of host immune response. Several genes in the flagella glycosylation locus
contain homopolymeric nucleotide tracts making them prone to slipped strand
mispairing and subsequent phase variation (Parkhill et al, 2000). There are two
paralogous groups of genes, rna! (cj 1318-like) families, located in the flagella
glycosylation locus and cj0617/0618 both of which contain polyG tracts. Although
the exact function of these genes is unknown, the rna! genes were found to be
involved in reversible expression of flagella (Karlyshev et al., 2002b). Phase variable
expression of flagellin, the ability to switch motility, as well as the potential to vary
the structure of the highly immunogenic glycan moieties on the flagella subunits may
be essential for bacterial adaptation to changing environmental conditions.
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Figure 4. Diagrammatic structure of pseudaminic acid found O-Iinked to serine and threonine residues
on C. jejuni flagellin. Adapted from Karlyshev et ai, 2005.
1.7.2 Lipooligosaccbaride
Lipopolysaccharide (LPS) is the predominant glycolipid found in the cell wall of
Gram-negative bacteria. This predominant microbial antigen is a major bacterial
virulence factor, exhibiting endotoxic properties as well as roles in adhesion and
antigenic variation. In Enterobacteriacae, LPS comprises three distinct regions;
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anchored in the outer membrane is the endotoxic lipid A moiety. Linked to the lipid A
moiety through 2-keto-3-deoxyoctulosonic acid (KDO) is a core consisting of an
inner and outer region. Finally, attached to the outer core is a long chain of covalently
linked oligosaccharides. In C. jejuni, the major glycolipid molecule in the cell wall is
lipooligosaccharide (LOS) the structure of which is analogous to LPS but with a
truncated oligosaccharide chain, limited to only 10 saccharide units (Preston et al.,
1996) (Figure 5). LOS, like LPS exhibits endotoxic and adhesive properties
(McSweegan and Walker, 1986; Naess and Hofstad, 1984). The genetic locus
responsible for the biosynthesis of LOS in C. jejuni has been identified, cj1120 to
cj1152. A gene cluster involved with a general N-linked protein glycosylation system
in C. jejuni directly flanks the LOS biosynthesis locus at the 5' end (Figure 6). These
genes were originally thought to be associated with LOS biosynthesis. However,
mutagenesis in genes from this locus in C. jejuni strain 81-176 resulted in no change
to LOS but altered the reactivity of multiple C. jejuni proteins to human and rabbit
sera (Szymanski et al., 1999; Szymanski et al., 2002). The metabolic pathways and
enzymes required to synthesise the antigen are not fully characterised. However
cj1131(galE) has been shown to have an essential role in LOS biosynthesis, encoding
UDP-galactose-4-epimerase. The product of galE catalyses the interconversion of
UDP-galactose and UDP-glucose and UDP-galactose is used in the synthesis of LOS.
Insertional inactivation of GalE resulted in a lipid A core molecule that did not react
with antiserum raised against the parental strain (Bernatchez et al., 2005; Fry et aI.,
2000a). Antigenic variation of LOS in C. jejuni has been documented for many years
(Mills et aI., 1992). Gilbert and colleagues have defined three classes, A, Band C, of
LOS biosynthesis loci based on the organisation of genes in eleven different C. jejuni
strains for which the LOS biosynthesis locus was sequenced. Class B appears to be an
evolutionary intermediary between classes A and C (Gilbert et al., 2002). The
sequencing of this locus has revealed further genetic mechanisms for LOS variation
including different gene complements, gene inactivation by deletion or insertion, a
single mutation leading to inactivation of a glycosyltransferase and single or multiple
mutations leading to allelic glycosyltransferases with different acceptor specificities
(Gilbert et al., 2002). Furthermore, the genome sequence ofNCTCll168 revealed a
mechanism for phase variation due to homopolymeric tracts in genes in the LOS
biosynthesis locus (Parkhill et al., 2000). Cell surface structures such as LOS are
recognised as antigens by the host and lipid A is responsible for many host immune
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responses such as platelet aggregation and cytokine activation (Preston et al., 1996). It
is therefore advantageous to the microbe to modulate its surface coat in order to evade
the host immune system (Gilbert et al., 2002).
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Figure 5. The complete LOS core structure of NCTCI 1168. Structures analogous to gangliosides GM1
and GM2 are shown in brackets. KDO, 2-keto-3-deoxyoctulosonic acid, Hep, L-glycero-D-
mannoheptose, Glc, glucose, Gal, galactose, Neu5Ac, N-acetylneuraminic acid, GaINAc, N-acetyl-D-
galactosamine. (from Karlyshev et ai, 2005)
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Figure 6. Schematic of the LOS biosynthesis locus and flanking genes associated with N-Iinked
protein glycosylation in NCTCll168. The ORF names are written above the arrows denoting the
direction of transcription. ORFs containing homopolymeric tracts are indicated with black arrows
(from Karlyshev et ai, 2005).
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1.7.3 Capsule
Another surface structure important in C. jejuni virulence and survival is capsular
polysaccharide. It was thought that all C. jejuni strains produced LOS with a third
producing high molecular weight (HMW) glycan structure, known as O-antigen.
However, work by Karlyshev and colleagues have shown that all strains possess the
HMW glycan that is distinct from LOS and similar to group II and III capsule
(Karlyshev et al., 2000). Genomic sequencing of strain NCTC11168 revealed a
cluster of genes encoding proteins with a significant degree of similarity to proteins
involved with the transport of type 111111capsules in other bacteria (Parkhill et al.,
2000) (Figure 7). The arrangement of these kps-like genes resembled the E. coli
paradigm; conserved kps-like genes associated with transport of the molecule flank a
central, variable 34 kb region, involved in the biosynthesis of diverse polysaccharide
structures (Karlyshev et al., 2000). Site-specific insertional mutagenesis of kpsM,
kpsS or kpsC in several strains resulted in the loss of a HMW glycan. Karlyshev and
colleagues went on to use electron microscopy (EM) to demonstrate that C. jejuni
produces a polysaccharide capsule that surrounds the cell surface (Karlyshev et al.,
2001; Karlyshev and Wren, 2001). CPS plays an important role in bacterial survival
in the environment and often contributes to pathogenesis (Roberts, 1996). Bacon et al
report an increase in mass and abundance of capsule in pathogenic strain 81-176
compared to other less invasive strains. Furthermore, a kpsM mutant demonstrated a
reduction in adhesion and invasion in INT407 intestinal epithelial cells and reduced
virulence in the ferret diarrhoea model. This implicates the HMW glycan structure
(capsule) as a virulence factor (Bacon et al., 2001). CPSs and exopolysaccharides
may also be involved in biofilm formation and in protecting bacteria from the effects
of desiccation and other unfavourable factors, such as heat and changes in pH (Mao et
al.,2001).
As with LOS, CPS is highly variable. Diversity in capsular polysaccharide between C.
jejuni strains occurs by multiple mechanisms including exchange of capsular genes
and gene clusters by horizontal transfer, gene duplication, deletion, fusion and
contingency gene variation (Karlyshev et al., 2005). Furthermore, kpsM, kpsS and
several genes in the central biosynthetic region are likely to be phase variable as they
possess intragenic homopolymeric tracts (Parkhill et al., 2000). C. jejuni virulence
determinants that have been identified to date are summarised in Table 1.
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11168
Figure 7. CPS biosynthesis loci in five C. jejuni strains, NCTC11168, HS:19, G1, 81-176 and HS:41.
Polysaccharide transport or assembly genes are coloured red. Sugar transferases are shown in blue,
genes associated with heptose biosynthesis are shown in pink. Other sugar biosynthesis related genes
are shown in green. Genes with no obvious link to sugar biosynthesis are coloured yellow and genes
with no similarity or similarity to hypothetical genes are shown in brown (Karlyshev et al., 2005)
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Table 1. Summary of putative virulence factors identified in C. jejuni
Putative virulence factor Associated CDS Reference
Capsular polysaccharide cj1410to cj1449 (Karlyshev et al., 2000)
Lipooligosaccharide cj1120 to cj1152 (Preston and Penner,
1987)
Flagella and O-linked cj1293 to cj1342 (Newell et al., 1984)
glycosylation (Thibault et al., 2001)
Cytolethal distending toxin cj0077, cj0078, cj0079 (Eyigor et al., 1999)
Putative virulence plasmid pVir (Bacon et al., 2000)
encoding type IV secretion
system
Adhesion to fibronectin cadF (Konkel et al., 1997)
Adhesion to INT 407 cells galE (Fry et al., 2000 )
Adhesion to Hep-2 cells j/pA (Jin et al., 2001)
1.8 DNA micro array technology
The availability of the genome sequence for the C. jejuni strain NCTCll168 (Parkhill
et aI., 2000) paved the way for the construction of C. jejuni DNA microarrays to
investigate the relative genome content of different strains. Whole genome
microarrays have the potential to demonstrate the link between genetic characteristics
and the ability of a strain to inhabit a preferred ecological niche and lor its ability to
cause disease. DNA microarrays have been used to compare the genome content of
several bacterial pathogens. The application of microarrays for comparative genomics
ranges from bacterial pathogens exhibiting wide diversity, genome plasticity to the
pathological outcome of infections. This technique, allied with the increasing
availability of genome sequence data, is set to revolutionise our ability to distinguish
bacteria. DNA microarray analyses have revealed a vast genetic diversity both
between genera and within species. Deciphering the mechanisms behind this
variability will help us to understand the phylogeny, physiology, ecology and
evolution of bacteria. Comparing the genomes of pathogens and non-pathogens
within a species can be particularly useful for identifying determinants that are
important in virulence, transmission and host specificity.
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1.8.1 DNA microarray terminology
In molecular biology terms a "probe" has traditionally been used to describe the
labelled sample in solution that hybridises to a bound target. However the term
"probe" with respect to microarray experiments has often been used not to describe
the labelled sample hybridised to the array, but the element attached to the array. This
confusion highlighted the need for a standard terminology that has been implemented
through development of MAGE-ML (MicroArray Gene Expression Markup
Language; http://www.mged.org). MAGE-ML avoids the use of the term "probe"
altogether through the use of the term "reporter" to refer to the elements bound to the
microarray surface and "sample" as the labelled nucleic acid in the hybridisation
solution that is derived from the DNA or RNA preparation. The "core genes" or
"minimal gene set" of a species refers to the number of genes that are present in the
genome of each strain hybridised with the micro array . These core genes are necessary
to maintain the living cell and are involved with metabolic, biosynthetic, cellular and
regulatory processes. As more strains are hybridised so a clearer picture is gained as
those genes that are absent or variable from strains exhibiting particular traits can be
eliminated from the core genes (Koonin 2003). Conversely, the "variable genes" or
"accessory genes" of a species comprise those genes identified as absent or divergent
in one or more of the strains hybridised with the microarray. Variable genes are
therefore not required for survival of the species but may correlate with specific
phenotypic traits. The term "flagged genes" refers to those reporter elements on the
microarray that did not produce data of sufficient quality to analyse. This may be due
to problems with the actual reporter element printed on the microarray e.g. a reporter
element printed on the microarray from small PCR product that produced only a weak
band may yield hybridisation data with low signal intensities. Alternatively flagged
genes may arise due poor experimental technique such as insufficient or slow washing
and rinsing of the microarray slides.
Membrane arrays are usually referred to as "macroarrays" due to the larger format
used and the low density of reporter elements on the array. Reporter elements printed
on nylon membranes have included both unknown sequences derived from cDNA
libraries and sequence defined peR products. The labelled samples are hybridised to
the reporter elements on the membranes using protocols similar to Southern blots. For
comparison between different samples, the hybridisation signals from one membrane
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must be compared to signals from another membrane, which can lead to problems
with normalising the different signal intensities from membranes hybridised at
different times.
Glass slide arrays are referred to as "microarrays" as the spot density of the reporter
elements is much higher (> 20 fold) than can be achieved using macroarrays. A
complete genome sequence enables the design of whole genome arrays, whereby at
least one reporter element is produced for every gene in the genome, but may also
include intergenic regions, any other additional genomic features or genes from other
organisms. The reporter elements are first synthesised, with double-stranded DNA
reporter elements often in the form of PCR products, generated from gene-specific
PCR or amplified clone inserts of DNA/cDNA libraries, or oligonucleotides. These
reporter elements are then spotted onto specially coated glass microscope slides
(Hinds, 2002). Direct comparison of two samples (both test and reference conditions)
can be achieved on a single array. Competitive hybridisation is one of the major
advantages of microarray-based experiments. The differences in signal intensity
produced by hybridisation of the two labels can be detected using a dual laser
confocal scanner. Another benefit of the microarray approach is the flexibility that
allows the arrays to be easily customised to suit particular applications.
Oligonucleotide arrays do not rely on PCR amplification of a gene but utilise
oligonucleotides as reporter elements. The target DNA sequence must be known to
facilitate oligonucleotide synthesis, which occurs in situ, on glass or silicon wafers
using combinational chemistry and photolithography (Pease et al., 1994).
Oligonucleotide arrays have several advantages over more traditional PCR products;
tens of thousands of reporter elements comprising custom designed 20-70 mers
promises increased specificity whilst maintaining the sensitivity of PCR products and
allowing better discrimination between gene families and overlapping genes.
Oligonucleotide reporter elements are more uniform in quality than PCR products,
However, cross-hybridisation between homologous DNA sequences is still a problem
when analysing array data using double-stranded DNA reporter elements, particularly
when performing gene expression studies. Microarrays printed with PCR products
may not allow detection of differential expression patterns for highly homologous or
overlapping genes. In addition, the PCR amplification process involved in generating
the individual reporter elements is labour intensive and expensive, and can have a
38
high failure rate (typically 5-10%). However, oligonucleotide arrays are often more
expensive to produce than PCR based arrays.
Oligonucleotide arrays are available from a number of companies including
Affymetrix and Qiagen. The GeneChip@ E. coli Genome Array was the first
Affymetrix microarray product for a prokaryotic organism. Campylobacter oligo
arrays are also commercially available. For example, one manufactured by MWG
Biotech in association with Affymetrix (www.mwg-biotech.com) and another by
Qiagen (www.qiagen.com).
1.8.2 Selected examples of the application of microarrays for comparative
genomics
DNA microarrays have been used to investigate bacterial pathogens exhibiting wide
diversity, genome plasticity, differences in pathological outcome of infections and to
study genomes of related species. Dobrindt et al 2001 proposed that bacterial
genomes consist of a core of genetic material that are conserved in most strains, a
minimal gene set shared by the vast majority of bacteria and a flexible pool of strain
specific genes allowing the organism to adapt to its environment (Table 2). These
principals are borne out in whole genome comparative microarray studies on Yersinia
pestis (Zhou et al., 2004). Forty-three Y. pestis strains of biovars antiqua, orientalis,
mediaevalis and microtus were selected to represent the diversity associated with the
adaptive evolution of plague. These strains were hybridised with Y. pestis microarray
containing 4005 ORFs from Y. pestis strains C092 and those unique to strain 91001.
Microarray data in this study indicates that the acquisition of genomic islands and
plasmids in Y.pestis induced the organism's rapid evolution from its close relative, Y.
pseudotuberculosis. DNA microarrays have also been used to study the evolutionary
genomics of22 strains of Yersinia pestis and 10 strains of Y. pseudotuberculosis. The
loss of eleven DNA loci in Y. pseudotuberculosis is thought to have led to the rapid
emergence of the life threatening Y.pestis species (Hinchliffe et al., 2003). This rapid
evolution is believed to have occurred only 1,500 to 20,000 years ago (Achtman et
al., 1999). Horizontal gene transfer is also responsible for the diversity between and
segregation of the distinct Y. pestis biovars. However, genome reduction was also
important in the parallel micro evolution of Y. pestis leading to distinct Y. pestis
biovars. Biovar Orientalis, associated with modern plague, was responsible for the
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mid 19th century plague pandemic that originated in China and continued to spread
globally affecting over 60 countries. Microarray data from this study suggests that
biovar Orientalis arose from biovar Antiqua, associated with the Justinian plague
through the acquisition of a genomic region (DFRI3). The authors propose that Y.
pestis may evolve through genome reduction into a unique ecological niche (natural
environment, reservoirs and vectons) causing the progeny to inhabit a host niche that
does not overlap with its progenitor (Zhou et al., 2004).
Whole genome micro array experiments have been applied to assess the genome
plasticity of the laboratory Mycobacterium tuberculosis strain H37Rv with the closely
related species Mycobacterium bovis and passage derivatives of M bovis BCG
vaccine strain (Behr et al., 1999). The original BCG vaccine strain was passaged in
vitro at least 230 times resulting in a strain that maintained immunogenicity but had
reduced virulence. Since then, this strain has continued to be passaged resulting in a
collection of daughter strains with different phenotypes. The genomic composition of
M bovis, M tuberculosis and the BCG daughter strains were compared in order to
explain why BCG efficacy varies in human trials. The differences observed indicate
that since original derivation, the BCG strains have evolved which may have resulted
in loss of protective efficacy. Compared to M tuberculosis 11 regions of 91 ORFs
were deleted from one or more pathogenic M bovis strains. For the attenuated BCG
vaccine strains, an additional five regions of 38 ORFs had been lost. Transcriptional
regulators were proportionally the most common class of genes lost from BCG
strains. These results demonstrate that microarray analysis can be used to reconstruct
the genealogy of related strains at the genome level.
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Table 2. Examples of the application of DNA microarrays for comparative
genomics of pathogenic bacteria
Arrayed strain Number of samples % variability of Reference
genome
Escherichia coli 4 10 (Ochman and Jones,
K12 MG1655 2000)
Mycobacterium 19 0.3 (Kato-Maeda et al.,
tuberculosis H37Rv 2001)
Mycobacterium 13 N/a (Behr et al., 1999)
tuberculosis H37Rv
Helicobacter pylori 42 3 (Israel et al., 2001)
J99
Helicobacter pylori 15 22 (Salama et al.,
J99 & NCTC 26695 2000)
Campylobacter 11 21 (Dorrell et al., 2001)
jejuni NCTC11168
Campylobacter 18 16 (Pearson et al.,
jejuni NCTC11168 2003)
Campylobacter 51 36 (Taboada et al.,
jejuni NCTC11168 2004)
Staphylococcus 36 22 (Fitzgerald et al.,
aureus COL 2001)
El Tor 01 Vibrio 9 1 (Dziejman et al.,
cholerae N 16961 2002)
Yersinia pestis and 22 Y. pestis 4 (Y. pestis) 16 (Y. (Hinchliffe et al.,
Yersinia 10 Y. pseudotuberculosis) 2003)
pseudotuberculosis pseudotuberculosis
Yersinia pestis 46 Y. pestis N/a (Zhou et al., 2004)
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It has been hypothesised that the V. cholerae strains associated with the current
seventh cholera pandemic have acquired genes that may have facilitated the
displacement of the pre-existing classical Vibrio cholerae strains (Dziejman et al.,
2002). The first six recorded cholera pandemics occurred between 1817 and 1923 and
were caused by the classical biotype of V cholerae. However in 1961 the El Tor
biotype emerged to cause the seventh cholera pandemic and resulted in the eventual
global replacement of the classical biotype strains as a cause of disease. A V cholerae
microarray based on the El Tor 01 strain N16961, was used to analyse a collection of
nine strains of diverse global origin isolated between 1910 and 1992 to investigate
this hypothesis. It was possible to differentiate classical biotype strains from El Tor
biotype strains and two putative chromosomal islands (VSP-I and VSP-II) with a
deviant G+C content were identified in El Tor biotypes. Genes associated with the
VSP-l and VSP-II islands may encode key properties that led to the global success of
the El Tor biotype and studies are in progress to determine their potential role both in
human infection and in promoting the fitness of V cholerae in environmental
ecosystems.
Similarly, the pathological outcome of Neisseria species infections has been
investigated using microarrays (Perrin et al., 2002). Neisseria meningitis (a causative
agent of meningitis) is very closely related to N. gonorrhoeae (the causative agent of
gonorrhoea) and N. lactamica, (a harmless commensal of the nasopharynx), yet their
disease profiles are very different. This study revealed a series of relatively small
sequences scattered throughout the genome which were either specific to N.
meningitis or shared with N. gonorrhoeae, but absent from N. lactamica. This study
confirmed that the capsule biosynthesis loci and the RTX toxin family were
meningococcal specific.
Microarray analysis can allow the rapid identification of genes in the genome of an
unsequenced bacterium using a microarray that has been constructed for a closely
related species. A microarray was constructed consisting of 96 putative virulence
factor genes from an orally toxic Photorhabdus luminescens strain W14 (Marokhazi
et al., 2003). Photorhabdus species are found in the guts of nematodes that invade
insects. Some strains are orally toxic and kill the insect host, whilst other strains are
non-toxic. The aim of this study was to identify the minimal subset of toxin complex
(tc) genes required for oral toxicity by hybridising genomic DNA from both orally
toxic and non-toxic strains to this array. A striking split was found in the distribution
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of tc genes between orally toxic and non-toxic strains. Orally toxic strains were found
to carry all three genes in the tea operon (tcaABC), whereas those lacking oral toxicity
lack tcaA and tcaB. This study clearly demonstrates that even a very limited
microarray can be an extremely useful tool for correlating phenotype and genotype,
with particular reference to virulence.
The above are only a small sample of recent microarray-based comparative genomic
studies of different bacterial species that were selected to highlight the range of
applications for comparative genomic studies that can be undertaken using
microarrays.
1.8.3 C. jejuni comparative genomics studies
An initial comparative genomics study of 11 human C. jejuni isolates using a C. jejuni
clone array revealed extensive genetic diversity between these C. jejuni strains
(Dorrell et aI., 2001). Many of the strain-variable genes are associated with the
biosynthesis of surface structures, including flagella, lipo-oligosaccharide and
capsule. This suggests that variation of these determinants may be important in
survival, transmission and pathogenesis, indicating that selective pressures have
driven profound evolutionary changes to create a diverse Campylobacter species.
Comparison of the capsule biosynthesis locus reveals conservation of all the genes in
this region in strains with the same Penner serotype as strain NCTC11168. By
contrast, between five and seventeen of the NCTC11168 genes in this region are
either absent or highly divergent in strains of a different serotype to the sequenced
strain, providing further evidence that the capsule accounts for Penner serotype
specificity (Dorrell et al., 2001). In all at least 21% of the genes present in the
sequenced strain appear dispensable, as they are absent or highly divergent in one or
more of the isolates tested, defining 1300 out of 1654 predicted CDSs as C. jejuni
species-specific. These genes mainly encode housekeeping functions such as
metabolic, biosynthetic, cellular and regulatory processes. However, many virulence
determinants are also conserved, indicating that they are indispensable for C. jejuni to
cause disease in humans. These include the cytolethal distending toxin, the flagellar
structural proteins, the PEB antigenic surface proteins and the general protein
glycosylation locus (Dorrell et al., 2001).
Four more C. jejuni comparative genomics studies have been published since this
original study and the commencement of this thesis using gene specific DNA
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microarrays. A comparison of random amplified polymorphic DNA (RAPD) and
Penner serotyping with DNA microarray analyses of clinical isolates associated with
five independent clusters of infection indicated that DNA microarrays provide a
highly specific epidemiological typing tool for analysis of C. jejuni isolates (Leonard
et al., 2003). In another study the genomic diversity of 18 C. jejuni strains from
diverse sources was investigated (Pearson et al., 2003). Seven hypervariable plasticity
regions (PR) were identified in the genome (PRI to PR7). PRI contains genes
important in the utilisation of alternative electron acceptors for respiration and may
confer a selective advantage to strains in restricted oxygen environments. PR2, 3 and
7 contain many outer membrane and periplasmic proteins and hypothetical proteins of
unknown function that might be linked to phenotypic variation and adaptation to
different ecological niches. PR4, 5 and 6 contain genes involved in the production and
modification of antigenic surface structures including the flagellin glycosylation
locus. In this study algorithms were used that selected a dynamic boundary between
the conserved and variable genes similar to the Genomotyping Analysis Charlie Kim
(GACK) algorithm (Kim et al., 2002). More recently genomic comparisons of 51
strains isolated from food and clinical sources have been integrated with data from
three previous C. jejuni DNA microarray studies to perform a meta-analysis that
included 97 strains from the four separate data sets (Taboada et al., 2004). In this
study a large proportion of the variable genes were found to be absent or divergent in
single strains only and these uniquely variable genes could be mapped to previously
defined variable loci. Thus the authors propose large regions of the C. jejuni genome
are genetically stable. Of the highly divergent genes that were identified 117 of 122
genes had divergent neighbours and showed high levels of intraspecies variability
(Taboada et al., 2004).
Microarrays have been used to investigate genetic markers capable of differentiating
strains that cause GBS from those that cause uncomplicated enteritis. Significant
genomic heterogeneity among the isolates was revealed but no specific GBS genes or
regions were identified (Leonard et al., 2004). DNA microarrays have also been
developed to identify C. jejuni directly from faecal cloacal swabs (Keramas et al.,
2003) in an effort to comply with consumer demands for food safety. Universal
bacterial sequences and specific Campylobacter sequences were amplified using
multiplex-PCR. This DNA-micro array facilitated the detection of two closely related
Campylobacter species, C. jejuni and C. coli directly from chicken faeces. A non-
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NCTC 11168 microarray based on C. jejuni strain ATCC 43431 has also been
developed. A shotgun DNA microarray to identify genes specific to this ATCC 43431
was constructed by spotting 9,000 DNA fragments from a C. jejuni ATCC43431
genomic library onto glass slides and hybridising with strain NCTCII168 (Poly et al.,
2004). Gene fragments unique to strain ATCC 43431 were sequenced and putative
functions were assigned. However, none of the aforementioned studies investigated
strains from diverse disease outcome or different ecological niches. Furthermore the
sample size used in these studies and from studies on other bacteria (see table 2) was
relatively small and the phylogenetic relationships of the strains were not thoroughly
examined.
1.9 Phylogenomics
Phylogenomics constitutes the inferral of phylogenies using comparative genomic
data from DNA micorarray comparisons or by comparing genome sequences. Such
'whole genome' trees allow evolutionary analysis to be introduced to comparative
genomics studies. This method facilitates the identification of clonal populations with
similar phenotypic traits. Moreover, genomic similarities and differences of
phylogenetically related strains may provide genetic markers specific to strains from
common ecological niches or strains causing a particular disease outcome. Such
genetic markers may then be further investigated for their biological significance.
Many molecular phylogenetic trees utilise highly conserved and ubiquitous genes
such as rRNA that may be amplified and sequenced to infer phylogenies. However,
rRNAs are not representative of the microbial genome demonstrated by the
discrepancy between phylogenies constructed from protein encoding gene sequences
and those from rRNA sequences. The noise and bias of single gene analysis may be
reduced through the inferral of phylogeny based on whole genome comparisons
(Charlebois et al., 2003). However, such analyses have only been possible due to the
completion of genome sequences and the development of high-density microarrays.
Current genotyping techniques infer relationships of strains based on a single gene or
several gene sequences. Consequently relationships based on genes other than those
used for the typing method may be missed.
The initial aim of this project was to develop an improved C. jejuni molecular typing
system based on genetic markers identified through DNA micro array studies to
further the understanding of C. jejuni epidemiology. The CPS locus was identified as
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the genetic basis for Penner serotyping (Karlyshev et al., 2000) and DNA microarray
studies confimed the correlation between variation in Penner serotype and variation in
CPS biosynthesis genes (Dorrell et al., 2001). Subsequently, the CPS locus was
selected for further investigation to identify potential genetic markers on which to
base a molecular epidemiological typing system. We sequenced the full CPS locus of
five C. jejuni strains representing five different serotypes (HS1, HS19, HS41, HS23
and HS23/36). Structural analyses of the CPS was also performed revealing a good
correlation between gene sequence and structure (Karlyshev et al., 2005) (Appendix
7).
Although the detailed genetic study of CPS identified potential genetic markers, we
reasoned that clonal populations with common phenotypes would be identified using
a comparative phylogenomics approach, through the combination of micro array
hybridisation data and robust phylogenetic algorithms. When performed on a
relatively large and diverse defined C. jejuni strain collection, such analyses may
provide novel information on genes relating to ecological niche or disease severity,
highlighting more pertinent genetic markers on which to base a molecular
epidemiological typing system. Therefore, in this study, strains from the United
Kingdom, isolated from a range of ecological niches and clinical outcomes of
infection, were selected for detailed comparative phylogenomic analyses.
1.10 Aims of this study
Although several comparative genomics studies of C. jejuni have been published, to
date none have used phylogenomic analyses to investigate the mechanism of
pathogenesis of C. jejuni. Furthermore, this method has not been used to identify
genetic differences in strains isolated from different ecological niches and thus
different sources of human infection. Therefore, the aims of this study were;
•
To use the gene specific, composite C. jejuni DNA micorarray to compare
different methods of analysis to ascertain the optimal method for assessing
absent or divergent genes.
To identify potentially non-pathogenic C. jejuni strains that may be used for
whole genome comparisons through DNA micro array hybridisations to
facilitate the identification of putative virulence determinants.
•
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• To undertake whole genome comparisons on strains from a range of clinical
outcomes to identify potential genetic markers characteristic of disease
outcome.
To develop a phylogenomics method to model C. jejuni phylogeny and allow
the identification of clade specific genetic markers that may be widely
applicable for studying other bacterial pathogens.
To apply comparative phylogenomics to investigate C. jejuni strains from a
range of hosts and environmental sources facilitating the identification of
clones associated with different hosts.
To identify genetic markers that may be informative for epidemiological
studies.
•
•
•
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2.0 Materials and Methods
2.1 Microbiology
2.1.1 Bacterial growth conditions
Campylobacter jejuni strains (Appendix 1) were streaked on Columbia blood agar
plates (Fluka Biochemika, Steinheim, Switzerland), containing 5% (v/v) horse blood
in a Variable Atmosphere Incubator (Don Whitley Scientific, Shipley, UK) for 48
hours. A microaerobic atmosphere of O2 5%, N2 85%, C02 10% was maintained at
3TC.
2.1.2 Storage of C.jejuni strains
Strains were stored in 50% Mueller Hinton (MH) Broth (Oxoid, Basingstoke, UK)
and 50% glycerol at -80·C.
2.1.3 Motility plates
Motility of C. jejuni strains was tested on 0.4% bacto™ agar plates (Scientific
Laboratory Supplies Ltd., Nottingham, UK) in MH broth. Plates were inoculated at
their centre, 2 mm beneath the agar surface, inverted and incubated for 48 hours in a
Variable Atmosphere Incubator in a microaerobic atmosphere of O2 5%, N2 85%,
CO2 10% at 37·C.
2.2 Molecular Microbiology
2.2.1 Isolation of genomic DNA
DNA isolations were performed using a Wizard genomic DNA purification kit
(Promega Ltd, Madison, USA). Briefly, 48 hour plate cultures of C. jejuni grown on
Columbia blood agar plates were suspended in 300 III of distilled water. 900 III of
Cell Lysis Solution were added and mixed by inversion five times. The cells were
incubated at room temperature for 10 minutes. Samples were then spun for 20
seconds at 10,000 g and the supernatant decanted leaving approximately 20 III for the
resuspension of the cells. The cells were resuspended by brief vortexing and 300 IIIof
Nuclei Lysis Solution was then added, mixed by pipetting five times, and incubated at
37°C for an hour. 1.5 III of RNase Solution was added, mixed by inversion 25 times
and incubated at 37°C for 15 minutes. The suspension was allowed to cool to room
temperature before 100 III of Protein Precipitation Solution was added. After
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vortexing for 20 seconds the suspension was spun at 10,000 x g for 10 minutes. The
clear supernatant was then decanted into 300 ul of absolute isopropanol and mixed
thoroughly. Following overnight incubation at - 20°C, the samples were spun for 10
minutes at 10,000 x g and the supernatant was decanted. 300 ul of 70% ethanol was
added to the genomic DNA and mixed gently by inversion. The samples were then
spun for a further minute at 10,000 x g and the supernatant was removed. The samples
were allowed to air dry for ten minutes before 100 ul of DNA Rehydration Solution
was added. Samples were incubated at 65°C for one hour and left at room temperature
overnight. The isolated genomic DNA was quantified using a Genequant
spectrophotometer and all DNA was stored at 4°C to minimise shearing due to freeze
thawing.
2.2.2 Primer design
Oligonucleotide primers for the amplification of nucleotide sequences were designed
USIng Primer3 (Rozen and Skaletsky, 1998; www-
genome. wi .mit.edu/genome _software/other/primer3 .html) or manually and
synthesised by Sigma Genosys Ltd (Haverhill, UK). Primers used in this study are
shown in Table 3.
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Table 3. Primers used in this study
CDS Name Sequence Length GC% TmoC
CjOO59c;jliY CjNCTCll168-0059c_f TACAACCTTAGGAGCCCAAAAA 22 40.9 59.9
CjOO59c;jliY CjNCTCII168-0059c_r TTAAAATTTCAAGCGGATCGTT 22 31.8 59.9
CjOJ05;atpA CjNCTCII168-0105_f AGCCAATTGATGCTAAAGGTGT 22 40.9 60.0
CjOJ05;atpA CjNCTCII168-0105_r CTTGTGTTTCAATTATCGGCAA 22 36.4 60.0
Cj0145 CjNCTCII168-0145_f AAAATCATCGACATGAATGCAG 22 36.4 60.0
Cj0145 CjNCTCII168-0145_r TTTCATCAAATTIIICCCATCC 22 31.8 60.0
Cj0266c CjNCTCII168-0266c_f TCAATCAATTCACCACTCAAGC 22 40.9 60.1
Cj0266c CjNCTCl1168-0266c_r ATTACCCGGGAGTGTGTCTATG 22 50 60.1
Cj08J8 CjNCTCI1168-0818_f CTTGCACTGTACTAAACGCAGC 22 50 60.1
Cj0818 CjNCTCI1168-0818_r AGCACCTACTACCCCCAATCTT 22 50 60.3
Cj0887c;jlaD CjNCTCI1168-0887c_f GGCGGTCAAAGTGCTTTATATC 22 45.5 59.9
Cj0887c;jlaD CjNCTClI168-0887c_r AAAGTATCTTCGGGTTTGACGA 22 40.9 60.0
Cj1321 CjNCTCI1168-1321_f AAAATGTCATCATCATAGGAGCG 23 39.1 60.3
Cj1321 CjNCTC11168-1321_r TCTAAGTTTACGCAAGGCAACA 22 40.9 59.9
Cj1322 CjNCTCII168-1322_f GACTTTGGTTTAATGGGTAAGCA 23 39.1 59.4
CjJ322 CjNCTCII168-1322_r TTCCGGCGTTAAAATTAGAAAA 22 31.8 59.9
CjJ323 CjNCTCII168-1323_f AGAACGATTTACCCCATTGAAA 22 36.4 59.7
Cj1323 CjNCTCI1168-1323_r ATTTGCTAAAGCTCCTCGATTG 22 40.9 59.8
Cj1324 CjNCTCl I I 68-1324_f TGCCGTAAGTGGAGGTAAAGAT 22 45.5 60.0
CjJ324 CjNCTCII168-1324_r TCTGCACACATTGTTCTATCCC 22 45.5 60.0
CjJ325 CjNCTCII168-1325_f ACGGATTACIIIIICCAGATGGT 23 39.1 60.1
Cj1325 CjNCTCII168-1325_r TTTGCTTTGAAAATACGCTGAA 22 31.8 59.8
Cj1326 CjNCTCI1168-1326_f TACATTTCATCGATAAAGCCGA 22 36.4 59.5
Cj1326 CjNCTClI168-1326_r AAATATAATGGTGTGCCGATCC 22 40.9 59.9
CjJ365 CjNCTCII168-1365_f TATGGGGCAAAATTTTATGGAG 22 36.4 60.0
CjJ365 CjNCTCII168-1365_r CTTCTATCCCAGGTGGATCTTG 22 50 59.9
Cj1376 CjNCTCII168-1376_f TACTCGATGGAAATGCCIIIII 22 36.4 59.9
Cj1376 CjNCTCll168-1376_r TCGCTAAGIIIIIGAGCATTGA 22 36.4 60.0
Cj1545 CjNCTCll168-1545_f CTGTGATCTATCAAATGCCAGC 22 45.5 59.7
CjJ545 CjNCTCI1168-1545_r ATGCAAATGCCAATACACCATA 22 36.4 60.1
Cj1678 CjNCTCll168-1678_f GGAGAAATGATTTTATCTGGCG 22 40.9 59.9
Cj1678 CjNCTCl1168-1678_r TATGGTTGAGCCTTGTGAATTG 22 40.9 60.0
Cj1686c;lopA CjNCTCI1168-1686c_f GCAAATTTTGGCAAGGACTATC 22 40.9 59.9
CjJ686c;lopA CjNCTCI1168-1686c_r TTGCACTTTTAAATTTTGGCCT 22 31.8 60.0
16SrRNA 16s rRNA f ATGGAGAGTTTGATC 15 40 43.0
16SrRNA 16s rRNA r TGATCCAACCGCAGG 15 60 60.3
23SrRNA 23srRNAf ACTAAGAGCGAATGG 15 46.7 47.8
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23SrRNA 23srRNA r ATTAGTACTGGTCAC
2.2.3 Polymerase Chain Reaction (PCR)
PCR reactions were performed in a reaction volume of 50 Ill. They consisted of 0.2
mM of each deoxynucleotide triphosphate (dNTP) (Promega, Southampton, UK), 1
Unit of Taq DNA polymerase (Promega, Southampton, UK), 0.1 nM of both the
forward and reverse primers and 1-100 ng of template DNA. All reactions were
carried out using an Omn-E thermal cycler using cycling parameters; denaturation of
template gDNA at 94°C for 1 minutes, 94°C for 15 seconds, annealing of primers to
single stranded DNA at xoC for 15 seconds, extension of the product at 72°C for Y
min (steps 2-4 were cycled 30 times), 72°C for 5 minutes (where X = temperature
varied depending on the annealing temperature of the primers (approximately 5°C
lower than the melting temperature) and Y = 1minute per kb expected product).
PCR products were separated in a horizontal 0.7% agarose gel prepared with lx TAE
(40 mM Tris Acetate, 1 mM EDTA (pHS)) by means of an electric current. The gel
contained 0.5% ethidium bromide (Promega, Madison, USA). Using 2 III of loading
buffer (0.25% bromophenol blue, 40% (w/v) sucrose) per sample, 5 III of PCR
product was loaded into the gel. A 1 kb ladder was used (Invitrogen, Paisley, UK) to
size fragments. An electric charge of 100 V was applied across the gel for
approximately 1 hour and PCR products were viewed using an ultraviolet light (Gene
Genius Bio Imaging System).
2.3 Construction of C.jejuni gene specific composite DNA microarray
2.3.1 Collaboration with the Bacterial Microarray Group at St Georges Hospital
Medical School, London (Bp.G@S)
Steps A-C in the construction of the gene specific C. jejuni microarray were all
carried out by staff at (BIlG@S) (The full protocols for the steps are available at
BIlG@S www.bugs.sghms.ac.uk).
A. Primer design
Oligonucleotide primers for the amplification of nucleotide sequences were designed
using Primer3 (Rozen and Skaletsky, 1998).
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B. PCR amplifications and purification
Amplification of gDNA from strain NCTCII168 and non-NCTCIII68 strains and
downstream liquid handling were performed using a RoboAmp 4200 (MWG Biotech,
London, UK). Amplicons were evaluated for size and concentration on agarose gels
and 5% of amplicons were sequenced to ensure the expected gene had been amplified.
PCR products were purified by precipitation carried out in 96-well plates. Of the total
PCR product 50 IJ-Iwas precipitated and 50 IJ-Iwas stored as an archive at -20°C. 4.5
ml 3M sodium acetate and 0.5 ml 100% glycogen were pre-mixed. Precipitation was
performed by adding 40 IJ-Iisopropanol and 5.0 IJ-Iof the sodium acetate and glycogen
mixture to 50 IJ-Iof the PCR product. This was spun at 3,000 x g for 1 hour at 4°C and
the supernatant was removed. A wash was performed using 150 IJ-Iof 70% ethanol
followed by a 15 minute spin at 3,000 x g at 4°C. The supernatant was removed and
the precipitated PCR products were air dried and resuspended in 15 IJ-150%DMSO.
C. Printing the microarray
A BioRobotics MicroGridII arrayer (Genomic Solutions, Huntingdon, UK) with a 4x4
split pin configuration was used to print PCR products representing each of the 1654
NCTCll168 predicted CDSs, the 73 non-NCTCIII68 genes and controls onto Poly-
L-Iysine coated slides made in-house at the BIlG@S facility and GAPSII-coated
slides (Corning Life Sciences, Koolhovenlaan, The Netherlands). Two replicate spots
for each predicted CDS were printed on the array. These were not printed adjacently
but spaced within a sub-grid to avoid any artefacts affecting both replicates.
D. peR amplification of positive controls
Positive control reporter elements, I6S rRNA and 23S rRNA, were amplified through
PCR reactions carried out manually using the reagents and conditions (Chapter 2.2.3).
Negative controls included on the microarray were human B-actin and glycerol
phosphate dehydrogenase (GAPDH). Negative controls such as spotting buffer 50%
DMSO printed after the top concentration of the I6S or 23S rRNA positive controls
were included to check for carry-over between samples when printing. In addition 5-
amino-propargyl-2' -deoxycytidine 5- triphosphate coupled to Cy3 fluorescent and
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Cy5 fluorescent dyes (herein referred to as Cy3 and Cy5) were printed on the
microarrays for orientation of glass slides.
E. Post print processing of microarray slides
Post print processing of slides was performed to acetylate free amino group on the
coated glass slides. A 2 L beaker containing 1 L of boiling distilled H20 was placed
on a hot plate whilst a slide drying bench was heated to 100°C. Wash A and Wash B
were prepared as follows;
Wash A; 1 x SSC and 0.05% SDS made up to 400 ml H20. Wash B; 0.06 x SSC
made up to 400 ml H20.
In addition, 400 ml of 95% ethanol was placed in a trough at -20°C and 6.0 g of
succinic anhydride was added to 335 ml I-methyl-2-pyrolidinone in a 500 ml bottle.
Slides printed with the microarray were held array side down in steam rising from the
beaker of boiling distilled H20 for approximately 5 s. The formation of large beads of
condensation at this point must be avoided to prevent the swelling of reporter
elements. The slides were then placed immediately on the slide drying bench to dry
for 10-20 s with the printed microarray facing upwards. Slides were then placed into a
UV crosslinker in a plastic tray with the printed microarray facing upwards. Reporter
elements spotted on the microarray were crosslinked using 200 ml/cm' (Energy=
2000) of UV radiation. Succinic anhydride was fully dissolved in I-methyl-2-
pyrolidinone and the blocking solution was buffered with 15 ml of 1 M sodium borate
(pH 8.0) forming a clear colourless solution. This was poured into a staining trough.
Slides were placed in a staining rack and washed in wash A with vigorous agitation
for 1 min. The slide rack was then drained and transferred to wash B. Washing with
vigorous agitation was then carried out for a further minute before blotting the slide
rack once more and transferring it to the blocking solution. Slides were vigorously
agitated in blocking solution for 2 min after which time the slides were allowed to
soak in blocking solution for a further 20 min.
The slides were then removed from the blocking solution, allowed to drain and then
plunged into boiling water and agitated vigorously for 2 min after which the slides
were then plunged into the ice cold 95% ethanol and washed for 1 min. Again the
slide rack was allowed to drain and slides were dried by centrifugation for 5 min at
1500 rpm.
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Slides were then stored in a dust free slide box. Poly L-Iysine coated glass slides were
used within three months or amino silane coated GAPSII slides within I year.
2.4 Comparative genomics
2.4.1 Competitive hybridisation
DNA microarray hybridisations were performed by comparing a chosen test strain
against the sequenced (NCTC11168) strain as control. Competitive hybridisation
reactions were carried out manually as follows;
A pre-hybridisation solution of 8.75 ml of 20x SSC, 0.25 ml of 20% SDS, 5.0 ml of
BSA (100 mg/ ml) made up to 50 ml with distilled water was set up in a Coplin jar
and incubated at 65°C during the labelling incubation period to equilibriate.
Control and test DNA were labelled as follows;
Reagent Control Test
Genomic DNA I ug 1 Ilg
Random Hexamers (Jug/ul) I fll I fll
(Invitrogen, Paisley UK)
Distilled H2O to 41.5 ul to 41.5 fll
Heated at 95°C for 5 minutes, snap cooled on ice and briefly centrifuged.
lOx buffer 5 III 5 III
(Invitrogen, Paisley UK)
dNIP's 1 III 1 fll
(Promega, Southampton,
UK)
Cy-labelled dCIP 1.5 III (Cy3) 1.5 III(Cy5)
(Amersham Biosciences,
Amersham, UK)
Klenow fragment (IOU/fll) I III 1 III
(Amer sham Biosciences,
Amersham, UK)
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Incubated at 37°C for 90 minutes in the dark.
Microarray slides were incubated in the Pre-hybridisation solution for 20 minutes at
65°C, beginning just before the end of the labelling reactions.
Test and control reactions were combined and purified using the Qiagen MinElute
PCR Purification kit, using a two step wash stage of 500 ~l and 250 ul volumes of PE
and eluting the labelled cDNA from the MinElute column with 21 ul H20. Columns
retain 1 Ill.
The pre-hybridised microarray slides were rinsed in distilled water for 1 minute, then
in isopropanol for 1 minute followed by centrifugation briefly at 1,000 x g to dry the
slides. Microarray slides were stored in a dust free, covered slide box.
The hybridisation solution was prepared as follows; 20 ul sample, 6.4 ~l filter
sterilised 20x SSC and 4.6 ul filter sterilised 2% SDS. This was heated at 95°C for 2
minutes and allowed to cool slowly to room temperature.
Hybridisation chambers (made to order, B~G@S) were taken, one per microarray
slide, and 2 x 20 ~l distilled water added to the corners. Slides were placed into the
chambers and Lifter slips (Erie Scientific Company, Portsmouth, US) positioned over
the microarray grid under which the hybridisation solution was applied, fully covering
the microarray grid. The chamber was then sealed and incubated in a water bath at 65
°C overnight.
2.4.2 High and low stringency washes
Wash solutions were prepared as follows: High stringency wash A; 20x SSC 20 ml,
20% SDS 1 ml, H20 to 400 ml incubated at 65°C overnight. Low stringency wash B;
20x SSC 2.4 ml, H20 to 800 ml. Wash solutions were dispensed into three glass
washing dishes. Microarray slides were removed from hybridisation chambers and
covers lips were removed by rinsing in wash A. Microarray slides were immediately
placed into a rack and rinsed with vigorous agitation for 5 minutes. Slides were
transferred to a clean rack and rinsed with agitation in wash B. Slides were then
washed for a further 2 minutes in fresh Buffer B. Microarray slides were dried by
brief centrifugation at 1,000 x g and stored in a dust free, covered slide box for no
longer than 2 hours.
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2.5 Data Analysis
2.5.1 Scanning of microarray slides
Hybridised microarray slides were stored in a dust free slide box for up to 2 hours.
Direct comparison of two samples (both test and reference conditions) was achieved
through detection of differences in signal intensity produced by hybridisation of the
two labels. This was achieved using a dual laser confocal GMS 418 Arrayscanner
(Affymetrix, Santa Clara, US). During a preliminary scan of each microarray slide the
gain was adjusted to optimise the intensity of the fluorescence in each channel
without allowing reporter elements to 'bleach out', thus preventing the correct
calculation of the ratio of fluorescence. The full scan was then performed at the
appropriate gain and the image for each channel saved as a TIFF file.
2.5.2 Initial calculation of ratio of fluorescence
TIFF files generated through the scanning process for the test and control channels
were overlaid and visualized in ImaGene v5.5 (BioDiscovery, El Segundo, US)
software. Following the automated alignment of the test and control channels, a grid
was fitted onto data points. The grid was created by entering detailed information
about the layout of the microarray. Initially each reporter element must be matched
back to its gene identity. To do this, the number of rows and columns in each grid
must be entered as well as the minimum and maximum diameter of the reporter
elements. This is calculated using a ruler tool available within ImaGene5.5. Subgrids
within the metagrid may also be defined. Once defined a grid template may be saved
for use on other microarrays from the same print run. However, updated templates
may need to be defined if subsequent microarrays differ slightly from an older
version. By overlaying the grid onto the reporter elements, gene ID files allow
information about reporter elements to be tracked and saved with the quantified signal
intensity values.
ImaGene5.5 software uses an automated process to identify reporter elements
unsuitable for analysis. These flagged genes included empty spots, negative spots and
poor spots. To enable ImaGene5.5 to recognise empty spots a sensitivity threshold
was set up of2.0. For each spot the following ratio is compared to the threshold:
R= signal mean - background mean
background standard deviation
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If this ratio is lower than the threshold value the spot is flagged.
Any spot with a signal mean value lower than the background was flagged as
negative. Low quality spots are detected based on a number of criteria:
1. Genes were flagged for background contamination whereby the background of
each individual spot is compared to the local background level distribution over the
image through a t-test. The resulting P-value is subtracted from 1 and is called
'confidence in contamination presence'. This confidence threshold was set at 1.0 and
genes were flagged if the contamination confidence level went over this threshold.
2. Genes were also flagged for a high-ignored percentage. Since some pixels may be
assigned to neither signal nor background in the presence of high local contamination
it is important that such contamination is excluded from the measurements. Such
exclusions are designated 'ignored regions'. If the ignored region was higher than the
pre-set threshold of25% the spot was flagged for low quality.
3. Low quality genes were flagged for a high open perimeter percentage. This is
designed to eliminate spots with a specific type of deformation. Imagene computes
the percentage of signal perimeter that touches the border of a rectangle. Such a
deformation may appear if the spot is significantly shifted from its expected position
or if its shape has an abnormal form. Whenever the percentage crossed the pre set
threshold of 25% the spot was flagged for low quality.
4. Genes were flagged for having abnormal shape regularity. An algorithm computed
a shape regularity measure that characterised the closeness of a spot border to a circle.
The first step of this algorithm inscribed the signal area of a spot into a circle. The
number of non-signal pixels that fall within this circle was computed and divided by
the circle area. This ratio was subtracted from I and was called the 'shape regularity'.
This variable ranges from 0 (highly non circular) to 1 (a perfect circle). If this ratio
fell below the preset threshold of 0.65 the spot was flagged for low quality.
5. Finally, genes were flagged for significant offset from their expected position. The
expected position of a spot in a grid is computed by fitting least square lines to the
grid's columns and rows. Whenever the offset became larger than a preset threshold
of 60% of the distance between grid and nodes, the spot was flagged for low quality.
The ratio of fluorescence for present and marginal data points was automatically
calculated. The extracted data was captured, quantified and stored automatically in a
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tab-delimited or XML file that may be exported into data analysis software tools
including GeneSpring6.1 (Silicon Genetics, Redwood City, US) and Genomotyping
Analysis Charlie Kim (GACK)
(http://falkow .stanford.edulwhatwedo/ software/ software.html).
2.5.3 Normalisation of DNA microarray hybridization data
Data output from ImaGeneS.S is recognised by GeneSpring6.1 and replicate
hybridisations were loaded into single experiments together. Raw microarray data
input from ImaGeneS.S was standardised by normalisation allowing biological
variations to be differentiated from variations due to the measurement process. Each
gene's measured intensity was divided by its control channel value in each sample; if
the control channel was below 10 then this value was used instead. If the control
channel and the signal channel were both below 10 then no data was reported.
Variations in intensity caused by inconsistencies in sample preparation or washing
were also accounted for by normalisations thus each measurement was divided by the
50.0th percentile of all measurements in that sample. Lowess was used as an
alternative DNA microarray normalisation. Using this method, a Lowess curve was
fitted to the log-intensity versus log-ratio plot. 20% of the data was used to calculate
the Lowess fit at each point. This curve was used to adjust the control value for each
measurement. Ifthe control value was lower than 10 then this value was used instead.
2.5.4 Comparative genomics analysis
Within GeneSpring6.1 software, hybridsation data was filtered to remove data points
unsuitable for further analysis. Empty, negative or poor reporter elements flagged
using ImaGene5.5 software (Chapter 2.5.2) were removed, leaving only data points
that fluoresced at a 1:1 ratio or above (present) and those between 0.5 and I
(marginal). A constant cut-off of O.S was selected to identify absent or divergent
genes in the test strain. Genes identified as absent or divergent were filtered on
confidence using a t-test cut off ofO.05.
GACK software was also used to analyse DNA microarray hybridisation data. Prior to
analysis with GACK, microarray hybridisation data was normalised using Lowess
normalisation. Normalised comparative genomics data was then entered into a data
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matrix for input into GACK. This matrix contained the genomic content of each strain
represented in binary an example of which is shown in Table 4.
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Table 4. A sample of GACK comparative genomics input data matrix
PNIOID NAIU: OlJEIOHT 1099E 118i8 11856 11919 11818 11973 1197i 12196 12211 12150ElJ!IGHT 1 1 1 1 1 1 1 1 1 1 11 Cj11168-0001 (lAl) 1 1 1 1 1 1 1 12 Cjl1168-0002 (lB1) 1 1 1 1 1 1 1 13 Cj11168-0003 (lCl) 1 1 1 1 1 1 1 1 1 14 Cj11168-0004c (lDl) 1 1 1 1 1 1 1 1 1 15 Cj11168-000Sc (lEI) 1 1 1 1 1 1 1 1 1 16 Cj11168-0006 (lFl) 1 1 1 1 1 1 1 1 1 17 Cj11168-0007 (101) 1 1 1 1 1 1 1 1 1 18 Cj11168-000a (lBl) 1 1 1 1 1 1 0 19 Cj11168-0009 (lAl) 1 1 1 1 1 1 1 1 1 110 Cjl1168-0010c (lB21 1 1 1 1 1 1 1 1 1 111 Cj11168-0011e (lC2) 1 1 1 1 1 1 112 Cj11168-0012c (ID2) 1 1 1 1 1 1 1 1 1 113 Cjl1168-0013 (lE2) 1 1 1 1 1 1 1 1 1 114 Cj11168-0014c (lF2) 1 1 1 1 0 1 1 1 1 115 Cj11168-0015c (102) 1 1 1 1 1 1 1 1 1 116 Cj11168-0016 (lH2) 1 1 1 1 1 1 1 1 1 117 Cj11168-0017c (lA3) 1 1 1 1 1 1 1 1 1 118 Cjll168-0018c (183) 1 1 1 1 1 1 1 1 1 119 Cj11168-001ge (lC3) 1 1 1 1 1 1 1 1 1 120 Cj11168-0020e (lD3) 1 1 1 1 1 1 1 1 1 121 Cj11168-0021c (lE3) 1 1 1 1 1 1 1 122 Cj11168-0022c (lF3) 1 1 1 1 1 1 1 0 1 1
23 CHU6e-0023 (103) 1 1 1 1 1 1 1 1 1 124 Cj11168-0024 (183) 1 1 1 1 1 1 1 125 Cj11168-002Se (IA4) 1 1 1 1 1 1 1 1 1 1
26 Cj11168-0026e (184) 1 1 1 1 1 1 1 1 1 127 Cjl1168-0027 (ICi) 1 1 I I 1 1 1 1 1
28 Cjl11Se-002e (ID4) 1 1 1 1 1 1 1 1 1 1
29 Cjl1168-0029 (lEi) 1 1 1 1 1 1 1 1 1 1
30 Cjl11S8-0030 (lF4) 1 I 1 1 1 1 1 1
31 Cjl11S8-0031 (104) 1 1 1 1 0 1 1 1 1 1
32 Cj11168-0032 (lBi) 1 1 1 1 0 1 1 1 0 0
33 Cj11168-0033 (lAS) 1 0 0 0 0 0 0 0 0 0
Using GACK a dynamic cut-off value for the identification of absent or divergent
genes was calculated. A normal probability density function was fitted to the major
peak and the ratio values at half the peaks maximum height on both sides. The
estimated probability or presence (EPP) of a gene was calculated as follows;
EPP= 100 x (expected normal value / observed value)
The mapped normal curve value (which is expected for a distribution in which all
spots are present on the array) was divided by the observed data distribution value.
Genes were then categorised as absent with an EPP of 0%, present with an EPP of
100% and into a transition region if the EPP was anything other than 0% or 100%.
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2.6 Comparative phylogenomics
2.6.1 Data transformation
Using NCTC11168 reporter elements only raw microarray data was transformed into
binary using a Perl script (provided by Adam Witney, BJ.1G@S).Using data derived
from GeneSpring genes falling below a 0.5 ratio were designated 0 and genes above
0.5 were designated 1. With data derived from GACK, genes that were present or
marginal were assigned a '1' and those that were absent were assigned '0'. In both
data sets the genes that were flagged using ImaGene5.5 software were denoted 'F'.
Strains in which over 5% of the total genes were flagged were manually removed
from both data sets as were genes flagged in over 10% of all strains. The remaining
flagged genes were denoted with a question mark. The data set was then cross
checked back against the raw microarray data, transposed so genes were on the X axis
and transformed into Nexus format (Maddison et al., 1997) (Figure 8). This is a
modular file format that is easily processed by many bioinformatics programs such as
Mr Bayes3.0 (Ronquist and Huelsenbeck, 2003) and MacClade4.0 (Maddison, 2001).
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Beqin data1
Dimensions nt.x=102 nch.r=16271
Format datatype=standard missinq=7 matchchar=.1
Matrix
1099 E
1111111111111111711111111110111111111111111111111111111111111111111111111111111111
1111111111111111111111171111111111111111111111111111111111111111111111111111111111
1111111111111111111111111111111111111111111111111111111111111111111111111111111111
1111111111111111111111111111111111111111111111111111111111111111111111111111111111
1111111111111111111111111111111111111111111111111111111111111111111111111111111111
1111111111111111111111111111111111111111111111111111111111111111111111111111111111
1111111111111111111111111111111111111111111111111111111111111111111111111111111111
1111111111111111111111111111111111111111111111111111111111111111111111111111111111
1111111111111111111111111111111111111111111111111111111111111111111111111111111111
1111111111111111111111111111111111111111111111111111111111111111111111111111111111
1111111111111111111111111111111111111111111111111111111111111111111111111111111111
1111111111111111111111111111111111111111111111111111111111111111111111111111111111
1111111111111111111111111111111111111111111111111111111111111111111111111111111111
1111110111111111111111111111111111111111111111111111111111117111111111111111111111
1111111111111111111111111111111111111111111111111111111111111111111111111111111111
1000000000000000000011111111111111111111111111111111111111111111111111111010011111
1111111111111111111111111111111111111111111111111111111111111111111111111111111111
1111111111111111111111111111111111111111111111111111111111111111111111111111111111
1111111111111111111111111111111111111111111111111111111111111111111111111111111111
111111111111111111111111111111111111111111111111111111111111111111111
11818
1111111111111111111111111110111111111111111111111111111111111111111111111111111111
1111111111111111111111111111111111111011111111111111111111111111111111111111111111
1111111111111111111111111111111111111111111101111111111111111110111111111111111111
1111111111111111111111011111111111111111111111111111111111111111111111111111111111
1111111111111111111111111111111111111111111111111111111111111111111111111111111111
1111111111111111111111111111111111100111111111111111111111111111111111111111111111
1111111111111111111111111111111111111111111111111111111111111111111111111111111111
1111111101111111111111111111111111111111111111111111111111111111111111111111111111
1111111111111111111111111111111111101111111111111111111111111111111111111111111111
1111111111111111111111111111111111111011111111111111001111111111111111111111111111
1111111111111111111111111111111111111111111111111111011111111111111110000000111111
1111111111111111111111111111111111111111111111111111111111111111111111111111111111
1111111111111111111111111111111111111111111111111111111111111111011000000000001001
1111111111111111111110111111111111111111111111111111111111111111111111111111111111
1101111111111111111111111111111111111111111111111111111111111111111111111111110111
1111111110111111010111011111111111111111111111111111111111111111111111111110011111
1111111111111111111000010000000000000000111100111111111101111111111111111111111111
1111111111111111111111111111111101111111111111111111111100000000100011111111111111
1111111111111111111111111111111111111111111111111111111111111111111111111111111111
111111111111111111111111111111111111111111111111111111111110001111111
11848
1111111110111111111111111110111111111111111111111111111111111111111111111111111111
1111111111111111111111111111111111110011111111111111111111111111111111111111111111
1111111111111111111111111111111111111111111111111111111111111111111111111111111111
1111111110001111111111111111111111111111111111111111111111111111111111111111111111
1111111111111111111111111111111111111111111111111111111111111111111111111111111111....................................................................................................................................................................
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~u~~~~~~~~~~~~~~~~~~~~~~~~uuuuuuu~~~u~~~~~~~~~~~~~~
1111111111111111111111111111111111111111111111111111111111111111111111111171111111
111111111111111110001111111111111111111111111111111111111110000111111,
beqin mrb.yes,
loq start fi1en.me-01ivi •• loq replaoe,
lset oodinq-no&hsenoe r.te-qamma nq.mm.o.t-1G nst-G,
mama nqen-2000000 noh.ins-4 temp-O.B print£reQ-40 sample£reQ-40
Startinqtree-Random hurnin-100000 s.vebr1ens-ye.,
end;
quit,
Figure 8. A sample of comparative genomic data in Nexus format with input code for MrBayes3.0
software. Input format for the phylogenetic program Mr Bayes. All microarray hybridisation ratios for
strains 1099_E, 11818 and 11848 were transformed into a modular binary file format (Nexus). In this
format" 1" represents a CDS that is present in the test strain, "0" a CDS that is absent and "?" a CDS
that was flagged. The code for running the phylogenetic program Mr Bayes is also shown.
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2.6.1 Inferral of phylogeny using Bayesian based algorithms
MrBayes v3.0B4 was used to generate Bayesian trees with a gamma distribution
using 16 discrete rates categories to model hybridisation rate heterogeneity between
loci. Four incrementally heated Metropolis coupling Markov Chain Monte Carlos
were run for 1000000 generations with a 10,0000 generation "burn-in". Phylogenies
were sampled every 40 generations.
Statistical support was calculated within PAUP* (Sinauer Associates, Sunderland,
Massachusetts) by Michael Gaunt (LSHTM) using Bayesian strict and 95% majority
rule consensus phylogeny based on 25,000 phylogenies of C. jejuni DNA-DNA
microarray binary data.
2.6.2 Graphical representation of phylogenetic tree topology
The topology of phylogenetic trees inferred using Bayesian based algorithms were
viewed using TreeView
(http://taxonomy.zoology.gla.ac. uklrodltreeview.html).
software
2.6.3 Identification of key CDSs contributing to clade formation
MacClade4: Analysis of Phylogeny and Character Evolution was used for CDS
analysis to identify genomic regions contributing to different clades within
phylogenetic trees. Data was entered into this programme in Nexus format and the
corresponding phylogenetic tree was also loaded. MacClade4 allows the user to
visualise the distribution of each CDS in the genome as it occurs throughout the
phylogenetic tree as designated by the microarray hybridisations. Strains in which a
CDS of interest is absent or divergent are coloured blue and strains in which the same
CDS is present are coloured yellow (Chapter 6.2.2). Through visualising the
distribution of each CDS in the genome, specific CDSs for a particular clade may be
identified.
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3.0 Results
Construction of a gene specific composite Campylobacter jejuni DNA
microarray
3.1 Introduction
3.1.1 Aims
The availability of the genome sequence for the C. jejuni strain NCTC 11168 (Parkhill
et al., 2000) has allowed the construction of DNA microarrays with reporter elements
representing each one of the 1654 predicted protein coding sequences (CDSs) for this
strain. This chapter describes the development and construction of a gene specific C.
jejuni DNA microarray containing reporter elements representing NCTC11168 CDSs
and novel CDSs not found in the sequenced genome. This type of DNA microarray is
more representative of the species and is described as composite.
3.1.2 Historical development of C.jejuni DNA microarrays
The first whole genome C. jejuni DNA microarray was produced by B~G@S
(http://bugs.sghms.ac.uklindex.php)inJanuary2000.This early C.jejuni array was an
amplified clone array from an optimal set of plasmid clones from the NCTC 11168
genome sequencing project. In 2000, most of the cost in producing PCR product-
based DNA microarrays was due to the synthesis of oligonucleotide primer pairs
required for the PCR amplification of gene fragments that make up the reporter
elements present on the array. This cost was dramatically reduced by utilising clone
libraries as the template for amplifying the PCR products. Using this method the same
two vector primers are utilised for the amplification of every clone. For example,
ordered pUC clone libraries that are a by-product of most bacterial genome
sequencing projects can be used by selecting an optimum clone to represent every
gene in the genome (Figure 9).
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cjOOOI cj0002 cj0003
Clone selected by tiling
programme
Figure 9. Selection of clones by tiling programme (Dorrell et a!., 2001) for DNA microarray. Predicted
protein CDSs for NCTC 11168 cjOOO1, cj0002 and cj0003 are diagrammatically represented with
arrows. Overlapping clones from the genome sequencing project for each CDS are coloured black.
Clones selected as optimal (coloured pink) using a tiling programme were selected to represent a CDS
on the clone array.
The ordered C. jejuni NCTCll168 plasmid library generated by the Sanger Institute
was used as the template and a single pair of primers based on the pUC19 vector
sequence were used to amplify gene fragments representative of the initial 1731
predicted CDSs from strain NCTCll168, to produce a low-cost representative whole
genome microarray. The predicted CDSs were based on the preliminary annotation of
the NCTCl1168 genome sequence (Julian Parkhill, unpublished data), however
following completion of this annotation, the number of predicted genes was reduced
to 1654 (Parkhill et al., 2000). Therefore the resulting 77 "non-genes" were each
flagged in the gene lists used by the analysis software as a "not annotated gene"
(Dorrell et al., 2001).
A drawback of this type of microarray is that many of the optimum clones available
were not gene-specific and contained adjacent genes or gene fragments. Only 34.5%
of the selected clones contained a single gene fragment, with 35.4% containing an
adjacent gene fragment and the remaining 30.1% containing more than one gene
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fragment adjacent to the selected gene. The presence of these adjacent gene fragments
could result in cross-hybridisation when the gene sequence present in the
hybridisation sample is present in more than one reporter element present on the
array, resulting in non-representative changes in hybridisation signal intensities.
However, this limitation of the clone array was balanced against the initial biological
information and microarray expertise that was gained from its use and the relative
cost effectiveness of this approach. Given the limitations of the clone microarray, a
second generation C. jejuni gene specific microarray was produced in collaboration
with BIlG@S in June 2002. Since the construction of the C. jejuni microarray used in
this project, several gene specific ORF C. jejuni microarrays have been constructed
(Carrillo et al., 2004; Leonard et al., 2003; Pearson et al., 2003; Stintzi, 2003).
However, none of these other microarrays represent non-NCTCll168 CDSs as well
as NCTCl1168 CDSs.
3.2 Results - non-NCTC1l168 CDSs
3.2.1 Identification ofnon-NCTC11168 CDSs
To make the microarray more representative of the C. jejuni species, non-
NCTCll168 CDSs were added to the microarray (Tables 5 and 6). These non-
NCTCll168 CDSs were obtained by contacting the Campylobacter research
community and by searching the literature. The percentage identity of these non-
NCTCll168 CDSs to the NCTC11168 sequenced strain was calculated using a Basic
Local Alignment Search Tool (BLAST) (http://www.sanger.ac.uk/cgi-
binlblast/submitblast/c_jejuni). BLASTn was used to compare the nucleotide
sequence against that ofNCTCll168. BLASTx was used to compare the six-frame
conceptual translation products of the non-NCTCII168 query sequence against a
protein sequence database for all sequenced genomes. Sequences with less than 80%
identity in the BLASTn search were selected for inclusion on the composite array.
MIAME compliant information for all reporter elements included on the gene
specific, composite C. jejuni microarray are available in the ArrayExpress public
repository at;
http://www.ebLac.uklarrayexpress/query/result?queryFor=PhysicalArrayDesign&aAc
cession=A-BUGS-8
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Table 5. Non-NCTC11168 CDSs included on the composite gene specific C.jejuni
microarray
CDSIO Accession No. BLASTn to BLASTx to Predicted protein
NCTCl1l68 NCTClIl68 similarity
11351-01 AF334961 4.IOE-28 0.1938/124 (30%) LOS region
sequences; ClpA
11828-01 AF343914 1.40E-07 l.4e-36 62/271 LOS region
(22%) sequences sugar
transferase
11828-02 AF343914 2.50E-06 0.7720/60 (33%) LOS region
4111705 (58%) sequences ABC
transport system
11828-03 AF343914 1.20E-28 2.0e-9 28/81 (34%) LOS region
743/1258 (59%) sequences CysE
11828-04 AF343914 9.60E-08 0.7537/114 (32%) LOS region probable
246/410 (60%) membrane protein
11828-05 AF343914 28/81 (34%) 6.3e-18 13/33 (39"10) LOS region
sequences galactosyl
transferase
11828-06 AF343914 1.20E-II 3.le-14 401111 LOS region
4601790 (58%) (36%) sequences
11828-07 AF343914 4.70E-28 3.ge-55 82/251 LOS region
616/1035 (59%) (32%) sequences
aminotransferase
11828-08 AF343914 5.40E-17 0.999723/61 (37%) LOS region
617/1089 (56%) sequences Cj0505c
11828-10 AF343914 4.00E-IO no matching pairs LOS region
424/725 (58%) sequences Cj 1137
11828-11 AF343914 3.30E-47 4.2e-44 33/95 (34%) LOS region
574/904 (63%) sequences transport
protein
11828-12 AF343914 3.50E-17
0.77520/59 (33%) LOS region
559/955 (58%) sequences Cj 1333
2523/90-01 AF334762 4.IOE-28 0.021 20/66 (30%)
LOSregion; possible
69/106 (56%)
43431-01 AF411225 4.1 e-20 395/650
2.4e-34 87/241 LOS region probable
(60%) (36%) two domain
glycosyltransferase
43431-02 AF411225 0.0026 335/588
9.7e-14 60/233 LOS region Cjl423c
(56%) (25%) possible sugar phosp
nucleotidytransferase
43431-03 AF411225 7.0e-08 336/580
I.Oe-17 59/160 LOS region Cj 1319
(57%) (36%) probable nucleotide
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sugar dehydratase
43432-01 AF215659 l. se-os 4401779 0.01533/131 (25%) LOS re g ion
(56%) sequences
43438-01 AF400048 4.8e-59 580/869 l.Oe-n 147/287 LOS region
(66%) (65%) sequences
43438-02 AF400048 8.3e-06 285/478 0.0012321131 (24%) LOS region
(59%) sequences CysE
43449-01 AF401529 I.Oe-56 578/869 7.le-73 144/287 LOS region
(66%) (50%) sequences
43449-02 AF401529 1.10E-05 0.0010 22/55 (40%) LOS region
4381779 (56%) sequences CysE
4344c-01 AFI67344 2.4e-05 461/825 0.001022/55 (40%) LOS region
(55%) sequences CysE
43456-01 AF401528 I.Oe-56 574/865 1.5e-79 153/287 LOS region Cjl140
(66%) (53%) unknown function
43456-02 AF401528 1.3e-0.5 462/826 0.001 22/55 (40%) LOS region
(55%) sequences CysE
480-01 8.le-Q.6 3.60E-12 Kfid
246/414(59%) 511171 (29%)
480-02 0.00097 4.60E-08 Kfid
98/152 (64%) 29/85 (34%)
480-03 9.00E-41 l.30E-70 GalE
412/728 (57%) 58/177 (32%)
480-04 1.60E-36 3.20E-63 Glf
505/887 (56%) 401137 (29%)
480-05 2.00E-14 1.30E-08 Sugar transferase
174/299 (65%) 26/59 (44%)
480-06 0.0058 3.30E-17 DMSO reductase
200/340 (58%) 78/238 (32%)
81176-01 0.00057 0.0057 VirB8 protein from
181/313 (57%) 181/313 (57%) B. suis
81176-02 0.055 0.9997 LvhB9 of L.
425/819 (51%) 36/139 (25%) pneumophila
81176-03 7.60E-06 No high scoring TrbI of plasmid RK2
172/292 (58%) segment pairs
81176-04 0.0046 0.0013 Type IV secretion
136/226 (60010) 57/184 (30%) protein
8F169-01 AF334378 1.40E-07 0.11 22172 (30%) LOS region Cjl042c
4401759 (57%) transcriptional
regulatory protein
P19-01 5.6e-83 610/873 1.ge-IOO 131/309 Capsule region
(69%) (42%)
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P19-02 9.3e-112 129712047 7.3e-199 971174 Capsule region
(63%) (55%)
X-I 1.2e-84 675/1019 3.5e-108 169/344 Capsule region
(66%) (49%)
X-2 1.3e-82 707/1042 2.3e-100 155/344 Capsule region
(67%) (45%)
X-3 6.3e-10 863/1524 2.5e-10 37/110 Capsule region
(56%) (33%)
X-4 9.8e-14 648/1148 1.7e-14 42/99 (42%) Capsule region
(56%)
X-5 2.1 e-42 2333/4167 7.4e-32 124/428 Capsule region
(55%) (28%)
X-6 4.1e-12 475/815 no high scoring pairs Capsule region
(58%)
Of the 69 non-NCTCII168 CDSs included on the array, 23 were identified from
strain 81116 using subtractive hybridisation (Ahmed et al., 2002). Similarity searches
had already been carried out for these CDSs and the data published thus BLAST
searches were not repeated and these sequences were automatically included on the
microarray .
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Table 6. Additional 23 non-NCTCl1168 sequences included on the microarray
identified using subtractive hybridisation (Ahmed et al., 2002)
Insert Size Predicted protein similarity/species Predicted amino Blast Accession no.
(bp) acid identity ('Yo) score
]0 259 1'\0 similarity" AjJ15005
.31 232 Arsenite export protein (arsll)·; Sinorbizobium sp, As4 64 2 x 10" AJ]15006
46 384 Putative oxidoreductase chain; Campylobaaer jejuni 61 I x 103s A)JISOO7
50 124 1'\0 similarity' Aj315008
60 170 Type I R-M protein (S subunit}; Haemopbilus ill{lllelllue Rd 51 2 x 1010 AJ315009
65 147 1'\0 similarity' Aj315010
68 443 Type I R-M protein (M subunit}; Salmonella entenca .32 I x 10" Aj.lIS011
117 280 1':0 similarity Aj315012
121 321 l'\o similarity AJ315013
135 644 Sty SPI type I R-M (M subunit)"; S.l/lIwllell.l enterica 32 2 x JOG "J315014
136 30S Putative type I R-.\l protein (5 subunit); Streptococcus 39 2 x 101• AJ3150LS
thermopbilus
141 301 Putative glycosylrransfcrase ; C. jeiuni 40 1 X JOII AJ 131.360.1
(CACOm3)
149 208 Hypothetical protein (C] 1337) ; C. iejuni 47 2 x 10" AJ31S016
183 I'H Hypothetical protein (Rv02.1Sc)·; M)'eobucterium .15 0'0.13 AJ,31S0l7
tuberculosis
186 196 Arsenate reductase (arsq; Aqui(e:;; aeolicus 3S II x 10' Aj315018
188 163 Cytochrome c oxidase 111*; '/'r),paIl05011Ia brucei 38 H AJ31S019
202 309 Type II R-M protein; Helicobacter trylori )99 68 5 x ID" AjJI5020
205 313 dTDP·~lucosc 4.6-dehydratasc (rm/H); l.egionella 51 7x 10" A) 1J1360.1
pneumopbila (CACOJ39S)
209 248 Hypothetical protein (Ci IJJJ); C. jejuni 48 z x 10" Aj315021
212 194 Probable membrane protein (CjI560)·; C. j<'julli 56 S x 10" AjJ15022
236 369 ,·Glutamyl transpcptidase ; llelicobacter pylori 26695 72 .5 x lO~Q AJ31S023
243 ISO No similarity" AJ31S024
246 2~7 Abortive phage-resistance protein; Lactococcus lactis 34 0'03] Aj315025
• Predicted membrane-spanning domain.
3.2.2 Acquisition ofnon-NCTC11168 strains
The C. jejuni strains from which non-NCTCII168 CDSs were identified were
requested from the research groups working with them (Table 7). These strains were
cultured and gDNA was isolated (Chapter 2.1.1 and 2.2.1).
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Table 7. C. jejuni strains from which novel CDSs were identified and the
research groups associated with them
C. jejuni strain Donated by;
NCTCI1351 Julian Ketley, University of Leicester,
UK.
NCTCI1828 Julian Ketley, University of Leicester,
UK.
2523/90 Julian Ketley, University of Leicester,
UK.
ATCC43431 Julian Ketley, University of Leicester,
UK.
ATCC43432 Julian Ketley, University of Leicester,
UK.
ATCC43438 Julian Ketley, University of Leicester,
UK.
ATCC43449 Julian Ketley, University of Leicester,
UK.
ATCC4344c Julian Ketley, University of Leicester,
UK.
ATCC43456 Julian Ketley, University of Leicester,
UK.
480 Neal Golden, New England Medical
Centre, USA
81116 If Ahmed, Veterinary Laboratory
Association, UK
81-176 Erin Gaynor, Stanford University, USA
8F 169 Julian Ketley, Birmingham University,
UK.
P19 Andrey Karlyshev, London School of
Hygiene and Tropical Medicine, UK
x Andrey Karlyshev, London School of
Hygiene and Tropical Medicine, UK
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3.3 Results - Construction of the microarray
3.3.1 Design of gene specific primers
An optimised pair of oligonucleotide primers were designed for the 69 additional non-
NCTCIII68 CDSs and the 1654 NCTCIII68 predicted CDSs using Primer3
software (Chapter 2.3.1). The PCR products for each CDS for this second generation
C. jejuni microarray were designed to have minimal cross-hybridisation to other
CDSs in the genome. Primers ranging from 22-25 bases in size were designed to have
closely matched melting temperature to aid high-throughput PCR amplification of
products ranging in size from 70 - 800 bases with an average length of388 bp.
3.3.2 Controls and orientation of the microarray slides
PCR products for the 16S and 23S rRNA genes were included on the microarray as
positive controls. These genes were amplified manually (Chapter 2.2.3). PCR
products of the expected size (1.55 kb (16s) and 3.0 kb (23s)) were observed (Figure
10).
1 2 3 4 5 6 7 8 9 10 11
1.6 kb
1.0 kb
3.0 kb
16sRNA
23sRNA
Figure 10. Visualisation of 16S and 23S rRNA peR products
Lanes 1 and 12 contain the molecular weight marker. Lanes 2-11 contain PCR products of 16S rRNA.
Lanes 13-23 contain PCR products for 23S rRNA.
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Negative controls and 'landing lights' for orientation of glass slides during scanning
were also printed on the arrays (Chapter 2.3.1.D).
3.3.3 Amplification and verification of NCTC11168 coding sequences and non
NCTC11168 sequences
Amplification ofNCTC11168 CDSs and the novel sequences selected for inclusion
on the microarray was carried out using a liquid handling robot RoboAmp 4200
(Chapter 2.3.1). Of the CDSs selected for inclusion on the array, five CDSs were
unsuccessfully amplified despite re-ordering the primers used for PCR. These CDSs
included one from the sequenced strain (cj11168-0776c) and four of the additional
CDSs (cj43456-03, cj466-01, cj466-02, cj81116-09). PCR products were run on
agarose gels to ensure a single product of the expected size and of suitable intensity
was observed (Figure 11). In addition 5% of the PCR products were sequenced to
verify the expected target CDS had been amplified.
Figure 11. Visualisation of PCR product microarray reporter elements
Gel picture of a sample of C. jejuni gene specific PCR products to be printed on microarray slides. The
observed size, intensity and presence of single product only was confirmed.
Purification of the PCR products and printing of the microarray slides was carried out
as described in Chapter 2.3.1.
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3.4 Discussion
Even with gene-specific microarrays, for some microbial species potential problems
will still occur with cross hybridisation between reporter elements representing
paralogous genes, meaning that genetic rearrangements, insertions, inversions and
duplications are difficult to detect. For example, differentiating between separate
genes in the C. jejuni NCTC 11168 ej0617 or ej 1318 paralogous gene families using
such whole gene PCR products as reporter elements would be difficult due to cross
hybridisation. This makes it difficult to distinguish whether a particular gene in a
paralogous gene family is really absent in a test strain. Using a more selective primer
design strategy (Hinds et al, 2002), the PCR products for each gene for this second
generation C. jejuni microarray were designed to have minimal cross-hybridisation to
other genes in the genome. This gene specific microarray represented 1654 annotated
NCTC11168 predicted CDSs as well as 69 additional CDSs, many of which have
been donated from the Campylobacter research community. Such non-NCTCII168
CDSs have been identified from the capsule and lipooligosaccharide biosynthesis
regions and a putative virulence plasmid, p Vir from strain 81-176. In addition 23 non-
NCTC 11168 CDSs were also identified from strain 81116 using subtractive
hybridisation. Non-NCTCII168 CDSs were also identified from the literature, such
as AF411225, AF215659, AF400048, AF167344, AF401529, AF401528 and
AJ131360.
However, since construction of the array, many more non-NCTCII168 CDSs have
been identified, including several from strain RM1221 that has been sequenced at The
Institute for Genome Research (TIGR). The genome of this C. jejuni isolate is larger
than that of strain NCTCll168. Thus, the current C. jejuni microarray reflects our
knowledge of the pathogen at the time of construction but will be continually
modified and updated with the addition of novel RM1221 CDSs, newly identified
CDSs, as well as the CDSs absent due to PCR failure. All microarray analyses are
limited by the genetic information on the array, however, this second generation array
moves away from a strain-specific array to an array more representative of the C.
jejuni species.
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4.0 Comparison of DNA microarray data analysis techniques for
comparative genomic hybridisations
4.1 Introduction
4.1.1 Aims
DNA microarrays facilitate genome composition analysis based on signal intensity
ratios of thousands of reporter elements. Nucleotide variation between test and control
strains leads to fluctuations in signal intensity that can be used to identify absent or
divergent genes in non-sequenced strains. Strains exhibiting specific phenotypes may
be genomotyped by categorising test strain genes as present or absent I divergent
based on signal cut-off values. This chapter describes the comparison of two DNA
microarray data analysis methods that use different criteria to select the signal cut-off
value and therefore designate genes as absent or divergent. A collection of 103 C.
jejuni strains (Appendix 1) was selected to carry out a comprehensive comparison of
fixed and dynamic cut-off values (Chapter 2.5.4) to identify absent or divergent genes
from the same data set. Furthermore, by using fixed and dynamic cut-off values to
compare the same DNA microarray hybridisation data from two sequenced C. jejuni
genomes, RM1221 and NCTC11168, the sensitivity of each method could be
quantified.
4.1.2 Methods available to analyse DNA microarray data
In order to process, analyse and determine the biological significance of genomic
comparisons, the vast data accumulated from each hybridisation experiment must first
be normalised allowing biological variations to be differentiated from variations due
to the experimental procedures and measurement process. To differentiate genes that
are present from genes that are absent or divergent in a test strain, a signal intensity
cut-off value must be calculated. There are two main ways used to calculate this cut-
off value. First, by selecting a constant cut-off value that applies across all
hybridisation experiments and second, by calculating a dynamic cut-off value
calculated for each hybridisation experiment. Using a constant cut-off method, a pre-
determined ratio of fluorescence between the test and control strain is used to
designate presence or absence I divergence for each reporter element on the array.
Using the software programme GeneSpring6.1, a constant cut-off value of 0.5 was
selected to determine genes that were present or absent! divergent in each microarray
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experiment. This value was selected based on initial hybridisation experiments carried
out at B!J.G@S.Hybridisation data indicates that the signal intensity ratio is 1 in the
test and control channel for the majority of genes. Thus the majority of genes are
present in both test and control strains. When the test channel fluoresces at half the
level or less of the control channel «0.5) the gene is deemed to be absent or divergent
in the test strain (Figure 12).
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Figure 12. Scatterplot showing the distribution of signal ratios for strain 3]485 against NCTCI 1168
using GeneSpring6.1 software. COSs that hybridised at a 1:1 ratio are distributed along the central
green line and are coloured yellow. The lower line represents the 0.5 cut-off. Test strain COSs with a
ratio of 0.5 or less of the control strain CDS found below the lower green line are coloured white.
These CDSs are designated absent or divergent in the test strain 31485.
The second method used to determine which reporter elements are absent or divergent
in the test strain utilises a dynamic cut-off value, calculated for each hybridisation
experiment. The expected distribution of the reporter elements is compared to the
observed distribution for an individual hybridisation and the cut-off value is
calculated based on the observed microarray hybridisation data (Chapter 2.5.4).
GACK has a singular comparative genomics function to determine genes that are
absent or divergent using an algorithm that selects a specific cut-off value for each
hybridisation. GACK utilises an algorithm that estimates the main ratio peak, the first
step of which is finding the location and height of the major peak and the ratio values
at half the peaks maximum height on both sides. A normal probability density
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function is fitted using these three parameters. The peak represents the genes that are
present in both the test and control strains. The tail to the left (Figure 13) represents
the absent or divergent genes. The estimated probability of presence (EPP) of a gene
is calculated by dividing the mapped normal curve value which is expected for a
distribution in which all spots are present on the array, by the observed data
distribution value (Chapter 2.5.4).
500r------- ~
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Figure 13. GACK histogram showing the distribution of signal ratios for strain 31485
The dynamic cut-off value for the competitive hybridisation of test strain 31485 against NCTC 11168 is
calculated within GACK by plotting the normal curve value that is expected for a distribution in which
all spots are present on the array (shown in green). The expected distribution is divided by the observed
data distribution (shown in red) giving the estimated probability of presence (EPP) (shown in blue).
4.2 Results - Identification of C jejuni functional core genes using a constant and
dynamic cut-off value
4.2.1 C jejuni functional core genes identified using a constant cut-ofT value
Microarray slides were scanned with a GMS 418 Array Scanner (Chapter 2.5.1) and
the ratio of fluorescence between the test and control strains was quantified using
ImaGene 5.5 software (Chapter 2.5.2). ImaGene5.5 output text files were loaded
directly into the GeneSpring6.1 programme with replicate hybridisations loaded into a
single experiment. Raw microarray data imported from Imagene5.5 was normalised
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(Chapter 2.5.3) allowing biological variations to be differentiated from variations due
to experimental procedures.
A constant cut-off value of 0.5 was selected to identify absent or divergent CDSs in
each test strain Le. reporter elements with signal intensity ratios of 0.5 or less
compared to the control channel were deemed absent or divergent in the test strain.
The species-specific functional core of the 103 C. jejuni included in the comparison
was determined by calculating the number of CDSs that were present in each of the C.
jejuni test strains as well as the control strain. In total, 579 CDSs were identified as
absent or divergent among the 103 C. jejuni strains using a constant cut-off value of
0.5. These data indicate a C. jejuni fuctional core of of 1148 genes comprising 66.0%
of the NCTC11168 genome.
4.2.2 C.jejuni functional core genes identified using a dynamic cut-off value
DNA microarray hybridisation data saved in the output file from ImaGene5.5 was not
compatible with GACK. These data were therefore manually converted into a suitable
format for analysis (Chapter 2.5.4). The functional core of the C. jejuni strains
included in the comparison was calculated. A total of 544 CDSs were identified as
absent or divergent in 103 C. jejuni strains using a dynamic cut-off value. Using
dynamic cut-off value a C. jejuni functional core of 1183 CDSs was therefore
identified, comprising 69.0% of the genome.
4.2.3 Comparison of absent or divergent CDSs identified in C. jejun! strains
using constant and dynamic cut-off values
Using a constant cut-off value ofO.5, a total of 579 CDSs were identified as absent or
divergent in one or more of the c. jejuni strains tested, compared with 544 identified
using a dynamic cut-off value. This corresponds to a functional core of 1148 CDSs
and 1183 CDSs respectively. The difference of 35 CDSs between the two results
suggested a variability of only 2% between the two methods for C. jejuni species
hybridisations. Overall, analysing DNA microarray hybridisation data using a
constant cut-off value resulted the designation of a higher proportion of the genome as
variable and therefore a smaller functional core. Absent or divergent CDSs identified
in C. jejuni using the two methods were compared using the Venn diagram function
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available within GeneSpring6.l sotware (Figure 14) to determine whether the same
CDSs were identified in both.
Comparison of the CDSs identified as absent or divergent using a constant and
dynamic cut-off value highlighted a discrepancy between the CDSs identified with
each method. Of the 579 CDSs identified as absent or divergent using a constant cut-
off value of 0.5, 479 CDSs were also identified using a dynamic cut-off value.
However, 100 CDSs were uniquely identified as absent or divergent using a constant
cut-off value. Similarly, of the 544 CDSs identified as absent or divergent using a
dynamic cut-off value, 479 CDSs were also identified using a constant cut-off value,
however, 65 CDSs were identified uniquely to this method.
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Figure 14. Venn Diagram showing CDSs that were designated absent or divergent in C. jejuni strains
using a constant cut-off of 0.5 (red circle) and a dynamic cut-off value (green circle). The distribution
of C. jejuni CDSs in the genome can be visualised in section (1\). CDSs present in both list are shown
in yellow can be clearly seen distributed throughout the genome. D s identified as absent or
divergent using a constant cut-off value of 0.5 are shown in the red circle. DSs identified as absent or
divergent using a dynamic cut-off value are shown in the green circle. D s identified as absent or
divergent using both methods are shown in the yellow section. ection (8) hows a Venn diagram with
the 579 CDSs (red and yellow) identified as absent or divergent using a constant cut-off value of 0.5. In
the green and yellow circles 544 identified as absent or divergent u ing a dynamic cut- ff value are
shown. CDSs in the yellow overlapping segment are D s identified as absent or divergent using both
cut-off values.
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4.3 Results - Comparison of DNA microarray hybridisation data of two
sequenced C.jejuni strains (NCTCII168 and RM1221)
4.3.1 Comparison of DNA microarray hybridisation data from C. jejuni strain
NCTC11168 and RM1221 using a constant cut-off value of 0.5 and a dynamic
cut-off value
The DNA of two fully sequenced and annotated C. jejuni strains (RM1221 and
NCTC11168) were competitively hybridised with the C. jejuni microarray in
duplicate.
Using a constant cut-off value ofO.S, 159 CDSs were identified as absent or divergent
from strain RM1221. Of these 159 variable CDSs, 31 CDSs were non-NCTC11l68
CDSs for which direct comparisons were not possible. Using the same RM1221 DNA
microarray hybridization data but analyzing with a dynamic cut-off value, 118 CDSs
were identified as absent or divergent of which 17 CDSs were non-NCTC 11168
CDSs (Appendix 2). The total number of CDSs identified as absent or divergent using
a dynamic cut-off value (118 CDSs) was also identified using the constant cut-off of
0.5. However, using a constant cut-off value an additional41 CDSs were identified as
absent or divergent (Appendix 3).
4.3.2 Comparison of DNA microarray data from RM1221 with sequence data
NCTC11168 and RM1221 genome sequences were compared using BLASTn at
BIlG@S. RM1221 CDSs against NCTC11168 CDS and C. jejuni microarray reporter
elements against RM1221 CDSs BLASTn results were supplied (Adam Witney,
personal communication). BLASTn results indicated whether each of the
NCTC11168 CDS had 'no match' to any RM1221 CDSs, or, if a match was found,
the nucleotide identity of the two CDSs.
CDSs identified as absent or divergent using constant and dynamic cut-off values
were compared back to the RM1221 BLASTn data to determine whether each CDS
was absent, divergent or present. Of the 159 CDSs identified as absent or divergent
using a constant cut-off value ofO.5, 128 were from NCTCl1168 and 31 were non-
NCTC11168 CDSs. Thus, 128 of a potential 159 CDSs were compared with the
NCTCll168 against RM1221 BLASTn data. No match was found in the genome
sequence ofRM1221 for 61 CDSs of the 128 NCTC11168 CDSs identified as absent
or divergent in RM1221 using a constant cut-off value of 0.5, that is 61 CDSs were
correctly identified as absent from RM1221 using a constant cut-off value of 0.5
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(Appendix 4). Additionally, 57 of the 128 NCTC11168 CDSs were identified as
absent or divergent from RM1221, using a constant cut-off value ofO.5. A total of 10
CDSs were incorrectly identified as absent or divergent using a constant cut-off value
of 0.5 as these 10 CDSs were found to have 100% nucleotide identity in both
NCTCl1168 and RMl221 (Appendix 5).
Analysing RMl221 DNA micro array data with a dynamic cut-off value method
identified 118 CDSs as absent or divergent of which 101 CDSs were from
NCTCl1168 and 17 were non-NCTCll168 CDSs. Comparing the 101 NCTCll168
CDSs that were identified as absent or divergent using a dynamic cut-off value with
the BLASTn sequence comparisons revealed that 57 CDSs were correctly identified
as absent as these CDSs had no match to any CDSs in the RM1221 genome
(Appendix 4). In addition 35 of the 101 absent or divergent CDSs were correctly
identified as divergent from the RM1221 genome. However, 9 CDSs were incorrectly
identified as absent or divergent as these 9 CDSs has 100% nucleotide identity in both
NCTCll168 and RM1221 (Appendix 5). These data are summarized in Table 8.
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4.3 Results - Comparison of DNA microarray hybridisation data of two
sequenced C.jejuni strains (NCTCl1168 and RM1221)
4.3.1 Comparison of DNA microarray hybridisation data from C. jejuni strain
NCTCl1l68 and RM1221 using a constant cut-off value of 0.5 and a dynamic
cut-off value
The DNA of two fully sequenced and annotated C. jejuni strains (RM1221 and
NCTC11168) were competitively hybridised with the C. jejuni microarray in
duplicate.
Using a constant cut-off value ofO.5, 159 CDSs were identified as absent or divergent
from strain RM1221. Of these 159 variable CDSs, 31 CDSs were non-NCTCll168
CDSs for which direct comparisons were not possible. Using the same RM1221 DNA
microarray hybridization data but analyzing with a dynamic cut-off value, 118 CDSs
were identified as absent or divergent of which 17 CDSs were non-NCTC11168
CDSs (Appendix 2). The total number of CDSs identified as absent or divergent using
a dynamic cut-off value (118 CDSs) was also identified using the constant cut-off of
0.5. However, using a constant cut-off value an additional41 CDSs were identified as
absent or divergent (Appendix 3).
4.3.2 Comparison of DNA micro array data from RM1221 with sequence data
NCTC11168 and RM1221 genome sequences were compared using BLASTn at
BJ.1G@S.RM1221 CDSs against NCTC11168 CDS and C. jejuni microarray reporter
elements against RM 1221 CDSs BLASTn results were supplied (Adam Witney,
personal communication). BLASTn results indicated whether each of the
NCTCll168 CDS had 'no match' to any RM1221 CDSs, or, if a match was found,
the nucleotide identity of the two CDSs.
CDSs identified as absent or divergent using constant and dynamic cut-off values
were compared back to the RM1221 BLASTn data to determine whether each CDS
was absent, divergent or present. Of the 159 CDSs identified as absent or divergent
using a constant cut-off value ofO.5, 128 were from NCTC11168 and 31 were non-
NCTC 11168 CDSs. Thus, 128 of a potential 159 CDSs were compared with the
NCTC11168 against RM1221 BLASTn data. No match was found in the genome
sequence ofRM1221 for 61 CDSs of the 128 NCTCll168 CDSs identified as absent
or divergent in RM1221 using a constant cut-off value ofO.5, that is 61 CDSs were
correctly identified as absent from RM1221 using a constant cut-off value of 0.5
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Table 8. Comparison of data analysis methods for identifying absent or divergent
CDSs from the sequenced C.jejuni strain RMl22l compared to NCTCll168
Cut-off Value Constant (0.5) Dynamic
Total number of CDSs 159 118
identified as absent or
divergent
Non-NCTCII168 CDS 31 17
identified as absent or
divergent
NCTC11168 128 101
CDSs identified
as absent or divergent
CDSs that are absent 61 57
from RM1221
CDSs that are divergent 57 35
in RM1221
CDSs identified as absent 10 9
or divergent from
RM1221 that are 100%
identical (false negatives)
4.4 Discussion
4.4.1 Calculation of the C. jejuni functional core using two different analysis
methods
One of the objectives of this chapter was to compare two DNA microarray data
analysis methods on the same collection of C. jejuni strains. These data would
indicate how the use of different cut-off criteria influences the identification of absent
or divergent genes.
Whole genome comparisons were carried out using GeneSpring6.1 software and
GACK. This comparison allowed the difference between a constant cut-off value of
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0.5 to denote absence or divergence used in GeneSpring6.l to be compared with a
dynamically selected cut-off value used in GACK. Within GeneSpring6.1 it is
assumed that most genes will be present in the test and control channel thus ratios are
normalised to represent a linear ratio of 1. Using GeneSpring6.1 a constant ratio cut-
off value is selected to categorise absent or divergent genes from those that are
present in the test strain. In this study genes were categorised as present with a ratio of
1, marginal when this ratio fell below 1 but above 0.5 and absent or divergent with a
ratio of 0.5 or below. In bacteria where more than one sequenced strain is available
this cut-off value may be chosen empirically by comparing CDSs in which nucleotide
variation is known. However, for C. jejuni only one annotated genome was available
until February 2005, thus the 0.5 cut-off value was not empirically determined but
was selected based on hybridisation data from the clone array.
By contrast GACK calculates an independent cut-off ratio for each
hybridisation. An EPP is calculated by dividing the expected distribution (if all
reporter elements were present in the test strain) by the observed distribution. GACK
categorises genes either in binary form as either absent or divergent or trinary (used in
this study) where genes are categorised as absent with an EPP of 0%, present with an
EPP of 100% and into a transition region if the EPP is anything other than 0% or
100%.
A comparison of these two DNA microarray data analysis methods using the
same data set of 103 C. jejuni strains identified 579 CDSs (constant cut-off value of
0.5) compared with 544 CDSs (dynamic cut-oft) as absent or divergent of which 479
were common to both methods. This corresponded to a functional core of 1148 CDSs
(constant cut-off) and 1183 (dynamic cut-oft) CDSs respectively. A discrepancy of
100 CDSs identified as absent or divergent only with the constant cut-off value and
65 CDSs were identified as absent or divergent only with a dynamic cut-off value.
4.4.2 Comparison of RM1221 and NCTC11168
The second objective of this chapter was to determine whether a DNA microarray
data analysis method utilising a constant or dynamic cut-off value was more sensitive
at identifying absent or divergent CDSs.
The publication of a second C. jejuni genome sequence, RM 1221, in 2005 facilitated
the BLASTn comparison of the two sequenced C. jejuni strains. BLASTn
comparisons ofRMI221 CDSs against NCTCll168 CDSs, as well as RM1221 CDSs
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against reporter elements were carried out by Adam Witney (BIlG@S). BLASTn data
provided a quantitative method to demonstrate whether a constant cut-off or a
dynamic cut-off value was more sensitive at identifying absent or divergent CDSs.
Direct comparisons of two sequenced C. jejuni strains, RM1221 and NCTCll168, on
the C. jejuni DNA microarray facilitated the validation of DNA microarray
hybridization data through direct comparisons against the sequence.
RM1221 DNA microarray hybridisation data analysed with a constant cut-off value of
0.5 identified 159 CDSs as absent or divergent of which 128 were NCTC 11168
CDSs. By comparing the genome sequences ofNCTCll168 and RM1221 the total
number of CDSs that had no match with RM1221, and were therefore correctly
identified as absent from RM1221 could be determined. Of the 128 CDSs, 61 were
correctly identified as absent from RM1221 and a further 57 were divergent. Using a
dynamic cut-off value to analyze RMl221 DNA microarray hybridization data 118
CDSs were identified as absent or divergent, including 101 NCTCll168 CDSs of
which 57 CDSs were correctly identified as absent and 35 CDSs correctly as
divergent. All of which were also identified using the constant cut-off value of 0.5.
Thus, the data analysis method utilising constant cut-off value of 0.5 identified all the
absent or divergent CDSs identified with a dynamic cut-off, with an additional four
absent CDSs and 22 divergent CDSs. However, ten CDSs and nine CDSs labeled as
absent or divergent using a constant cut-off and dynamic cut-off value respectively
were, in fact, present in RM1221 with 100% nucleotide identity. It is uncertain why
these CDSs were identified as absent or divergent in RMl221. However, nine CDSs
were mistakenly identified as absent or divergent using both methods (with an extra
one CDS identified using the constant cut-off value). It is possible that if multiple
paralogous CDSs are present in NCTC 11168 for a single RM 1221 gene, cross
hybridization may occur leading to lower signal intensity in the test channel. This
would result in the output data for that reporter element indicating that the CDSs was
absent or divergent in the test strain, explaining the identification of false negatives
with both analysis methods.
Overall, these data indicate that the use of a DNA microarray data analysis
method that utilises a constant cut-off value compared with a dynamic cut-off value
facilitates the identification of more of the genuinely absent (61CDSs compared with
57 CDSs) and divergent CDSs (57 CDSs compared with 35 CDSs) in a test strain.
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5.0 Comparative genomics of potentially non-pathogenic strains and
human C. jejuni strains from patients with different clinical
presentations
5.1 Introduction
5.1.1 Aims
C. jejuni strain diversity combined with variable host responses results in a complex
spectrum of disease outcomes, ranging from asymptomatic colonisation to severe
inflammatory diarrhoea and occasionally sequelae such as OBS. Previous studies
have shown that remarkable differences also exist between C. jejuni strains with
respect to phenotypic properties such as cell invasiveness, rates of translocation
across cell mono layers, toxin production and colonisation of chickens (Hu and
Kopecko, 1999), but the genetic differences between C. jejuni strains exhibiting these
observed differences are unknown. Precise strain comparisons from well-
characterised strains of diverse origins may allow correlates of pathogenesis to be
determined and the subsequent identification of potential virulence determinants. In
this chapter, strains representing the spectrum of clinical presentations and outcomes
of human C. jejuni infection have been identified for comparative genomics analysis.
The overall aim of this chapter was to identify putative virulence determinants and
genetic markers of clinical outcome through the comparative hybridisation of DNA
from strains representing a range of clinical outcomes with the C. jejuni composite
DNA microarray. The strains were divided into four clinical sets to facilitate data
comparison; potentially non-pathogenic, gastroenteritis, septicaemia and GBS.
5.1.2 Strains included in the study
Potentially non-pathogenic strains from asymptomatic carriers were identified from
the lID study (Chapter 1.2.1). Phenotypic information about these strains is shown in
Table 9.
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Table 9. Phenotypic information for C. jejuni strains isolated from asymptomatic
carriers identified from the lID study
*UT= untypeable
**RDNC = reacts with phage but does not conform to designated type
Strain Serotype Phage Source
type
33084 HS35 I Human
33106 HS4 1 Human
31481 HS37 76 Human
31485 UT* 2 Human
31467 HS18 RDNC** Human
32787 HSl8 RDNC** Human
32799 HS50 5 Human
A second set of potentially non-pathogenic strains, identified by MLST, were
included in the study. Two clonal complexes associated with the sand of bathing
beaches, and not with human disease cases, livestock or chickens have been identified
using MLST (K.E. Dingle, Personal Communication). It is thought that the natural
host of these isolates may be wild birds. In Sweden, C. jejuni has been identified in
black-headed gulls (Larus ridibundus) and it is thought that wild birds may act as an
important reservoir for C. jejuni (Broman et al., 2002). We can, therefore, hypothesise
that faecal contamination of the beaches by birds may have preceded the isolation of
these strains which may lack genes with potentially important roles in human
virulence or chicken colonisation. Six such isolates were included in the study for
which phenotypic information is provided in Table 10.
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Table 10. Phenotypic information for potentially non-pathogenic C. jejuni strains
from sand samples
"'UT= untypeable
Strain Penner serotype Source
1771 (79309) UT'" Beach isolate
1772 (79260) HS 55 Beach isolate
1773 (79196) UT'" Beach isolate
1791 (79207) HS2 Beach isolate
1792 (79046) No data Beach isolate
1793 (79044) HS5 Beach isolate
Having established two potential sources of non-pathogenic strains, strains from
different clinical presentations were identified through the Sentinel study (Chapter
1.2.2). Strains representing three cohorts of patients presenting with distinct clinical
symptoms; diarrhoea, bloody diarrhoea and vomiting (Table 11) were selected for
comparative genomics investigations.
Table 11. Phenotypic information for C. jejuni strains with different clinical
presentations
"'UT= untypeable
Bloody
Strain Serotype Phage type Diarrhoea stool Vomiting
34555 HS5 34 1 0 0
35424 UT'" 1 1 0 0
35535 UT'" 1 1 1 0
35799 UT'" 1 0 0 0
36069 HS 5 1 1 0 1
36439 HS12 1 1 0 0
36860 HS21 44 1 0 0
36952 UT'" 36 1 0 0
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37537 UT'" 1 1 1 0
38353 HS5 1 1 1 0
38556 HS13 No data 1 0 1
38576 UT'" 33 1 1 0
38762 HS18 No data 1 1 0
38857 HS23 1 1 0 1
39182 HS13 1 1 0 1
39640 UT'" 1 1 1 0
39828 HS42 1 1 0 1
40917 HS21 8 1 1 0
41651 HS16 5 1 0 1
42724 UT'" 1 1 1 0
43157 HS13 2 1 0 1
43205 HS2 33 1 1 0
44464 HS37 44 1 0 0
44811 HS2 36 1 0 1
44933 HS13 1 1 0 0
44958 HS50 34 1 0 1
45557 HS60 No data 1 1 0
45631 HS4 1 1 0 0
48612 HS2 36 1 1 0
50097 HS13 39 1 1 0
52331 HS50 34 1 0 1
52368 UT'" 44 1 1 0
53259 HS2 1 1 0 1
54489 UT'" 33 1 0 0
55320 HS13 2 1 1 0
55703 HS13 1 1 0 1
56281 HS50 5 1 1 0
56282 HS50 5 1 0 0
56519 HS12 2 1 1 0
56832 HS50 1 1 0 1
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58473 HS2 62 1 0 0
59161 HS2 1 1 0 1
59214 UT'" 33 1 0 0
59364 HS31 2 1 0 0
59424 HS31 2 1 0 1
59627 UT'" 19 1 0 0
62567 UT'" 1 1 0 0
62914 UT'" 1 1 0 1
63326 HS31 1 1 0 0
64555 HS31 2 1 1 0
The symptoms most commonly associated with campylobacteriosis are fever,
abdominal cramps and diarrhoea. However, sequelae can occur, including
endocarditis, bacteraemia, meningitis and OBS (Blaser, 1995) (Chapter 1.2.3). OBS is
a sequela to infection and C. jejuni is the most commonly associated organism that
triggers this neuropathy. We may hypothesise that strains associated with sequelae
may differ at a genomic level to strain NCTCll168 that was isolated from a patient
with gastroenteritis who apparently did not develop OBS.
To investigate a potentially hyperinvasive group of C. jejuni strains, seven isolates
from the blood samples of patients with C. jejuni septicaemia and two C. jejuni strains
isolated from patients who subsequently developed OBS were selected (Table 12).
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Table 12. Phenotypic information on C. jejuni strains associated with sequelae
*UT= untypeable
Strain Source Serotype Phage type Clinical data
(HS)
46979 Human 50 6 Immunocompromised -
blood Chronic leukaemia
43983 Human 50 6 Infected in USA
blood
44119 Human 18 2 Immunocompromised -
blood Non-Hodgkins lymphoma
34007 Human 18 2 Immune system intact
blood
52472 Human UT* 1 Immune system intact
blood
53250 Human 60 2 Immunocompromised -
blood Post operation sternaortic
biopsy
47439 Human 67 1 Immune system intact
blood
15168 GBS 19 2 No data
18836 OBS 19 2 No data
5.2 Results - DNA microarray hybridisation data
5.2.1 Asymptomatic carriage and other potentially non-pathogenic strains
Microarray hybrisidisations were carried out in duplicate on two experimental
replicates for each strain using the method described in Chapter 2.4. Variation
between seven C. jejuni strains isolated from asymptomatic patients and strain
NCTC 11168 was observed with between 92 CDSs and 172 CDSs absent or divergent.
CDSs that were designated absent or divergent in each individual strain were
compared using the Venn diagram function in GeneSpring6.1 producing a gene list
containing only genes that were absent or divergent in each of the seven strains.
Twenty-two CDSs were consistently absent or divergent in the seven strains (Table
13). This diversity was found largely in the CPS biosynthesis locus in which CDSs
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cj1421 and cj1422 were consistently absent or divergent from all seven isolates. CfrA,
a probable iron uptake protein (ferric receptor) was also absent or divergent in each of
the seven strains from asymptomatic carriers. In addition, one of the novel non-
NCTCll168 CDSs, cj11828-05 involved with LOS biosynthesis, was also absent or
divergent in each of the potentially non-pathogenic strains isolated from
asymptomatic patients.
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Table 13. CDSs absent or divergent in seven potentially non-pathogenic strains
isolated from asymptomatic carriers
CDS Genbank Annotation
cj0755 CfrA, probable iron uptake protein (ferric siderophore receptor)
cj0139 possible endonuclease
cj1421c capsule polysaccharide biosynthesis locus
cj1422c capsule polysaccharide biosynthesis locus
cj1426c capsule polysaccharide biosynthesis locus
cj1428c capsule polysaccharide biosynthesis locus
cj1429c capsule polysaccharide biosynthesis locus
cj1430c capsule polysaccharide biosynthesis locus
cj1431c capsule polysaccharide biosynthesis locus
cj1432c capsule polysaccharide biosynthesis locus
cj1433c capsule polysaccharide biosynthesis locus
cj1434c capsule polysaccharide biosynthesis locus
cj1435c capsule polysaccharide biosynthesis locus
cj1436c capsule polysaccharide biosynthesis locus
cj1437c capsule polysaccharide biosynthesis locus
cj1438c capsule polysaccharide biosynthesis locus
cj1439c capsule polysaccharide biosynthesis locus
cj1440c capsule polysaccharide biosynthesis locus
cj1441c capsule polysaccharide biosynthesis locus
cj1447c kpsT, probable capsule polysaccharide export ATP-binding protein
cj1448c kpsM, probable capsule polysaccharide export system inner membrane
protein
cjl1828-05 Lipo oligosaccharide sequence from non-NCTC11168 strain 11828
Six potentially non-pathogenic strains isolated from bathing beaches were also
hybridised with the microarray. Higher levels of variation throughout the genome
were observed in the beach isolates than for the potentially non-pathogenic strains
from asymptomatic patients. Between 127 CDSs and 225 CDSs were absent or
divergent in the beach isolates compared to the control strain, NCTC 11168. CDSs
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that were designated absent or divergent in each individual strain were compared
using Venn diagrams to produce a gene list indicating only CDSs absent or divergent
to all the strains included in the study. Forty-eight CDSs were consistently absent or
divergent in the six strains (Appendix 6). This diversity was found largely in the LOS
biosynthesis locus with five CDSs from this locus, cj1138, cj1139, cj1142, cj1143 and
cj1144, divergent in all six isolates. Interestingly, a probable secreted serine protease
(cj 1365) as well as three CDSs associated with iron uptake (cj0178, cj0179 and
cj0181) were also absent or divergent in each of the six strains. Only two CDSs
identified as absent or divergent in strains isolated from asymptomatic carriers were
absent or divergent in the beach isolates, cj0755 and cj0139 encoding a probable
ferric receptor and possible endonuclease respectively. Over 15% of the genes that
were absent or divergent in the beach isolated were of unknown function. Table 14
shows a selection of CDSs identified as absent or divergent from each of the
potentially non-pathogenic beach isolates.
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Table 14. Selected CDSs that were absent or divergent in all potentially non-
pathogenic beach isolates (full list in Appendix 6)
CDS Genbank Annotation
cj0755 CfrA, probable iron uptake protein (ferric siderophore receptor)
cj0139 possible endonuclease
cjJl38 LOS biosynthesis
cjJl39c LOS biosynthesis
cjJl42 LOS biosynthesis
cj1143 LOS biosynthesis
cjJl44 LOS biosynthesis
cjJ365c probable secreted serine protease
cj0178 possible outer membrane siderophore receptor
cj0179 ExbB 1, biopolymer transport protein
cj0181 TonB 1, possible tonB transport protein
5.2.2 Gastroenteritis; diarrhoea, bloody diarrhoea and vomiting
In total, 14 C. jejuni isolates from patients presenting with diarrhoea, 15 with bloody
diarrhoea and 15 with vomiting as the predominant symptom of campylobacterioisis
were competitively hybridised with NCTC11168 (a clinical isolate from a patient with
diarrhoea). Analysis of the hybridisation data revealed no CDSs that were absent or
divergent in all of the 14 C. jejuni strains from patients presenting with diarrhoea as
the predominant symptom compared to NCTC 11168. Furthermore, of the 15 isolates
from patients with bloody diarrhoea and 15 isolates from patients with vomiting as the
predominant symptom, no CDSs were identified as absent or divergent from strains
associated with either clinical presentation.
5.2.3 Septicaemia
Seven strains isolated from the blood samples of patients with C. jejuni septicaemia
were hybridised with the composite DNA micorarray. Between 13 and 130 CDSs were
absent or divergent in the strains with a median of 117 CDSs that were absent or
divergent. Twenty CDSs were absent/divergent from five of the strains (Table 15), with
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six of these CDSs common to six strains and just one, Cj1677 encoding a probable
lipoprotein, absent or divergent in all seven strains.
Table 15. eDSs absent or divergent in five septicaemia strains 52472, 47939,
44119,43983 and 34007
eDS Genbank annotation
cjOO33 probable integral membrane protein
cj0815 unknown
cj0816 unknown
cj0818 probable lipoprotein
cjl051c probable restriction modification enzyme
cj1136 LOS biosynthesis locus
cj1137c LOS biosynthesis locus
cj1138 LOS biosynthesis locus
cj1139c LOS biosynthesis locus
cj1l41 neuBl LOS biosynthesis locus
cj1l42 neue 1 LOS biosynthesis locus
cjl143 neuAl LOS biosynthesis locus
cj1l44c LOS biosynthesis locus
cj1l45c LOS biosynthesis locus
cj1395 possible pseudogene
cj1677 probable lipoprotein
cj1721c possible outer membrane protein
cj1722c unknown
cj1723c probable periplasmic protein
5.2.4 Microarray analysis of strains associated with GBS sequelae
A total of 131 CDSs were absent or divergent to both GBS strains included in the study,
including cj1686, or TopA encoding DNA topoisomerase I.
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5.3 Results - Comparative phylogenomics of human C. jejuni strains from the
spectrum of disease outcome
5.3.1 Phylogenetic relationships
DNA microarray hybridisation data for 91 C. jejuni strains was collated. The strains
were all isolated in the UK and included 63 isolates from the spectrum of clinical
outcomes described above and 28 non-clinical C. jejuni strains (including six
potentially non-pathogenic strains isolated from sand from beaches) (Appendix 1).
The ratio of fluorescence for each NCTCl1168 reporter element was converted into
binary form manually and later using a Perl script (provided by Adam Witney). Zero
was taken to represent a gene that was absent or divergent (with a ratio of 0.5 or
below) and' l' represented a gene that was present in both the control and test strain
(with a ratio of above 0.5) (Chapter 2.6.1). This was repeated for 91 C. jejuni strains
for which whole genome comparisons were carried out.
Clinical strains 39640 and 53259 in which over 5% of the total genes were flagged
were manually removed from both data sets as were genes flagged in over 10% of all
strains (Table 16). Remaining flagged genes were denoted with a question mark.
98
Table 16. Flagged genes removed from data sets
Gene removed from data Percentage of strains in
set which gene is flagged
cjOOOI 18%
cjOOO2 11%
cjOOO8 18%
cjOO11 22%
cjOO30 23%
cjOO36 14%
cjOl18 66%
cjOl21 53%
cjOl24 37%
cjO]28 26%
cjOl43 11%
cjOl85 12%
cj0395 22%
cj0735 16%
cj0747 24%
cj0748 21%
cj0776 17%
cj0782 10%
cj0797 10%
cj080] 50%
cj0896 63%
cjlO24 63%
cjlO63 55%
cjlO72 67%
cjlO73 66%
cj1J06 73%
cjl694 23%
The data set was then cross checked back against the raw microarray data to ensure
that genes were correctly named' 1', '0' and I?' according to the original gene lists in
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GeneSpring6.1. These data were then transformed into Nexus format (Chapter 2.6.1).
The Nexus format matrix was used to determine the relationship of strains using
Bayesian based algorithms implemented through Mr Bayes v.3.0 software. With
samples and saves from every fortieth tree, two million generations of Markov Chain
Monte Carlo (MCMC) were completed and this process was optimised by adjusting
parameters such as annealing temperature. The first one million trees were then
discarded for each optimisation and statistical stability was calculated to determine
the robustness of the phylogeny of the last 750,000 trees. Majority rule consensus
trees and clade credibility values were obtained for each tree using Phylogenetic
Analysis Using Parsimony (PAUP*). Tree topology was viewed using TreeView.
The optimal tree was selected based on statistical support for the phylogeny. The tree
showed a topology comprising two major clades (two or more strains with a common
ancestor), herein referred to as clade A and B. Clade A contained 26/63 (41%) of the
total number of clinical isolates including 1/9 (11%) of those that were associated
with sequelae (Figure 15). Clade B contained the remaining 37/63 (59%) of clinical
isolates including 8/9 (89%) of those that were involved with sequelae Le. post
infection neuropathy and septicaemia.
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Figure 15. Phylogenetic relationship of strains associated with different clinical outcomes. Bayesian
strict and 95% majority rule consensus phylogeny of C. jejuni DNA-DNA microarray binary data
(hybridisiation threshold 0.5) with associated branch lengths. The phylogeny incorporates a 16
category gamma distribution to model hybridisation rate heterogeneity between genes. Genes were
omitted if more than 10% of taxa showed erroneous hybridisation. Four incrementally heated
Metropolis coupling Markov Chain Monte Carlos were run for 1000000. Phylogenies were sampled
every 40 generations providing a consensus based on 25,000 phylogenies. P = 1.0, represents 100% of
all phylogenies showing a given topology. Strains are coloured according to the clinical outcome of the
C. jejuni infection.
5.3.2 Identification of genetic markers indicative of clinical outcome
Phylogenetic analysis of C. jejuni strains from different clinical outcomes indicated that
strains associated with asymptomatic carriage, diarrhoea, bloody diarrhoea, vomiting
and septicaemia did not form distinct clonal populations, related by a common ancestor.
Moreover, 22 CDSs that were identified as absent or divergent from all seven strains
isolated from asymptomatic carriers (Table 13) were also identified as absent or
divergent from strains associated with diarrhoeal disease. The 22 CDSs do not,
therefore, form genetic markers indicative of C. jejuni associated with asymptomatic
carriage. Similarly, cj 1677 was identified as absent or divergent from all seven
septicaemia isolates. However, this CDS was found to be absent or divergent in strains
from other clinical outcomes and presentations of C. jejuni human disease and does not
form a genetic marker associated with septicaemia. Furthermore, in five of the seven
septicaemia strains, eight CDSs involved with LOS biosynthesis were absent or
divergent (cjl136-cj 1139, cjl141-cj 1145). LOS variation in these strains was
subsequently investigated at National Research Canada using mass spectrometry to
establish whether septicaemia strains possess a unique LOS structure. Three LOS
classes have been described in the literature (Gilbert et aI, 2000), although at the time of
writing a further two have subsequently been identified (M. Gilbert, personal
communication). A unique LOS outer core structure could form a clear genetic marker
to distinguish C. jejuni strains associated with septicaemia. However, six of the
septicaemia strains fell into four different LOS classes (Table 17) with two of the
strains exhibiting previously undescribed LOS structures.
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Table 17. Summary of mass spectrometry analysis of LOS outer core structures
from seven C.jejuni septicaemia strains
Septicaemia strain LOS class
34007 D
43983 A
44119 D
47439 Unknown*
47886 C
52472 Unknown*
53250 E
*The unknown LOS outer cores appear to be different from each other so there may be
six different outer LOS cores expressed by seven different septicaemia strains
It is clear from these structural analyses that the C. jejuni strains associated with
septicaemia in this study do not possess a unique LOS structure. Moreover, a high
level of structural diversity in the LOS outer core exists between these isolates.
Therefore, the LOS outer core structure does not form a genetic marker indicative of
C. jejuni strains that cause septicaemia.
Unlike strains from all other clinical outcomes, C. jejuni strains associated with GBS
and the 6 potentially non-pathogenic strains from beaches did form distinct clonal
populations. The two GBS isolates also formed a unique clade, demonstrating that
these two strains possessed a similar genomic make up distinct from strains associated
with other clinical outcomes. Of the 131 CDSs that were identified as absent or
divergent from both GBS strains using DNA microarray hybridization data, cj1686, or
topA encoding DNA topoisomerase I,was identified as present in the remaining 89
isolates included in the study.
5.3.3 Identification of genetic markers associated with potentially non-
pathogenic strains isolated from sand
Potentially non-pathogenic C. jejuni strains isolated from beaches also formed distinct
clonal populations (Figure 15). Three beach isolates of MLST ST 177 formed a clonal
population unique and distinct from a clonal population formed by three MLST ST
179 beach isolates. Analysis of the DNA microarray hybridisation data indicated that
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CDS cj0059, putatively encoding FliY, the flagellar motor protein switch, was absent
or divergent from beach strains of MLST ST 179 but present in every other strain in
the study. PCR amplification of cj0059 in strains 1791, 1792 and 1793 revealed weak
products for strains 1791 and 1793. However, a strong band was observed for 1792
and the control (NCTC11168) (Figure 16).
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Figure 16. PCR analysis of cj0059 in beach isolates. Lane 1 shows molecular weight marker. Lane 2
shows product of 1791, lane 3 shows product of 1792, lane 4 shows product of 1793 and lane 5 shows
product of control strain NCTCII168.
Five CDSs were identified as uniquely absent or divergent in 3 beach strains of
MLST ST 177 (Table 18).
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Table 18. eDSs uniquely absent or divergent to beach isolates of MSL T ST 177
eDS Annotated function
cj0145 unknown
probable integral
cj0266 membrane protein
cj0887 flaD possible flagellin
mdaB protein
cj1545 homologue
cj1674 unknown
PCR analysis of the five CDSs in the MLST ST 177 beach isolates indicated that
cj0145, cj0887 and cj1545 were absent from each of the beach strains and present in
the control strain NCTC1116S (Figures 17 and IS). However, weak products for
cj0266 were observed in all three strains (Figure IS) and cj1674 was present in the
three beach isolates and the control strain (Figure 19).
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Figure 17. PCR analysis of cj0145 in MLST ST 179 beach isolates. Lane 1 shows the molecular
weight marker. Lane 2 shows strain 1791, lane 3 shows strain 1792, lane 4 shows strain 1793 and lane
5 shows control strain NCTC11168.
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Figure 18. PCR analysis of cj0266, cj0887 and cj 1545 in beach isolates. Lane 1 shows the molecular
weight marker, lane 2 shows the observed product for strain 1771 for cj0266, lane 3 shows the
observed product for strain 1772 for cj0266, lane 4 shows the observed product for strain 1773 for
cj0266 and lane 5 shows the observed product for control strain NCTC11168 for cj0266. Lane 6 shows
the observed product for strain 1771 for cj0887, lane 7 shows the observed product for strain 1772 for
cj0887, lane 8 shows the observed product for strain 1773 for cj0887 and lane 9 shows the observed
product for control strain NCTC1l168 for cj0887. Lane 10 shows the observed product for strain 1771
for cj 1545, lane 11 shows the observed product for strain 1772 for cj 1545, lane 12 shows the observed
product for strain 1773 for cj 1545 and lane 13 shows the observed product for control strain
NCTCl1168 forcjl545.
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Figure 19. PCR analysis of cj 1674 in beach isolates. Lane 1 shows molecular weight marker, lane 2
shows strain 1771, lane 3 shows strain 1772, lane 4 shows strain 1773 and lane 5 shows control strain
NCTC11168.
CDS cj1365, encoding a putative secreted serine protease, was identified as absent or
divergent from all potentially non-pathogenic beach isolates, both those of MLST ST
177 and MLST ST 179. Although this CDS was identified as absent or divergent in
several clinical isolates, cj1365 was present in 88% of the clinical isolates included in
the study (Figure 20). PCR analysis of beach isolates 1771, 1772, 1773, 1791, 1792
and 1793 indicated that cj1365 is absent from all six environmental isolates (Figure
21). Further analysis of the DNA microarray hybridisation data for these isolates
indicated that the CDSs flanking ej1365 were present in each strain. Subsequent
sequencing of this region in the six beach isolates clearly demonstrated that cj1365
was absent whilst the flanking CDSs were present (Andrey Karlyshev, personal
communication), validating the microarray data for this CDS.
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Non-chicken clade chicken clade
Figure 20. Distribution of cj 1365 among C. jejuni strains. Parsimony based gene analysis for
determining the distribution of individual CDS cj 1365 throughout the phylogenetic tree. Strains in
which cj 1365 are absent are coloured yellow. Strains in which cj 1365 are present are coloured blue.
Cj1365 is absent from beach isolates and 8 clinical isolates. In all other isolates cj 1365 is present.
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Figure 21. PCR analysis of cj 1365 in beach isolates. Lane 1 shows the molecular weight marker. Lane
2 shows 1771, lane 3 shows 1772, lane 4 shows 1773, lane 5 shows 1791, lane 6 shows 1792, lane 7
shows 1793 and lane 8 shows the control strain NCTCII168.
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5.4 Discussion
5.4.1 Comparative genomics of C. jejuni strains from different clinical outcomes
The aim of this study was to identify potential virulence determinants and genetic
markers associated with strains correlating to different clinical presentations through
comparative genomics of a strain collection representative of the full spectrum of
campylobacter disease outcome. A major reason for developing new comparative
genomics studies for C. jejuni is the absence of an animal model that can be used to
verify virulence determinants or genetic markers of disease. A consequence of the
lack of animal infection model is that, to date, no definitive non-pathogenic C. jejuni
strains have been characterised. Therefore, in this chapter potentially non-pathogenic
C. jejuni isolates as well as isolates from different clinical outcomes were examined at
the genome level in detail. This approach has the advantage over traditional
approaches that use animal models because the isolates are studied in the natural
model of infection, the human host.
In order to detect differences between the control strain NCTC 11168, and the group
of test strains representing a particular clinical outcome, CDSs that were absent or
divergent in each strain were compared using Venn diagrams. A gene list was then
generated comprising only genes absent or divergent in all the strains from the clinical
outcome of interest. This list was then compared back against every other strain
hybridised with the array to determine whether any absent or divergent CDSs were
unique to that group of strains that may account for the observed differences in
clinical outcome of C. jejuni infection. CDSs that were absent or divergent from all
strains associated with distinct specific clinical outcome were identified, with the
exception of strains associated with gastroenteritis. The strain used as a control in
each of the competitive hybridisations was NCTCll168, a clinical strain originally
isolated in 1977 from a patient with gastroenteritis in Worcester. It may therefore be
difficult to tease out subtle genetic differences between strains associated with
gastroenteritis using this control strain. The CDSs that were identified as absent or
divergent in other clinical outcomes were mainly from the loci encoding surface
antigens, in particular the CPS and LOS biosynthesis loci. CPSs and LOS are highly
antigenic surface antigens and it is hypothesised that structural variation of these
surface glycolipids may play a role in evasion of host immune responses and high
levels of variability in these loci has been previously documented in both clinical and
animal isolates (Dorrell et al., 2001; Pearson et al., 2003). None of the CDSs
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encoding surface antigens formed unique genetic markers for strains associated with
different clinical outcomes. However, the LOS biosynthesis locus was identified as a
highly variable region in six out of seven septicaemia strains, with eDSs cj1136-
cj1139 and cj1141-cj1l49 identified as absent or divergent in five of the strains.
Although this locus was highly variable amongst C. jejuni strains from other clinical
outcomes the consistency of variable genes found in the majority of strains from this
unusual clinical outcome was interesting. The LOS loci of the septicaemia strains
were further investigated by mass spectrometry analysis to establish whether the
consistent variation in LOS genes found in these strains correlated with a unique LOS
outer core. LOS structural analysis revealed that the seven strains possessed four
different LOS outer core structures that had been identified in strains from previous
studies (M. Gilbert, personal communication). A further two LOS outer core
structures that were previously unidentified were also discovered. Thus, of the seven
strains analysed six different LOS outer cores were expressed. This study has shown
that strains associated with septicaemia do not have a unique LOS outer core but
instead display highly variable outer core structures. These data also indicate that
there may be many more LOS classes as yet undescribed.
Only strains associated with the post C. jejuni infection sequela, GBS, demonstrated a
potential genetic marker. Cj1686 or topA encoding DNA topoisomerase 1was uniquely
absent or divergent in the two strains associated with GBS by microarray analysis and
no product was observed for cj1686 in either GBS strain using peR. However,
microarray analysis indicated that cj 1686 was present in the remaining 89 isolates
included in the study that weren't associated with GBS. Topoisomerases are enzymes
that introduce additional turns in the DNA alpha helix causing the DNA to supercoil
making it more compact. The relevance of this single gene in the development of GBS
is difficult to speculate on and further GBS associated strains must be investigated. One
previous DNA microarray study investigating the genomic composition of twentysix C.
jejuni strains compared GBS isolates with strains associated with enteritis and did not
identify any regions of genetic diversity specific to GBS strains (Leonard et al., 2004).
It would be interesting to analyse the DNA microarray hybridisation data from this
study using the analysis method employed in this project to determine whether cj1686
was absent or divergent from GBS associated strains, or more simply to screen the GBS
isolates by peR to determine whether cj1686 was present. Similarly, Engberg et al
investigated a worldwide selected population of non-HS 19 C. jejuni strains associated
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with GBS and uncomplicated gastroenteritis (Engberg et al., 2001). The authors were
looking for an epidemiologic marker for GBS associated strains. None was found. Such
a collection of strains would be ideal to investigate with the C. jejuni DNA microarray
to determine a genetic basis for their c1onality, as well as a potential genetic marker for
GBS associated strains.
In conclusion, the analysis of strains from different clinical outcomes using DNA
microarrays is limited by the reporter elements represented on the microarray. CDSs
that are absent or divergent from a particular group of strains in relation to the control
strain may be identified. However, the presence of additional CDSs that may correlate
with a particular disease outcome cannot be ruled out. For instance, strains associated
with septicaemia may possess "hypervirulent" additional genes not present in
NCTCI1168. Furthermore, host factors rather than genomic differences between C.
jejuni strains may be responsible for the differences in the predominant clinical
presentations observed in patients.
5.4.2 Identification of CDSs and a potential virulence determinant, cj1365,
absent from potentially non-pathogenic sand isolates
Six potentially non-pathogenic beach strains isolated from sand on Blackpool beach
were included in this study with the aim of identifying putative virulence genes.
These six strains each possess MLST types previously undetected in human and
chicken isolates and so it was hypothesised that these strains may be potentially non-
pathogenic. The beach isolates also formed distinct clades following phylogenomic
analysis, indicating that they are distinct from other clinical strains included in the
study.
Microarray hybridisation data identified only one CDS, cj0059 encoding FliY, the
putative flagellar motor switch protein, as uniquely absent or divergent in beach
isolates of MLST ST179. Using PCR, weak products of the expected size were
observed in strains 1791 and 1793 and a strong product was observed in strain 1792.
Unfortunately it was not possible to check the motility of these strains as DNA only
was provided for these studies. Five genes were identified as uniquely absent or
divergent in beach isolates of MLST ST179 (cj0145, cj0266, cj0887, cj 1545 and
cj1674). Using peR, weak products were observed for cj0266, encoding a probable
integral membrane protein, and products were observed for cj 1674 encoding a
hypothetical protein. Microarray data is based on the intensity of signal for a
113
particular CDS in both the control and the test strain. The signal intensity in the test
strain may be lower than the control if the portion of the CDS represented on the array
is variable or the size of the fragment is small compared to many other reporter
elements. Data from such reporter elements may result in the categorisation of a CDS
as absent or divergent when it is in fact present in the test strain. However, nucleotide
variation in the CDS in the test strain would also result in lower signal intensity in the
test channel than that in the control channel. The use of PCR screening to verify
microarray hybridisation data for key CDSs is therefore important.
Cj0145 encoding a hypothetical protein, cj0887 encoding FlaD and cj1545 encoding a
MdaB protein homologue were absent in 1771, 1772 and 1773 by PCR. MdaB was
recently characterized as a novel potential antioxidant protein in H pylori. Phenotypic
assays of the H. pylori mdaB mutant indicated that it was more sensitive to H202,
organic hydroperoxides, and the superoxide-generating agent paraquat and 10%
oxygen for growth than the wild type. Exposure of the mutant strain to air for 8 h
resulted in the recovery of no viable cells whereas the wild-type strain survived more
than 10 h of air exposure. The oxidative stress sensitivity of the mdaB mutant resulted
in a deficiency in the ability of the mutant to colonize mouse stomachs (Wang and
Maier, 2004). The absence of cj1545 (mdaB) suggests that these beach strains may be
less able to survive in the human gut than strains expressing the potential antioxidant.
A probable secreted serine protease, encoded by CDS cj1365 was also identified as
absent or divergent in all six of the potentially non-pathogenic 'beach' isolates. PCR
amplification of cj1365 indicated that this gene was absent in the six isolates and
subsequent sequencing of this region revealed that cj1365 was absent from each of the
beach isolates whilst the flanking genes were present in each (Andrey karlyshev,
personal communication). It is unknown whether this gene was 'lost' in beach isolates
or gained in other strains. Secreted serine proteases are well- documented virulence
factors in pathogens, serving multiple functions including the cleavage of human
factor V that aggravates the haemorrhagic colitis characteristic of EHEC infections
(Dutta et al., 2002). The cleavage of factor V is widespread amongst bacterial serine
proteases secreted by pathogens that cause bloody diarrhoea (Dutta et al., 2002). C.
jejuni strains isolated from humans have been shown to produce cytotoxic effects
include the rounding of CHO and HeLA cells indicating the presence of a toxin that
inhibits actin filament formation (Lee et al., 2000). EHEC secretes a serine protease,
EspP, which is thought to act as a cytotoxin, disrupting the actin network when
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applied to Vero cells (Brunder et a!., 1997). Host functional proteins as well as
proteins involved in defence are often targeted by bacterial serine proteases. For
example, Enteropathogenic E. coli (EPEC) produces EspC (Stein et al., 1996). This
cleaves both pepsin and human coagulation factor V, exacerbating haemorrhagic
colitis. EspP is secreted by enterohaemorrhagic E. coli (EHEC). EspP may act as a
cytotoxin, disrupting the actin network when applied to Vero cells (Brunder et al.,
1997). SepA has a role in intestinal inflammation and tissue invasion in Shigellosis
(Benjelloun-Touimi et al., 1995) and Hbp cleaves haemaglobin, playing a role in
abscess formation by Bacteroides fragilis (Otto et al., 2002). Many pathogenic
bacteria secrete proteases but no common role in virulence has been determined.
Cytotoxin production by some human C. jejuni isolates has been demonstrated and
although the nature of the toxin is unknown, detection in human isolates may suggest
relevance to clinical disease. However, the secretion pathway utilised by the putative
serine protease is unknown and requires further investigation. The absence of cj1365
from the potentially non-pathogenic strains is noteworthy as this CDS is present in
88% of the clinical isolates hybridised with the microarray . Thus the putative secreted
serine protease may form part of the arsenal of virulence factors found in pathogenic
C. jejuni. Over 15% of the CDSs that were absent or divergent in the six potentially
non-pathogenic beach isolates were of unknown function. CDSs of unknown function
that have little or no homology to CDSs found in other pathogens are interesting
candidates for further investigation as the mechanism of pathogenesis of C. jejuni
bears little in common to that of well characterized enteropathogens such as E. coli
and Salmonella. We can speculate that the potentially non-pathogenic beach strains
may be poorly adapted to survive and cause disease in the human host but this genetic
make up may confer a selective advantage for survival in this environmental niche.
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6.0 Comparative phylogenomics of C. jejuni strains from different
ecological niches
6.1 Introduction
6.1.1 Aims
This chapter describes the development of a robust and improved method for the
analysis of C. jejuni phylogeny to establish whether strains from the same ecological
niche are related. Furthermore, the aim was to use this method to identify genetic
markers that may distinguish strains from different ecological niches. We have
investigated the relationships of C. jejuni strains through comparative phylogenomics.
This method combines the power of DNA microarrays and robust statistical
algorithms to model phylogeny facilitating the inferral of relationships between
strains from specific sources. Using this novel approach we can determine whether
two or more strains with a common ancestor (herein referred to as a clade) were
isolated from the same host and identify the genomic relatedness of strains isolated
from different hosts. An understanding of genetic differences between C. jejuni
strains from different ecological niches should allow the identification of improved
epidemiological markers and in the long term, the development of rational approaches
to reduce C. jejuni in the food chain.
6.1.2 Sources of human C. jejuni disease
The consumption of undercooked poultry is the most commonly documented source
of human C. jejuni infection. This is partly a result of the citation of chicken as the
principal risk factor in large case-control studies and the fact that C. jejuni is a gut
commensal of avians and is therefore easily transferred onto the skin of chicken
carcasses during food processing (Friedman et al., 2004; Rodrigues et al., 2001). The
presence of C. jejuni on raw chicken may result in human disease if the chicken is
undercooked. Furthermore, cross-contamination from the chicken to other foods for
human consumption may also lead to human C. jejuni infection. However, a variety
of other sources including cattle, water, milk and wild birds also act as a reservoir
(Broman et al., 2002; Engberg et al., 1998; Inglis et al., 2004; Wood et al., 1992).
This may account for the isolation of C. jejuni from diverse environmental samples.
Little is known regarding the contribution of non-chicken sources to the burden of
human C. jejuni infection and this, in turn, has hindered effective control strategies to
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reduce Campylobacter in the food chain. Traditional methods for typing were
introduced to facilitate epidemiological investigations, in particular the tracing of
routes and sources of C. jejuni human infection. Phenotypic typing methods such as
Penner serotyping are largely based on variation in the surface expressed capsular
polysaccharide (CPS) antigen (Karlyshev et al., 2000). However, variation in surface
antigens such as CPS and LOS do not correlate with clinical outcome, source or
pathogenicity. This is partly because C. jejuni strains are genetically diverse (Dingle
et al., 2001a), with loci encoding surface antigens exhibiting particularly high levels
of variation (Dorrell et al., 2001; Gilbert et al., 2002; Karlyshev et aI., 2005). Thus,
since current typing methods have generally been unable to identify strains with
phenotypic characteristics associated with different ecological habitats, the proportion
of human disease attributable to different sources of infection is unknown.
6.2 Results - Comparative phylogenomics
6.2.1 Comparative genomics of C. jejuni from different animal hosts
C. jejuni strains were selected for comparative phylogenomics based on the source
from which the strains were isolated. Partial funding for this study was provided by
the Food Standards Agency (FSA) and so UK isolates only (91) were included
represented by 17 C. jejuni chicken isolates (19%) and five ovine and bovine isolates
(5%). In addition, C. jejuni 6 environmental strains (7%) isolated from sand on
Blackpool beach (Chapter 5.1.2) were also chosen with the 63 C. jejuni clinical
isolates mentioned in the previous chapter. The chicken isolates were collected over a
ten year period (1991-2001) from three different points in the food chain; broiler
flocks, abattoirs and supermarket chicken portions. Using traditional phenotypic
typing methods the 17 chicken isolates were represented by five different serotypes
(HS2, HS5, HS27, HS44 and HS50) and 11 different phage types (PT1, PT2, PT5,
PTI5, PTI9, PT25, PT34, PT35, PT36, PT44 and PT59). Three of the ovinel bovine
strains were isolated from animals (all HS50) and two from supermarket ox liver
portions. All isolates were competitively hybridised in duplicate with the microarray
using the sequenced strain NCTC11168 as a control as described in the previous
chapter.
The distribution of the strains from different ecological niches within the tree
comprised 94% (16/17) of strains from chicken sources falling within the "chicken
clade" (a single isolate was not found in this clade) (Figure 22). Strains from ovinel
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bovine and sand (environmental, beach) formed distinct clades that were
unequivocally supported within the "non-chicken clade". Both clades contained
clinical isolates of which 41% (26/63) were found in the "chicken clade" and 59%
(37/63) in the "non-chicken clade".
6.2.2 Identification of CDSs differenting the "chicken clade" from the "non
chicken clade"
CDSs differentiating the strains in the "chicken clade" from those strains in the "non-
chicken clade" were identified using parsimony-based methods implemented through
MacClade 4 software (Chapter 2.6.3). Similarly, CDSs contributing to ovine, bovine
and environmental sub-clades within clade A were identified. Table 19 shows the
CDSs contributing to the formation of the "chicken clade" and table 20 shows the
CDSs contributing to the strains forming the "non-chicken clade". These tables
indicate whether the CDSs are unique to the clade or if the genotype is shared with
strains from other clades and indicate whether these CDSs are randomly dispersed or
are associated with other flanking CDSs. Additional data including the number of
reconstructed evolutionary changes (RC) of a CDS in a particular branch (this is the
value from which the length of the branch is calculated). For example, a value of 1.0
indicates that a CDS is unique to a clade whereas a value of 0.0 indicates that a CDS
does not contribute to the formation of a clade. Whether the CDS is absent or
divergent and the annotated function of the CDSs are also shown.
118
__ ----- HS2
HS5
HSUT
---0.1
CHICKEN
CLINICAL
ENVIRONMENTAL
OVINE I BOVINE
Figure 11. As Figure 15 but strains labelled according to animal/environmental source.
HS = serotype * = ovine / bovine strain isolated from supermarket meat portion
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Table 19. CDSs specific to "chicken clade" strains
CDS
unique
cj RC to Present or
number value clade? Random? absent/divergent Function
probable DNA
restriction/modification
0032 0.02 no random absent/divergent enzyme
putative Mep domain
signal transduction
0246 0.05 no random absent/divergent protein
panD probable
aspartate 1
decarboxy lase
0296 0.06 no random present precursor
0416 0.03 no random present unknown
0452 0.05 no random present dnaQ exonuclease
0814 0.03 no cj0814-0819 present unknown
0815 0.14 no cj0814-0819 present unknown
0816 0.14 no cj0814-0819 present unknown
0818 0.23 no cj0814-0819 present probable lipoprotein
small hydrophobic
0819 0.07 no cj0814-0819 present protein
probable DNA
restriction/modification
1051 0.04 no random present enzyme
1255 0.05 no random present Possible isomerase
1296 0.18 no cj1296/1297 present unknown
1297 0.14 no cj1296/1297 present unknown
putative acetyl
1321 0.18 no cj1321-1339 present transferase
1322 0.15 no cj1321-1339 present probable hydroxyacyl
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dehydrogenases
probable hydroxyacyl
1323 0.06 no cjJ321-1339 present dehydrogenases
similarity to wbpG,
associated with LPS
1324 0.18 no cjl 321-1339 present biosynthesis
similar to cj1330
involved in the
synthesis of
1325 0.08 no cjJ321-1339 present pseudaminic acid
1338 O.l no cjJ321-1339 present flaB
1339 0.07 no cjl 321-1339 present flaA
putative periplasmic
1376 0.12 no random present protein
1442 0.08 no random present unknown
putative transcriptional
1561 0.07 no cj1561-1562 absent/divergent regulator
1562 0.03 no cj1561-1562 absent/divergent unknown
1677 0.l1 no cj1677/1679 present probable lipoprotein
1679 0.12 no cj1677/1679 present unknown
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Table 20. CDSs specific to "non-chicken clade" strains
CDS
unique
cj RC to Present or
number value clade? Random? absent/divergent Function
panD probable aspartate 1
0296 0.06 no random absent/divergent decarboxy lase precursor
0815 0.14 no cj0815-0819 absent/divergent unknown
0816 0.14 no cj0815-0819 absent/divergent unknown
0818 0.23 no cj0815-0819 absent/divergent probable lipoprotein
0819 0.07 no cj0815-0819 absent/divergent small hydrophobic protein
1321 0.18 no cj1321-1339 absent/divergent putative acetyl transferase
1322 0.15 no cj1321-1339 absent/divergent unknown
1323 0.06 no cj1321-1339 absent/divergent unknown
1324 0.18 no cj1321-1339 absent/ divergent unknown
1325 0.08 no cj1321-1339 absent/divergent unknown
1338 0.1 no cj1321-1339 absent/ divergent flaB
1339 0.07 no cj1321-1339 absent/divergent jlaA
1442 0.08 no random absent/divergent unknown
putative transcriptional
1561 0.07 no cj1561-1562 absent/divergent regulator
1562 0.03 no cj1561-1562 absent/divergent unknown
1677 0.11 no cj1677-1679 present probable lipoprotein
1679 0.12 no cj1677-1679 present unknown
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These data indicate that the most striking gene clusters absent in the "non-chicken
clade" are CDSs cj1321-cj1325 and cj1338 and cj1339. The genes are present in
strains in the "chicken clade". Thus the loss or divergence of this locus is a major
genetic region distinguishing the majority of strains from chicken sources from those
of other animal and environmental sources. Cj1326 is closely associated with this
genetic island and so this CDS was investigated. The distribution of the differential
CDS cj1321 is shown in Figure 23. This graphical representation clearly shows how
cj1321 is distributed in the two clades.
"non-chicken clade" "chicken clade"
Figure 23. Distribution of cj 132 1 among C. jejuni strains. Parsimony based gene analysis for
determining the distribution of individual CDS cj 1321 throughout the phylogenetic tree. Strains in
which cj1321 are absent are coloured yellow, strains in which cjJ321 are present are coloured blue.
Strains in the "chicken clade" all contain cj 1321. Cj 1321 is absent in strains in the "non chicken" clade
with 7 exceptions (5 beach isolates and 2 clinical isolates).
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6.2.3 Identification of CDSs distinguishing strains from ovine and bovine animal
sources
Three ovine and bovine strains formed a clade with two clinical isolates. The
remaining two bovine strains that were isolated from ox liver portions from a
supermarket did not fall in this clade. CDSs that were specific to this clade
comprising ovinelbovine strains isolated from animals were identified and are shown
in Table 21.
Table 21. CDSs specific to ovinelbovine clade
CDS
unique
cj RC to Present or
number value clade? Random'! absent/divergent Function
atpA probable ATP
0105 1.00 no random absent/divergent synthase
putative MCP
domain signal
0246 0.04 no random absent/divergent transduction protein
glpT glycerol-3-
phosphate
0291 0.09 no random absent/divergent transporter
OR14 0.03 no cjOB14-0B19 present unknown
0815 0.14 no cj0814-0819 present unknown
0859 0.05 no cj0859-0860 absent/divergent unknown
putative integral
0860 0.05 no cj0859-0860 absent/divergent membrane protein
0969 0.04 no cj0969-0972 present pseudogene
0970 0.13 no cj0969-0972 present unknown
0972 0.05 no cj0969-0972 present unknown
0987 0.18 no random absent/divergent unknown
small hydrophobic
1159 0.05 no cj1159-1164 absent!divergent protein
1160 0.04 no cj1159-1164 absent/divergent small hydrophobic
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protein
1164 0.06 no cj 1159-1164 absent/divergent unknown
1296 0.18 no cj129611301 present unknown
1297 0.l4 no cj 129611301 present unknown
1300 0.08 no cj129611301 present unknown
1301 0.08 no cj 129611301 present unknown
putative peri plasmic
1376 0.12 no random lost protein
putative sugar
nucleotide
epomerasel
1427 O.l no random present dehydratase
1442 0.08 no random present unknown
putative type 1
restriction enzyme R
1549 0.l2 no cj1549-1560 present protein
putative ATP/GTP
1550 0.14 no cj1549-1560 present binding protein
putative type 1
restriction enzyme S
1551 0.14 no cj1549-1560 present protein
1552 0.l8 no cj1549-1560 present unknown
putative type 1
restriction enzyme
1553 0.l2 no cj1549-1560 present M protein
1555 0.l2 no cj1549-1560 present unknown
1556 O.l no cj1549-1560 present unknown
putative membrane
1558 0.05 no cj1549-1560 present protein
putative membrane
1560 0.09 no cj1549-1560 present protein
possible
1585 0.l7 no random present oxidoreductase
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Nine contiguous CDSs, cj1549-cj1553, cj1555-cj1556 and cj1558-cj1560 encoding
probable restriction enzymes, putative periplasmic proteins and proteins of unknown
function form a large proportion of the CDSs responsible for the differentiation of the
ovine and bovine strains in this clade from other strains. However, these CDSs are
also present in strains from other sources. CDS cj0105 (atpA), encoding a probable
ATP synthase, was identified as absent or divergent from strains found in the ovinel
bovine clade yet this CDS was present in every other isolate (Figure 24).
Figure 24. Distribution of cjO J05 among C. jejuni strains. Parsimony based gene analysis for
determining the distribution of individual CDS cjOJ05 throughout the phylogenetic tree. Strains in
which cjOJ05 are absent are coloured yellow, strains in which cjOJ05 are present are coloured blue.
CjOJ05 is absent from strains in the "ovine / bovine clade". All other isolates contain cjOJ05.
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6.3 Results - Validation of microarray data
6.3.1 peR analysis of CDSs differentiating "chicken clade" strains from "non
chicken clade" strains
CDSs cj1321-cj1326 were screened in strain NCTCll168 as a positive control as well
as chicken strains from the "chicken clade" (Figures 25 and 26). In addition
uncharacterised chicken isolates not previously investigated by micro array analysis
were screened for cj 1321-cj 1326 (Figures 27 and 28) as were clinical strains,
ovine/bovine and beach strain from the "non chicken clade" (Figures 29 and 30).
Moreover, the presence of cj1321-cj1326 in the single chicken isolate found in the
"non chicken clade" was screened for by PCR. Tables 22 to 26 contain the
information for each gel lane.
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Figure 25. Detection of cjJ32J-cjJ326 in strain NCTCII168 and chicken isolates 11919 and 11818.
Lane 1 contains molecular weight marker. Lanes 2 to 7 show the observed PCR products from DNA
isolated from NCTCl1168 amplified with primers for cjJ32J to cjJ326 inclusive. Lanes 8 to 13 show
the observed peR products from DNA isolated from chicken isolate 11919 amplified with primers for
cjJ321 to cjJ326 inclusive. Lanes 14 to 19 show the observed PCR products from DNA isolated from
chicken isolate 11818 amplified with primers for cj 132 J- cj J326 inclusive. Table 22 shows the
information for each gel lane.
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Table 22. Key to Figure 25
Lane Strain Source CDS Expected Observed
2 NCTC11168 sequenced cjJ32J + +
strain
3 NCTCll168 sequenced cjJ322 + +
strain
4 NCTC11168 sequenced cjJ323 + +
strain
5 NCTCl1168 sequenced cjJ324 + +
strain
6 NCTCll168 sequenced cjJ325 + +
strain
7 NCTCll168 sequenced cjJ326 + +
strain
8 11919 chicken cjJ32J + +
9 11919 chicken cjJ322 + +
10 11919 chicken cjJ323 + +
11 11919 chicken cjJ324 + +
12 11919 chicken cjJ325 + +
13 11919 chicken cjJ326 + +
14 11818 chicken cjJ32J + +
15 11818 chicken cjJ322 + +
16 11818 chicken cjJ323 + +
17 11818 chicken cjJ324 + +
18 11818 chicken cjJ325 + +
19 11818 chicken cjJ326 + +
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Figure 26. Detection of cj 1321-cj 1326 in chicken strain 13411. Lane I = molecular weight marker,
lane 2 = peR product for cj1321, lane 3 = peR product for cjI322, lane 4 = PCR product for cj1323,
lane 5 = peR product for cj 1324, lane 6 = peR product for cj 1325, lane 7 = PCRproduct for cj 1326.
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Figure 27. Detection of cj 1321-cj 1326 in uncharacterised chicken strains B, 17M and A. Lanes 1 and
20 contain molecular weight marker. Lanes 2 to 7 show the observed peR products from DNA isolated
from uncharacterised chicken isolate B amplified with primers for cj 1321 to cj 1326 inclusive. Lanes 8
to 13 show the observed peR products from DNA isolated from uncharacterised chicken isolate 17M
amplified with primers for cj 1321 to cj 1326 inclusive. Lanes 14 to 19 show the observed peR products
from DNA isolated from uncharacterised chicken isolate A amplified with primers for cj1321- cj1326
inclusive. Table 23 contains the information for each gel lane.
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Table 23. Key for Figure 27
Lane Strain Source CDS Expected Observed
2 B chicken cj1321 + +
3 B chicken cj1322 + +
4 B chicken cj1323 + +
5 B chicken cj1324 + +
6 B chicken cj1325 + +
7 B chicken cj1326 + +
8 17M chicken cj1321 + +
9 17M chicken cj1322 + +
10 17M chicken cj1323 + +
11 17M chicken cj1324 + +
12 17M chicken cj1325 + +
13 17M chicken cj1326 + +
14 A chicken cj1321 + +
15 A chicken cj1322 + +
16 A chicken cj1323 + +
17 A chicken cj1324 + +
18 A chicken cj1325 + +
19 A chicken cj1326 + +
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Figure 28. Detection of cj 1321-e} 1326 in uncharacterised chicken strains 3852, e and D.
Lanes 1 and 20 contain molecular weight marker. Lanes 2 to 7 show the observed peR products from
DNA isolated from uncharacterised chicken isolate 3852 amplified with primers for ej 1321 to cj J 326
inclusive. Lanes 8 to 13 show the observed peR products from DNA isolated from uncharacterised
chicken isolate e amplified with primers for cj 1321 to cj 1326 inclusive. Lanes 14 to 19 show the
observed peR products from DNA isolated from uncharacterised chicken isolate D amplified with
primers for cj 1321- ej J 326 inclusive. Table 24 contains the information for each gel lane.
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Table 24. Key for Figure 28
Lane Strain Source CDS Expected Observed
1 3852 chicken cj1321 + +
2 3852 chicken cj1322 + +
3 3852 chicken cj1323 + +
4 3852 chicken cj1324 + +
5 3852 chicken cj1325 + +
6 3852 chicken cj1326 + +
7 C chicken cj1321 + +
8 C chicken cj1322 + +
9 C chicken cj1323 + +
10 C chicken cj1324 + +
11 C chicken cj1325 + +
12 C chicken cj1326 + +
13 D chicken cj1321 + +
14 D chicken cj1322 + +
15 D chicken cj1323 + +
16 D chicken cj1324 + +
17 D chicken cj1325 + +
18 D chicken cj1326 + +
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Figure 29. Detection ofcj1321-cjJ326 in strains 47693,1771 and 15168 from the "non chicken clade".
All peR reactions were carried out at the same time as those in figure 25, thus lanes 2 to 7 of figure 25
are the positive control for this gel. Lanes 1 and 20 contain molecular weight marker. Lanes 2 to 7
show the observed peR products from DNA isolated from the outlier chicken isolate found in the "non
chicken" clade amplified with primers for cj 1321 to cj 1326 inclusive. Lanes 8 to 13 show the observed
peR products from DNA isolated from beach isolate 1771 amplified with primers for cjJ321 to cj1326
inclusive. Lanes 14 to 19 show the observed peR products from DNA isolated from clinical isolate
15168 found in the "non chicken" clade amplified with primers for cj1321- cj1326 inclusive. Table 25
contains the information for each gel lane.
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Table 25. Key to figure 29
Lane Strain Source CDS Expected Observed
2 47693 chicken cj1321 - -
3 47693 chicken cj1322 - -
4 47693 chicken cj1323 - -
5 47693 chicken cj1324 - -
6 47693 chicken cj1325 - -
7 47693 chicken cj1326 - -
8 1771 beach cj1321 - -
9 1771 beach cj1322 - -
10 1771 beach cj1323 - -
11 1771 beach cj1324 - -
12 1771 beach cj1325 - -
13 1771 beach cj1326 - -
14 15168 clinical (A) cj1321 - -
15 15168 clinical (A) cj1322 - -
16 15168 clinical (A) cj1323 - -
17 15168 clinical (A) cj1324 - -
18 15168 clinical (A) cj1325 - -
19 15168 clinical CA) cj1326 - -
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Figure 30. Detection ofcj1321-cj1326 in strains 34007,18836 and 12241 from "non chicken clade".
All peR reactions were carried out at the same time as those in figure 25, thus lanes 2 to 7 of figure 25
are the positive control for this gel. Lanes 1 and 20 contain molecular weight marker. Lanes 2 to 7
show the observed peR products from DNA isolated from clinical isolate 34007 found in the "non
chicken" clade amplified with primers for cj 1321 to cj 1326 inclusive. Lanes 8 to 13 show the observed
peR products from DNA isolated from clinical isolate 18836 found in the "non chicken" clade
amplified with primers for cj1321 to cj1326 inclusive. Lanes 14 to 19 show the observed peR products
from DNA isolated from ovine isolate 12241 found in the "non chicken" clade amplified with primers
for cj 1321- cj 1326 inclusive. Table 26 contains the information for each gel lane.
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Table 26. Key for Figure 30
Lane Strain Source CDS Expected Observed
2 34007 clinical (A) cjJ32J - -
3 34007 clinical (A) cjJ322 - -
4 34007 clinical (A) cj1323 - -
5 34007 clinical (A) cjJ324 - -
6 34007 clinical (A) cjJ325 - -
7 34007 clinical (A) cj1326 - -
8 18836 clinical (A) cjJ32J - -
9 18836 clinical (A) cjJ322 - -
10 18836 clinical (A) cj1323 - -
11 18836 clinical (A) cjJ324 - -
12 18836 clinical (A) cj1325 - -
13 18836 clinical (A) cjJ326 - -
14 12241 ovinelbovine cjJ 321 - -
15 12241 ovinelbovine cjJ322 - -
16 12241 ovinelbovine cj1323 - -
17 12241 ovinelbovine cj1324 - -
18 12241 ovinelbovine cj1325 - -
19 12241 ovinelbovine cjJ326 - -
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6.3.2 Confirmation of motility in selected strains from the "chicken clade" and
"non chicken clade"
Due to the location of the cj 1321-cj 1326 in the flagellin modification locus, the
motility of strains from both the chicken and non-chicken clade was tested to
determine whether the absence or presence of these CDSs affected motility. One
chicken strain (11818) from the "chicken clade" in which cj 1321-13 26 were
confirmed as present both by microarray data and PCR was tested for motility. In
addition, one clinical isolate (18836) from the "non chicken clade", in which cj1321-
1326 were identified as absent both by microarray analysis and PCR was tested for
motility. The motile sequenced strain NCTCl1168 (hypermotile variant) was used as
a positive control in motility tests (Figure 31). The motility of chicken strain 11818
(Figure 32) and clinical strain, 18836 (Figure 33) was checked by growing the isolates
on motility agar, in triplicate (Chapter 2.1.3).
Figure 31. Motility after 48 hours of strain NCTCI1168 - positive control. Hypermotile NCTCI1168
positive control for motility phenotype. Innoculum placed at centre of motility agar plate and incubated
for 48 hours. High levels of motility demonstrated by growth out from centre of plate towards the edge
of the petri dish.
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Figure 32. Motility after 48 hours of strain 11818 - chicken isolate from "chicken clade". Three
replicates of chicken isolate 11818 tested for motility phenotype. Innoculum placed at centre of
motility agar plate and incubated for 48 hours. High levels of motility demonstrated by growth out
from centre of plate towards the edge of the petri dish.
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Figure 33. Motility after 48 hours of strain 18836 - clinical isolate from "non chicken clade". Three
replicates of clinical isolate 18836 tested for motility phenotype. Innoculum placed at centre of motility
agar plate and incubated for 48 hours. High levels of motility demonstrated by growth out from centre
of plate towards the edge ofthe petri dish.
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6.4 Discussion
6.4.1 Comparative phylogenomics
In this study phylogenomics utilising comparative genomic data from 91
characterised C. jejuni strains from diverse sources combined with Bayesian based
algorithms were used to determine the phylogeny of the strains. The aim was to
establish whether strains from the same source could be distinguished from strains
isolated from other hosts, facilitating the identification of host specific genetic
markers that could potentially be used to predict the source of human C. jejuni
infection.
Bayesian based algorithms implemented through MrBayes3.0 software were used to
infer robust hypotheses of phylogenetic relationships using whole genome data from
microarray analyses. Relationships were tested using the majority rule and consensus
trees generated using the computer programme Phylogenetic Analysis Using
Parsimony (PAUP*). Phylogenetic trees indicated that strains isolated from the same
host formed distinctive clades with a few exceptions. The "non chicken clade"
comprised 52% (47/91) of the total number of strains including 59% (37/63) clinical
isolates. Ovine, bovine and environmental source strains formed distinct sub clades
within the "non chicken clade". Statistically these were all unequivocally supported
(P=l.O). Several CDSs distinguished strains of ovine and bovine origin from other C.
jejuni strains in the study. However, CDS cjOJ05, encoding a probable ATP synthase,
was uniquely absent or divergent in strains isolated from cows and sheep and the two
clinical isolates present in this clade. Further research is required to substantiate
cjOJ05 as a C.jejuni-specific ovinelbovine genetic marker.
The "chicken clade", so called as 94% (16/17) of the chicken isolates were all found
in this clade, comprised 48% (44/91) of the total number of strains including 41%
(26/63) clinical isolates. The chicken isolates included in this study were highly
diverse by traditional typing methods, comprising five different serotypes (HS2, HS5,
HS27, HS44 and HSSO) and eleven different phage types (PTI, PT2, PTS, PTIS,
PTI9, PT25, PT34, PT35, PT36, PT44 and PT59). In addition, chicken strains were
isolated from both supermarket poultry portions, abattoirs and flocks between 1991
and 2001 from different geographical locations throughout the UK. Based on the
phenotypic and geographic diversity and time frame of isolation of these strains it is
highly unlikely that this phylogeny was due to the presence of a clonal C. jejuni
population found in poultry. Furthermore, traditional typing methods such as
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serotyping and phage typing have failed to identify any relationship between these
isolates.
Some exceptions to the general host specific trends were seen. One chicken strain was
found in the "non-chicken clade"and two ovine bovine strains that were isolated from
supermarket ox liver portions, were found in the "chicken clade". We hypothesise that
C. jejuni adapts to live in specific ecological niches and therefore strains have a
preferred host, yet they are able to survive in other hosts. Furthermore, processing of
animal carcasses post slaughter may lead to cross contamination of a C. jejuni strain
to a source other than its preferred host from where it could be isolated. Moreover,
this population structure may be specific to UK chicken strains. A representative
sample of strains from different geographic locations worldwide would be required
for further investigation to establish whether non-UK chicken isolates were also
distinguishable from strains isolated from different ecological niches. Other
ecological niches that could be investigated include pigs, wild birds, water, milk and
pets.
6.4.2 Identification of an avian genetic marker
Using MacClade 4 software, CDS evolution within the hypothesised phylogenetic tree
was traced. Tracing shows the most parsimonious hypothesis of ancestral states. That
is, the simplest placing of presence and absence or divergence of genes in the
common ancestor of a clade. This indicates how the presence and absence or
divergence of certain genes in an ancestral strain has led to the formation of a new
clade. Conserved regions may be indicative of the selective pressures that caused a
CDS to be lost or to diverge or to remain stable. CDSs that were present and absent or
divergent at the basal node of the major clades were identified. This technique
facilitates the identification of CDS patterns that have been inherited from a common
ancestor. Strains in a clade may exhibit common phenotypic traits and so genetic
markers correlating to phenotype may be identified. Many of the regions of the
genome causing these strains to cluster together into clades were shared with strains
in other clades. For example, a CDS may be absent in all strains in one clade, but also
absent from strains found in other clades. Likewise, all strains in a clade may possess
a CDS with the exception of one. However, some CDSs were clade specific.
Microarray analyses were validated by PCR in (16/91) 18% of the strains through the
amplification of CDSs that differentiated "chicken" and "non chicken" clades or were
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identified as absent or divergent unique to specific clades. These results validated
microarray data.
A significant finding was that an "islet" of CDSs, cj1321-cj 1326, as well as cj1338
and cj1339, were absent or divergent in the common ancestor of the "non-chicken
clade". These CDSs form part of the putative flagellin glycosylation locus of C. jejuni
(Figure 3). Genes cj1338 and cj1339 encode flagellin structural proteins FlaA and
FlaB which are known to be highly diverse between C. jejuni isolates from previous
studies. Variability of C. jejuni flagellar genes flaA and flaB has been well
documented in both the pre-microarray and microarray eras. In Pseudomonas
aeruginosa there is a correlation between flagellin sequence variants and the
inheritance of a genetic island essential for the glycosylation of flagellin (Arora et al.,
2004). This relationship has not been investigated in C. jejuni. However, variation in
flaA between isolates forms the basis of the Fla typing scheme (Meinersmann et al.,
1997) and more recently microarray studies carried out by Pearson and colleagues
also found low levels of hybridisation of genes cj 1338 and cj1339 with reporter
elements on their microarray (Pearson et al., 2003). Thus the absence or divergence of
genes cj1338 and cj1339 in this study was not unexpected and may well be indicative
of strain-strain variation in these genes.
However, CDSs cj1321-cj1326 were present in the majority of chicken isolates and
clinical strains in the "chicken clade". No studies have been reported so far on CDSs
cj1321 to cj1326. From the predicted amino acid sequences, Cj 1321 is similar to
acetyl transferases from many bacterial species, Cj1322 and Cj1323 have similarity to
hydroxy acyl dehydrogenases, Cj 1324 has similarity to WbpG, a LPS biosynthesis
protein found in several bacteria, Cj 1325 is similar to Cj 1330 involved in the
synthesis of pseudaminic acid and Cj1326 has no obvious similarity to any known
protein. Given the similarity of most of the cj1321 to cj1326 CDSs to genes involved
in carbohydrate biosynthesis or sugar modifications, plus the CDSs' location within
the O-linked glycosylation locus, this strongly suggests that these eDSs are involved
in carbohydrate modification of the flagellum. The presence of this potential
glycosylation islet was confirmed by peR in all chicken isolates included in the
study. Additionally, the presence of cj1321-cj1326 was screened for by peR in six
chicken isolates not included in the comparative phylogenomics study. peR products
were observed for cj 1321-cj 1326 in all chicken isolates screened. Furthermore,
cj1321-cj1326 were not observed following peR screening in ovinel bovine, beach
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isolates and clinical isolates from the "non chicken clade". Thus the loss or
divergence of cj1321-cj1326 from "non chicken clade" strains appears to form the
basis of differentiation between the "chicken" and "non-chicken" clades.
In C. jejuni, genetic organisation of flagella glycosylation regions varies dramatically
not only between different species, but also between the strains. For example, the 81-
176 strain of C. jejuni lacks a large contiguous region corresponding to CDSs cj1318-
cj1332 present in C. jejuni strain NCTCI1168 (Figure 3). The deletion may be a
result of the presence of several highly similar genes of the rna! family in the latter
strain, which may have created a recombinational hot spot (Karlyshev et al., 2002a).
In particular, rna! genes 1 and 4 are identical at the nucleotide level (Karlyshev et aI.,
2002a). Microarray studies by Pearson and colleagues also found this locus to be
highly variable between strains (Pearson et al., 2003). To date structural studies on
the flagellin modification system have focused on C. jejuni 81-176 and the C. coli
strain VC167. No structural data has been reported for NCTCI1168 but given this
strain contains several additional genes it is likely that other sugar modifications of
the flagellin (e.g. modification of pseudaminic acid) are yet to be identified.
Glycosylation of flagellin is increasingly being recognised in a number of Gram-
negative pathogenic bacteria, including Pseudomonas aeruginosa, Helicobacter
pylori, Vibrio parahaemolyticus and Aeromonas spp (Castric et al., 2001; Gavin et
al., 2002; Schirm et al., 2003). The modifications increase the hydrophilicity of
flagellin, and often influence the cells' immunogenicity and their interaction with
eukaryotic cells (Castric et al., 2001; Gavin et al., 2002; Logan et al., 2002; Schirm et
al., 2003). The biological significance of the presence of cj1321-cj1326 in chicken
isolates in unknown. However, we hypothesise that it may playa role in the
colonization of chicken caeca.
Given the unequivocal clade separation of chicken and non-chicken strains it is
possible that clinical isolates found in the "chicken clade" were infected from C.
jejuni contaminated chicken. Conversely, the source of infection of human strains in
the "non chicken clade" may have been from other animal and possibly
environmental sources. Genetic markers distinguishing C. jejuni strains from different
ecological niches may allow the source of human infection to be predicted.
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7.0 Overall discussion and conclusions
7.1 Background to this project
At the outset of this project the mechanism of pathogenesis of C. jejuni was poorly
understood. Moreover, it was unknown whether differences in human C. jejuni
disease outcomes, ranging from asymptomatic colonisation to severe inflammatory
diarrhoea and rare sequelae, were due to genetic differences in C. jejuni strains and/
or other factors. The epidemiology of C. jejuni was also poorly characterised.
Traditional typing methods such as serotyping, phage typing and PFGE had been
unsuccessful at distinguishing C. jejuni strains from different ecological niches.
Therefore, the proportion of human disease attributable to different sources of C.
jejuni infection was unknown, although the predominant source had frequently been
cited as poultry (Friedman et al., 2004). Comparative genomics studies into the
genetic diversity of C. jejuni carried out before and during this project have identified
the functional core of various C. jejuni strain collections and have attempted to
identify genetic markers distinguishing C. jejuni strains associated with GBS (Dorrell
et al., 2001; Leonard et al., 2004; Pearson et al., 2003; Taboada et al., 2004).
However, none of these studies had used detailed phylogenetic analysis to compare
large and diverse strain collections.
7.2 Aims of project
The application of DNA microarray analysis of C. jejuni strains of diverse origin
provides information about which CDSs are present or absent/ divergent in the
genomes of individual isolates. Through the development of a gene specific C. jejuni
DNA microarray and improved data analyses methods the objective of this study was
to distinguish C. jejuni from well-characterised UK strains of diverse origins,
identifying determinants important in virulence, transmission and host specificity.
7.3 Results and conclusions
This project began with the design and construction of a gene specific composite C.
jejuni DNA microarray following the success of the proof of principal C. jejuni clone
array (Chapter 3). Reporter elements incorporating PCR products from each CDS in
the NCTC11168 genome were amplified using primers designed to amplify
NCTCll168 CDSs for minimal cross hybridisation. Finally, the microarray also
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included 69 CDSs absent from the NCTCll168 genome. Thus, this second generation
array begins the move away from a strain-specific array to a more representative array
of the C. jejuni species. Additional CDSs included on the microarray were identified,
largely from loci encoding surface antigens, and were highlighted in some
hybridisation experiments.
When considering the microarray approach to comparative genomics, the limitations
of this technology include its inability to detect novel genes absent from the array, so
while microarray analysis will reveal genes absent or divergent from the genes
represented by the reporter elements, no information on any extra genes present in the
test strain will be obtained. The latest C. jejuni microarrays produced by BJlG@S
contain reporter elements representing 69 C. jejuni genes that are absent in the
sequenced strain NCTCl1168. As more C. jejuni strains are sequenced and our
knowledge of the CDSs they contain increases, microarrays will become less strain-
specific and more representative of the species. Another limitation of microarrays is
that they cannot detect gene rearrangements. Arrays that use PCR products as reporter
elements will also be unable to detect point mutations and small deletions or
insertions. Microarrays do not usually include intergenic regions, so variation in
promoter sequences will not be analysed. The use of oligonucleotide microarrays or
Affymetrix GeneChipTM technology should reduce these limitations considerably.
Despite this, microarray-based comparative genomics have already provided
important information on the genetic diversity of C. jejuni isolates and a clearer
picture of the role of genetic diversity in the pathogenesis of this organism has been
shown through this study.
Prior to carrying out detailed analysis of DNA microarray hybridisation data, two
methods of analysis were compared. The definition of absent or divergent CDSs using
a constant cut-off of 0.5, implemented through GeneSpring6.1 was compared with a
dynamic cut-off calculated using GACK. Raw microarray data are initially processed
and saved using ImaGene5.5 in a format that is recognised by GeneSpring6.1. The
data format used by ImaGene5.5 was not compatible with GACK therefore manual
data formatting was required. This is labour intensive with room for human error and
there is scope for improvement by automating the process. The binary or trinary
output of GACK is easily manipulated into formats such as Nexus required for
phylogenetic simulations using search methods such as Bayesian based algorithms
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that consider each gene directly. However, genome composition data acquired
through GeneSpring6.1 must be manually converted into binary format. This process
has been semi automated through the development of a perl script by Adam Witney
and used in this study. Some discrepancies were found between the number of CDSs
identified as absent or divergent from the same strains using these two techniques
leading to a direct comparison of two sequenced C. jejuni strains, RM 1221 and
NCTC11168, to determine which data analysis method was more sensitive. This
direct comparison of the same hybridisation data using the two methods of analysis
indicated that, overall, the use of a constant cut-off of 0.5 through GeneSpring6.1
correctly identified slightly more absent and divergent CDSs. This validated the use
of a constant cut-off value of 0.5 for DNA microarray hybridisation data analysis.
Precise strain comparisons of well-characterised UK strains from diverse clinical
outcomes were carried out to gain a better understanding the genetic differences
between C. jejuni strains from the whole spectrum of disease outcome. One aim was
to identify correlates of pathogenesis and epidemiological markers for hyperinvasive
strains associated with serious sequelae, septicaemia and GBS, that are occasionally
associated with C. jejuni infection. High levels of LOS variation between strains
associated with septicaemia were noted and these strains were subsequently tested at
the National Research Canada, Ottawa, for LOS outer core structural analysis to
determine whether strains associated with septicaemia possessed a unique LOS outer
core structure. Rather than a conserved LOS structure, analysis of these strains
identified high levels of variation with the seven strains possessing six different LOS
outer cores. This result indicates that the septicaemia isolates included in this study do
not lack key CDSs present in NCTC 11168 through which the mechanism of
pathogenesis may be determined or septicaemia isolates distinguished from less
invasive C. jejuni strains. However, DNA micro array analysis is limited by the CDSs
represented on the microarray. It is possible that C. jejuni isolates that cause
septicaemia possess additional CDSs that facilitate this hyperinvasive phenotype
absent in NCTC11168 or represented in the non-NCTC11168 reporter elements. Such
additional CDSs could be identified using methods such as subtractive hybridisation
(Ahmed et al., 2002). One of the septicaemia strains from this study, 52471, has been
sent to Emily Kay at the Sanger Institute, Cambridge, UK for subtractive
hybridisation to determine whether additional CDSs are present. This analysis was
underway at the time of writing.
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TopA, encoding DNA topoisomeraseI, was absent from two C. jejuni strains
associated with GBS but present in every other isolate in the study. Although
interesting, a previous study carried out to identify genetic markers of C. jejuni strains
associated with GBS found no specific genes or loci associated with GBS. It would
therefore be necessary to screen for topA in a larger collection of OBS associated
strains to determine whether this single gene is a genetic marker for OBS and to
attempt to underpin its biological significance.
It was hypothesised that genome comparisons between pathogenic and non-
pathogenic strains would highlight CDSs with a role in causing human diarrhoeal
disease. Potentially non-pathogenic strains were identified both from the environment
and from human asymptomatic carriers (Chapter 5). Comparison of the genomes of
these potentially non-pathogenic C. jejuni strains using DNA microarrays revealed
detailed information about which CDSs were present and absent or divergent in the
genomes of individual isolates. Regions of the genome that were absent or divergent
in each of these potentially non-pathogenic strains were highlighted. Common regions
of variability included highly divergent loci encoding the surface antigens capsular
polysaccharide and LOS. However, a probable secreted serine protease, cj1365, was
identified as absent or divergent in all six potentially non-pathogenic beach isolates, a
result confirmed by PCR analysis and subsequent sequencing of the region.
Moreover, cj1365 was identified as present in 88% of the clinical isolates included in
the study by microarray analysis. Secreted serine proteases have a role in virulence in
enteric pathogens such as enteropathogenic and enterohaemorrhagic E. coli (Brunder
et al., 1997; Stein et al., 1996). CDS cj1365 represents a putative C. jejuni virulence
determinant and consequently a defined cj1365 mutant has been constructed in our
laboratory for further investigation. Furthermore, 15% of the CDSs identified as
absent or divergent in the potentially non-pathogenic beach isolates showed no amino
acid similarity to proteins from other bacteria. To date, the beach strains represent the
most well characterised potentially non-pathogenic strain collection available. C.
jejuni appears to have a unique mechanism of pathogenesis, the function unknown
CDS are interesting candidates for further investigation into their role in the
mechanism of pathogenesis of C. jejuni. Consequently, defined mutants in these
function unknown CDSs are under construction in our laboratory and phenotypic
assays will be used to ascertain their biological function.
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In addition to investigating human clinical isolates of diverse origins, differences in
genomic content of C. jejuni strains from a wider variety of sources were investigated.
Whole genome comparisons through microarray hybridisations were coupled with
phylogenetic analysis identifying regions within the C. jejuni genome that show a
high degree of variation between strains. The study of these regions has highlighted
genetic factors that may be linked to phenotypic variation and adaptation to different
ecological niches. DNA microarrays represent an efficient technology for whole
genome comparisons, allowing a bird' s eye view of the absence and presence of
genes in a given genome compared to the reference genome on the microarray and
'whole genome' trees allow evolutionary analysis to be introduced to comparative
genomics studies (Eisen and Fraser, 2003). Cluster algorithms available within
software programs such as GeneSpring6.1 facilitate the rapid identification of
phylogenetic relationships of strains, identifying patterns of genome content with
relation to different parameters including source and serotype. However, the
robustness of these phylogenetic relationships cannot be tested. This is because
cluster methods lose much of the information present in the data matrix by converting
the aligned binary whole genome data into a pairwise distance matrix. The distance
matrix is then entered into a tree building method. Search methods such as the
Bayesian based algorithms used in this study consider each site directly. Such
methods employ greater processing power and consequently analyses take
significantly longer than those methods using a distance matrix. However, if trees
generated using methods with a distance matrix and those with discrete characters
revealed identical phylogeny, the latter tree would provide additional information of
the sites in the genome that contribute to each branch. This information is lost when
data is converted into a distance matrix. Therefore trees produced using clustering
algorithms do not relate back to the original data thus the identification of genes
specific to particular groups of strains is not possible. Moreover, clade credibility
values cannot be calculated for phylogeny inferred using clustering algorithms.
Bayesian inference of phylogeny has only been proposed relatively recently and has
several advantages over other methods including easy interpretation of results, the
ability to incorporate prior information if available. Phylogenetic relationships
simulated using Bayesian based algorithms require the conversion of microarray data
into Nexus format. This is more labour intensive than using clustering algorithms
available through GeneSpring6.1, simulations require large amount of processing
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power and time and the results must be viewed using a second program, TreeView.
Furthermore, during the development of the comparative phylogenomics approach
non-NCTCII168 reporter elements included on the composite C. jejuni microarray
were excluded from the analysis. This was due to difficulties standardising the cut-off
level at which CDSs were designated absent/divergent or present in non-NCTCll168
reporter elements for which no control DNA was present. The comparative
phylogenomics technique developed in this study may be refined through the
inclusion of a greater number of non-NCTCII168 CDSs on the microarray and the
inclusion of gDNA from non-NCTC11168 strains in competitive hybridisations. This
would facilitate the devlopment of a system where strains were not compared with the
genome content of a single strain.
However, this is the first study using this robust comparative phylogenomics
approach to investigate bacterial population structures and more specifically, the
phylogeny of C. jejuni. Relationships between strains with specific phenotypes at a
whole genome level were clearly demonstrated and correlation between strains of a
particular genomotype and host were apparent. Furthermore, genetic markers
associated with specific phenotypes were identified. We have demonstrated a
population structure comprising two robust clades; a "chicken clade" containing
strains from chicken and clinical sources and a "non-chicken clade" containing strains
from non-chicken and clinical sources. A single chicken isolate was also found in the
non-chicken clade. Using majority rule consensus trees unequivocal clade credibility
values were obtained for the non-chicken and chicken clades, a clade containing
strains isolated from ovine and bovine animal sources and clades comprising isolates
from beaches. These data clearly show that C. jejuni strains in this study, from
different animal and environmental sources, can be distinguished. Unexpectedly, 59%
of clinical isolates included shared a common ancestor with strains from non-chicken
sources. We could hypothesise that clinical isolates found in the "non chicken clade"
were transmitted to humans from non-chicken sources. Likewise, strains in the
"chicken clade" may have been transmitted from chickens. The results of this study
suggest that ovine, bovine and environmental sources contribute substantially to the
burden of UK human C. jejuni infection. This is supported by the findings of a study
by Brown et al that the risk of human exposure to Campylobacter spp, and in
particular C. jejuni from the environment is very high (Brown et al., 2004). If
predictions of the source of human C. jejuni infection were robust, several important
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C. jejuni public health questions could potentially be answered through the
implementation of large-scale comparative phylogenomics studies on representative
C. jejuni isolates for which full epidemiological information is available. Such
questions include;
• The proportion of human Campylobacter disease caused by infected chicken;
• The proportion of disease caused by infected chicken due to direct
consumption compared with the proportion caused by cross contamination;
• The cost of human Campylobacter disease caused by infected chicken;
• Trends in the incidence of Campylobacter could be retrospectively
investigated. For example to determine whether disease caused by infected
chicken decreased as fast as disease not caused by infected chicken.
The genomic regions differentiating strains in the "chicken clade" (comprising the
94% of strains from poultry sources and 41% of clinical isolates) from strains in the
"non-chicken clade" (comprising strains from ovine and bovine animal sources, beach
samples as well as 59% of clinical isolates) were identified. CDSs cj1321-cj1326
were identified as a key locus differentiating the two clades, with the majority of
strains in the "chicken clade" possessing the CDSs whilst they were absent from
strains in the "non chicken clade". Little is known about the biological function of
genes cj1321-cj1326. However, from their location (cjJ314-cj1338), some genes in
this region are involved with O-linked glycosylation of flagellin proteins (Szymanski
et al., 2003) and cj1321-cj1326 may have a related function. Therefore we have
termed this region a "glycosylation islet". Cj1321-cj1326 are flanked by mall and
mafs, genes that are 100% homologous at a nucleotide level (Karlyshev et al., 2002a).
This suggests a possible mechanism through which this "glycosylation islet" may be
lost, through homologous recombination between mall and mafs, Presence of this
"glycosylation islet" in the majority of strains isolated from poultry may correlate
with post- translational modifications on flagellin. Through O-linked glycosylation
the flagellin may be masked with sialic acid preventing a proinflammatory response
in poultry therefore increasing pathogen survival within the host. The biological role
of cj1321-cj 1326 with relation to host specificity is therefore a prime candidate for
further research. Research has begun into this genetic locus and preliminary PCR
screening studies show that cj 1321-cj I 326 are present in UK chicken isolates
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included in the comparative genomics study as well as six further UK chicken isolates
that were not part of the bank of strains used in the comparative phylogenomic study.
In addition strains tested, in which cj1321-cj1326 were absent, were still fully motile.
This was demonstrated using motility agar plates for strains that both possess and lack
these CDSs revealing high levels of motility. In addition, strain 81-176 lacks cj1321-
cjJ326 and yet has been shown to be highly motile.
7.4 Future studies
We hypothesise that the cj1321-26 islet enables C. jejuni strains that possess it to
persist in poultry, by encoding a variant flagellin glycoform. This may playa key role
in the bacterium's interaction with its avian host, relating to colonisation, survival
and/or immune response. Future studies to investigate this hypothesis may include a
thorough investigation of the flagella locus of chicken and non-chicken strains
through DNA sequencing of the region. The ability of the different strains to colonise
and survive in chickens should then be tested, as well as histological and avian
immune response studies. In addition, the structure of the flagellin glycan in the
parent NCTCl1168 strain and in defined cj1321-26 mutants could be determined by
NMR and mass spectroscopy.
However, to fulfil the promise of these studies, a larger collection of diverse strains of
known origin must be investigated. The remit of this study was to investigate isolates
from the UK only (due to partial funding of the study by the FSA). Further studies on
a large and well-characterised strain collection from non-UK sources would allow the
robustness of these phylogenetic relationships to be determined and the main factors
contributing to human C. jejuni infection could be unequivocally calculated. This may
contribute toward the development of an improved molecular typing method such as
PCR and would improve our understanding of C. jejuni epidemiology to a point
where targeted control strategies to prevent this enteropathogen entering and passing
through the food chain could be introduced.
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8.0 appendices
Appendix 1. Strains used in C. jejuni comparative genomics study. Strains in blue were
included to calculate the C. jejuni functional core genes.
Strain Source Origin US serotype
33106 Clinical Campylobacter 4
asymptomatic Reference Lab, UK
33084 Clinical Campylobacter 35
asymptomatic Reference Lab, UK
32799 Clinical Campylobacter 50
asymptomatic Reference Lab, UK
31485 Clinical Campylobacter untypeable
asymptomatic Reference Lab, UK
32787 Clinical Campylobacter 18
asymptomatic Reference Lab, UK
31481 Clinical Campylobacter 37
asymptomatic Reference Lab, UK
31467 Clinical Campylobacter 18
asymptomatic Reference Lab, UK
43983 Clinical Campylobacter 50
septicaemia Reference Lab, UK
44119 Clinical Campylobacter 18
septicaemia Reference Lab, UK
34007 Clinical Campylobacter 18
septicaemia Reference Lab, UK
52471 Clinical Campylobacter untypeable
septicaemia Reference Lab, UK
53250 Clinical Campylobacter 60
septicaemia Reference Lab, UK
47886 Clinical Campylobacter untypeable
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septicaemia Reference Lab, UK
47939 Clinical Campylobacter 67
septicaemia Reference Lab, UK
15168 Clinical Campy lobacter 19
GBS Reference Lab, UK
18836 Clinical Campylobacter 19
GBS Reference Lab, UK
Ml Clinical Veterinary 21
Laboratory Agency,
UK
81116 Clinical Veterinary 6
Laboratory Agency,
UK
40671 Clinical Campylobacter 50
Reference Lab, UK
30280 Clinical Campy lobacter 16
Reference Lab, UK
30328 Clinical Campylobacter 16
Reference Lab, UK
34555 Clinical Campylobacter 5
diarrhoea Reference Lab, UK
35335 Clinical Campylobacter untypeable
diarrhoea Reference Lab, UK
35424 Clinical Campylobacter untypeable
bloody diarrhoea Reference Lab, UK
36069 Clinical Campy lobacter 5
vomiting Reference Lab, UK
36439 Clinical Campylobacter 12
diarrhoea Reference Lab, UK
36860 Clinical Campylobacter 21
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diarrhoea Reference Lab, UK
36952 Clinical Campylobacter untypeable
diarrhoea Reference Lab, UK
37537 Clinical Campylobacter untypeable
bloody diarrhoea Reference Lab, UK
35799 Clinical Campylobacter untypeable
diarrhoea Reference Lab, UK
38353 Clinical Campylobacter 5
bloody diarrhoea Reference Lab, UK
38556 Clinical Campylobacter 13
vomiting Reference Lab, UK
38762 Clinical Campylobacter 18
bloody diarrhoea Reference Lab, UK
38857 Clinical Campylobacter 23
vomiting Reference Lab, UK
39182 Clinical Campylobacter 13
vomiting Reference Lab, UK
39828 Clinical Campylobacter 42
vomiting Reference Lab, UK
40917 Clinical Campylobacter 21
bloody diarrhoea Reference Lab, UK
41651 Clinical Campylobacter 16
vomiting Reference Lab, UK
42724 Clinical Campylobacter untypeable
bloody diarrhoea Reference Lab, UK
43205 Clinical Campylobacter 2
bloody diarrhoea Reference Lab, UK
44811 Clinical Campylobacter 2
vomiting Reference Lab, UK
44933 Clinical Campylobacter 13
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diarrhoea Reference Lab, UK
44958 Clinical Campylobacter 50
vomiting Reference Lab, UK
45557 Clinical Campylobacter 60
bloody diarrhoea Reference Lab, UK
45631 Clinical Campylobacter 13
diarrhoea Reference Lab, UK
48612 Clinical Campylobacter 2
bloody diarrhoea Reference Lab, UK
52331 Clinical Campylobacter 50
vomiting Reference Lab, UK
52368 Clinical Campylobacter untypeable
bloody diarrhoea Reference Lab, UK
55320 Clinical Campylobacter 13
bloody diarrhoea Reference Lab, UK
55703 Clinical Campylobacter 13
vomiting Reference Lab, UK
56281 Clinical Campylobacter 50
bloody diarrhoea Reference Lab, UK
56282 Clinical Campylobacter 50
diarrhoea Reference Lab, UK
56519 Clinical Campylobacter 12
bloody diarrhoea Reference Lab, UK
56832 Clinical Campylobacter 50
vomiting Reference Lab, UK
58473 Clinical Campylobacter 2
diarrhoea Reference Lab, UK
59161 Clinical Campylobacter 2
vomiting Reference Lab, UK
59214 Clinical Campylobacter untypeable
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diarrhoea Reference Lab, UK
59364 Clinical Campylobacter 31
diarrhoea Reference Lab, UK
59424 Clinical Campylobacter 31
vomiting Reference Lab, UK
62567 Clinical Campylobacter untypeable
diarrhoea Reference Lab, UK
62914 Clinical Campy lobacter untypeable
vomiting Reference Lab, UK
63326 Clinical Campy lobacter 31
diarrhoea Reference Lab, UK
64555 Clinical Campylobacter 31
bloody diarrhoea Reference Lab, UK
12241 ovme Campy lobacter 50
Reference Lab, UK
12481 ovine Campy lobacter 50
Reference Lab, UK
13305 bovine Campy lobacter 50
Reference Lab, UK
13713 Ox liver portion Campy lobacter 2
Reference Lab, UK
12912 Ox liver portion Campy lobacter 50
Reference Lab, UK
11818 chicken Campy lobacter 50
Reference Lab, UK
11848 chicken Campy lobacter 2
Reference Lab, UK
11974 chicken Campy lobacter 44
Reference Lab, UK
12196 chicken Campylobacter 50
157
Reference Lab, UK
12450 chicken Campylobacter 50
Reference Lab, UK
12487 chicken Campylobacter 50
Reference Lab, UK
12567 chicken Campylobacter 2
Reference Lab, UK
13082 chicken Campylobacter 50
Reference Lab, UK
13249 chicken Campylobacter 44
Reference Lab, UK
40217 chicken Campylobacter 5
Reference Lab, UK
13040 chicken Campylobacter 50
Reference Lab, UK
13411 chicken Campylobacter 44
Reference Lab, UK
47693 chicken Campylobacter 27
Reference Lab, UK
11919 chicken Campylobacter 2
Reference Lab, UK
11856 chicken Campylobacter 50
Reference Lab, UK
40209 chicken Campy lobacter 5
Reference Lab, UK
11973 chicken Campylobacter 2
Reference Lab, UK
79260 (1771) beach Preston Public 55
Health Laboratory
79309 (1772) beach Preston Public untypeable
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Health Laboratory
79196 (1773) beach Preston Public untypeable
Health Laboratory
79207 (1791) beach Preston Public 2
Health Laboratory
79046 (1792) beach Preston Public -
Health Laboratory
79044 (1793) beach Preston Public 5
Health Laboratory
B60 Clinical Brazil untypeable
Kl Clinical A ga Kh a n -
Watery diarrhoea University, Pakistan
K4 Clinical A ga Kh an -
Watery diarrhoea University, Pakistan
K5 Clinical A ga Kh a n -
Watery diarrhoea University, Paki stan
K6 Clinical A ga Kha n 52
Watery diarrhoea University, Pakistan
K8 Clinical A ga Khan -
Watery diarrhoea University, Pakistan
1099 (E) chicken Denmark
922 (F) chicken Denmark
1425 (0) chicken Denmark
835-770 (H) chicken Denmark
RM1221 chicken USA
44464 Clinical Cam py 1obaete r 37
diarrhoea Reference Lab, UK
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Appendix 2. CDSs identified as absent or divergent in C. jejuni strain RM1221 using
both a dynamic and constant cut-off value ofO.5.
CDS Genbank annotation
cjOO33 probable integral membrane protein
modC, probable molybdenum transport ATP-binding
cj0300c protein
cj0819 small hydrophobic protein
cj1J22c wlal, possible integral membrane protein
cj1J38 probable galactosyltransferase
cj1418c unknown
cj1427c probable sugar-nucleotide epimerase/dehydratease
cj1432c possible sugar transferase
cj1440c probable sugar transferase
cj0815 unknown
cj0970 unknown
neuAl, probable acylneuraminate cytidylyltransferase
cj1143 (CMP-N-acetylneuraminic acid synthetase)
neuC1, probable N-acetylglucosamine-6-phosphate 2-
cj1142 epimerase/N -acety Iglucosamine-6-phosphatase
cj1679 unknown
cj0139 possible endonuclease
cj1324 unknown
cj1434c probable sugar transferase
cj1438c probable sugar transferase
cj1333 unknown
cj1338c fiaB, flagellin B
cj1J44c unknown
cj1395 pseudogene
cj1296 unknown
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cj1430c probable nucleotide-sugar epimerase/dehydratase
cj1423c possible sugar-phosphate nucleotidyltransferase
cj1421c possible sugar transferase
cj1422c possible sugar transferase
cjOO55c unknown
cj1308 acpP4, possible acyl carrier protein
cj1l45c unknown
cj1300 unknown
cj1431c unknown
cj0816 unknown
cj0306c bioF, probable 8-amino-7-oxononanoate synthase
cj0304c bioC, possible biotin synthesis protein
cj0303c modA, probable molybdate-binding lipoprotein
cj1259 porA, major outer membrane protein (MOMP)
cjl72lc possible outer membrane protein
modB, probable molybdenum transport system
cj0301c permease protein
cjll39c probable galactosyltransferase
cj0302c unknown
cj0305c unknown
cj0259 pyrC, probable dihydroorotase
cj1l36 probable galactosyltransferase
cjOO56c unknown
cjOl70 unknown
cjOl71 unknown
cj0260c unknown
cj0264c probable molybdopterin-containing oxidoreductase
probable cytochrome C-type haem-binding periplasmic
cj0265c protein
cj0295 possible acetyltransferase
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ej0423 probable integral membrane protein
cj0424 probable acidic periplasmic protein
ej0425 probable periplasmic protein
cj0565 pseudogene
ej0566 unknown
cj0567 unknown
ej0568 unknown
cj0569 unknown
ej0628 probable lipoprotein
cj0629 possible lipoprotein
ej0818 probable lipoprotein
cjl055c probable integral membrane protein
ej1137e unknown
cj1140 unknown
cj1l41 neuBl, probable N-acetylneuraminic acid synthetase
ej1255 possible isomerase
ej1297 unknown
ej1301 unknown
cj1309c unknown
cj1321 probable transferase
cj1322 unknown
cj1323 unknown
cj1325 unknown
cj1326 unknown
cj1376 probable periplasmic protein
cj1415e cysC, possible adenylylsulfate kinase
cj1416c probable sugar nucleotidyltransferase
cj1417c unknown
cj1419c possible methyltransferase
cj1420e unknown
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cj1426c unknown
cj142Bc fel, probable fucose synthetase
cj1429c unknown
cj1433c unknown
cj1435c unknown
cj1436c probable aminotransferase
cj1437c probable aminotransferase
cjJ439c glf, probable UDP-galactopyranose mutase
cjJ441c kfiD, probable UDP-glucose 6-dehydrogenase
cjJ442c unknown
cjJ549c probable type I restriction enzyme R protein
cjJ550c probable ATP/GTP-binding protein
cjJ55Jc probable type I restriction enzyme S protein
cjJ552c unknown
cjJ553c probable type I restriction enzyme M
cjJ556 unknown
cjl677 probable lipoprotein
cjJ678 possible lipoprotein
cjJ722c unknown
cj1723c probable periplasmic protein
cj l J828-03 LOS
cjJ J828-04 LOS
cjJJ828-06 LOS
cjJ J828-JO LOS
cjJJ828-JJ LOS
cj43431-01 LOS region sequences
cj43438-0J LOS region sequences
cj460-03 Neal Golden ORF
cj460-04 Neal Golden ORF
cj81 JJ6-14 Subtractive hybridisation sequence from strain 81116
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cj81176-02 virulence plasmid genes
cjP19-01 capsule region
cjX-Ol capsule region
cjX-02 capsule region
cjX-03 capsule region
cjX-04 capsule region
cjX-05 capsule region
Appendix 3. Additional 41 CDSs identified as absent or divergent in C. jejuni strain
RM1221 using a constant cut-off value ofO.5.
CDS Genbank annotation
cjOO08 unknown
exbB3, probable exbB/tolQ
cjOl09 family transport protein
probable MCP-domain signal
cj0246c transduction protein
cj0261c unknown
cj 0294 unknown
panD, probable aspartate 1-
ej0296c decarboxylase precursor
ej0416 unknown
ej0417 unknown
ej0494 small hydrophobic protein
efrA, probable iron uptake
ej0755 protein (ferric receptor)
ruvA, probable Holliday
ej0799c junction DNA helicase
ej0814 unknown
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cj0969 pseudogene
probable integral membrane
cj0987c protein
probable restriction
cjl051c modification enzyme
acpP2, probable acyl carrier
cj1299 protein
cj1339c jlaA, flagellin A
cj1340c unknown
cj1341c Unknown
cj1394 probable fumarate lyase
gmhA2, probable
cjI424c phosphoheptose isomerase
cjI425c possible sugar kinase
kpsM, probable capsule
polysaccharide export system
cjI448c inner membrane protein
cj1520 unknown
cjI555c unknown
cjI562 unknown
cjI724c unknown
cjII828-05 LOS
cj11828-08 LOS
cj4343I-02 LOS region sequences
cj43431-03 LOS region sequences
cj43438-02 LOS region sequences
cj43449-02 LOS region sequences
Subtractive hybridisation
cj81116-03 sequence
cj81116-09 Subtractive hybridisation
165
sequence
Subtractive hybridisation
cj81116-23 sequence
cj81116-25 LOS region sequences
cj81116-26 LOS region sequences
Plasmid ComB 1virulence
cj81176-01 plasmid gene
Plasmid ComB3 virulence
cj81176-03 plasmid gene
cjP19-02 capsule region
Appendix 4. CDSs correctly identified as absent in C. jejuni strain RMl221 using two
data analysis methods. CDS shown in red were not identified using a dynamic cut-off
value.
CDS Genbank annotation
cjOO56c unknown
cj0170 unknown
cj0171 unknown
cj0260c unknown
probable molybdopterin-containing
cj0264c oxidoreductase
probable cytochrome C-type haem-
cj0265c binding periplasmic protein
cj0295 possible acetyltransferase
cj0423 probable integral membrane protein
cj0424 probable acidic periplasmic protein
cj0425 probable periplasmic protein
cj0565 pseudogene
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cj0566 unknown
cj0567 unknown
cj0568 unknown
cj0569 unknown
cj0628 probable lipoprotein
cj0629 possible lipoprotein
ej0818 probable lipoprotein
ej1055e probable integral membrane protein
ejJJ37c unknown
cj1l40 unknown
neuB1, probable N-acetylneuraminic
ejl141 acid synthetase
cj1255 possible isomerase
ej1297 unknown
ejl301 unknown
cjl309c unknown
cjl321 probable transferase
cjl322 unknown
cjl323 unknown
cj1325 unknown
cjl326 unknown
ejl376 probable periplasmic protein
Cj1415c cysC. possible adenylylsulfate kinase
cj1416c probable sugar nucleotidyltransferase
cj1417c unknown
cj14/9c possible methyltransferase
ej1420c unknown
cj/426c unknown
ej1428e fcl, probable fucose synthetase
cj/42ge unknown
167
cj1433c unknown
cj1435c unknown
cj1436c probable aminotransferase
cj1437c probable aminotransferase
glf, probable UDP-galactopyranose
cj1439c mutase
kjiD, probable UDP-glucose 6-
cj1441c dehydrogenase
cj1442c unknown
probable type I restriction enzyme R
cj1549c protein
cj1550c probable ATP/GTP-binding protein
probable type I restriction enzyme S
cj1551c protein
cj1552c unknown
probable type I restriction enzyme M
cj1553c protein
cj1556 unknown
cj1677 probable lipoprotein
cj1678 possible lipoprotein
cj1722c unknown
cj1723c probable periplasmic protein
cjOOO8 unknown
cj0417 unknown
cjJ520 unknown
cjJ555c unknown
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Appendix 5. CDSs incorrectly identified as absent in C. jejuni strain RM1221 using two
data analysis methods. CDS shown in red was not identified using a dynamic cut-off
value.
CDS Genbank annotation
probable integral membrane
cjOO33 protein
mode, probable molybdenum
cj0300 transport ATP-binding protein
cj0819 small hydrophobic protein
w l a.l , possible integral
cj 1122c membrane protein
cj1138 probable galactosy ltransferase
cj1418c unknown
probable sugar-n ucleotide
cjJ427c epimerasel dehydratease
cjl432c possible sugar transferase
cj1440c probable sugar transferase
cj1340c unknown
Appendix 6. CDSs that are absent or divergent in all putatively non-pathogenic beach
isolates
CDS Genbank annotation
L)1122c wZaJ, possible integral membrane protein
CjOO33 probable integral membrane protein
C·Ol39 possible endonuclease.J
Cj0177 probable lipoprotein
Cj0178 possible outer membrane siderophore receptor
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Cj0179 exbBl, biopolymer transport protein
Cj0181 tonBl, possible tonB transport protein
Cj0259 pyrC, probable dihydroorotase
Cj0261c unknown
Cj0295 possible acetyltransferase
Cj0297c panC, probable pantoate--beta-alanine ligase
panB, probable 3-methyl-2-oxobutanoate
Cj0298c hydroxymethyltransferase
Cj0299 possible periplasmic beta-Iactamase
modC, probable molybdenum transport ATP-
Cj0300c binding protein
Cj0380c unknown
Cj0424 probable acidic periplasmic protein
Cj0425 probable periplasmic protein
Cj050l pseudogene
Cj0565 pseudogene
Cj0569 unknown
Cj06l7 unknown
Cj0628 probable lipoprotein
Cj0629 possible lipoprotein
Cj0737 probable periplasmic protein
cfr A, probable iron uptake protein (ferric
Cj0755 receptor)
Cj0765c hisS, probable histidyl-tRNA synthetase
Cj0818 probable lipoprotein
Cj0970 unknown
Cj1138 probable galactosyltransferase
Cjll39c probable galactosy ltransferase
neu'Cl , probable N -acety 19lucosamine-6-
Cj1142 phosphate 2-epimeraselN -acety lglucosamine-S-
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phosphatase
ne uA 1, probable acylneuraminate
cytidylyltransferase (CMP-N-acetylneuraminic
Cjl143 acid synthetase)
Cj1144c unknown
Cj1365c probable secreted serine protease
Cj1376 probable periplasmic protein
Cj1395 pseudogene
Cj1550c probable ATP/GTP-binding protein
Cj1551c probable type I restriction enzyme S protein
Cj1555c unknown
Cj1560 probable membrane protein
CjJ585c probable oxidoreductase
CjJ677 probable lipoprotein
CjJ72Jc possible outer membrane protein
Cj1722c unknown
Cj1723c probable periplasmic protein
CjJ725 probable periplasmic protein
met A, probable homo serine 0-
Cj1726c succinyltransferase
Cj1727c metf, possible O-acetylhomoserine (thiol)-lyase
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Summary
We recently demonstrated that Campy/obacter jejun;
produces a capsular polysaccharide (CPS) that Is the
major antigenic component of the classical Penner
serotyping system distinguishing Campylobacter
Into >60 groups. Although the wide variety of C.JeJunl
serotypes are suggestive of structural differences In
CPS, the genetic mechanisms of such differences are
unknown. In this study we sequenced blosynthetlc
cps regions, ranging In size from 15 to 34 kb, from
selected C. jejun; strains of HS:1, HS:19, HS:23,
HS:36, HS:23/36 and HS:41 serotypes. Comparison of
the determined cps sequences of the HS:1, HS:19
and HS:41 strains with the sequenced strain,
NCTC11168 (HS:2), provides evidence for multiple
mechanisms of structural variation Including
exchange of capsular genes and entire clusters by
horizontal transfer, gene duplication, deletion, fusion
and contingency gene variation. In contrast, the
HS:23, HS:36 and HS:23/36 cps sequences were
highly conserved. We report the first detailed struc-
tural analysis of 81-176 (HS:23/36) and G1 (HS:1) and
refine the previous structural Interpretations of the
HS:19, HS:23, HS:36 and HS:41 serostralns. For the
first time, we demonstrate the commonality and func-
Accepted 23 August, 2004. "For correspondence. E-mail
christine.szymanski@nrc-cnrc.gc.ca; Tel. (+1)613 990 1569; Fax
(+1)613 952 9092; and E-mail brendan.wren@lshtm.ac.uk;Tel. (44)
02079272288; Fax (44) 0 207 6374314.
© 2004 Blackwell Publishing Ltd
tion of a second heptose blosynthetic pathway for
Campylobacter CPS independent of the pathway for
llpooligosaccharide (LOS) biosynthesis and identify a
novel heptosyltransferase utilized by this alternate
pathway. Furthermore, we show the retention of two
functional heptose isomerases in Campylobacter and
the sharing of a phosphatase for both LOS and CPS
heptose biosynthesis.
Introduction
Capsular polysaccharides (CPSs) are found on the sur-
face of a large number of bacterial species. CPSs are
known to play an important role in bacterial survival and
persistence in the environment and often contribute to
pathogenesis (Roberts, 1996). In addition, through struc-
tural variation, the potential to mimic host cell antigens,
and the ability to resist innate mechanisms such as
phagocytosis and complement-mediated killing, bacterial
CPSs playa role in evasion of host immune responses.
Assembly of these surface polysaccharides is remark-
ably conserved in bacteria (reviewed in Whitfield and
Roberts, 1999). Nucleotide diphosphate sugars are syn-
thesized in the cytoplasm and sequentially added by gly-
cosyltransferases to an undecaprenyl pyrophosphate
carrier anchored in the membrane. Many Gram-negative
bacteria flip the assembled polysaccharide across the
membrane using an ABC transporter consisting of the
transmembrane channel, KpsM, and the ATPase, KpsT.
These transporters form a complex with four to five addi-
tional Kps proteins to ensure proper translocation of the
polysaccharide to the bacterial surface. The genetic orga-
nization of the capsule gene clusters is also conserved in
bacteria with kps transporter genes flanking polysaccha-
ride biosynthesis genes, an organization conducive to
genetic recombination and reorganization.
Production of CPSs by the enteric pathogen, Campylo-
baeter jejuni, remained unnoticed until we initiated
sequencing of its genome in 1998. Identification of kps
genes potentially involved in capsule biosynthesis during
sample sequencing of the shot-gun library of NCTC11168
(Karlyshev et al., 1999) prompted a systematiC genetic
analysis of the corresponding locus and resulted in iden-
tification of CPSs in a number of strains of C. jejuni (Karly-
shev et al., 2000a). These molecules were found to be the
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major antigens in the Penner serotyping scheme (Karly-
shev et a/., 2000a). Similar experiments performed on C.
jejuni 81-176 confirmed these findings and demonstrated
a role for the capsule in serum resistance, epithelial cell
invasion and diarrhoeal disease (Bacon et ei., 2001). Sub-
sequent characterization of the CPSs by Alcian blue stain-
ing (Karlyshev and Wren, 2001) led to the visualization of
capsule by electron microscopy (Karlyshev et a/., 2001).
These experiments suggested that the previously
described high-molecular-weight 'Iipopolysaccharides'
(HMW LPSs) of C. jejuni are in fact CPSs.
Recently, the CPS structure of NCTC11168 was
determined to contain 6-0-methyl-o-g/ycero-a-L-gluco-
heptose, ~-o-glucuronic acid modified with 2-amino-2-
deoxyglycerol, ~-o-GaIlNAc and ~-D-ribose (St Michael
et a/., 2002). There are several notable features encoded
by the cps locus of NCTC11168 (St Michael et a/., 2002)
that correlate well with the published structure: homo-
logues of the GDP-o-glycero-o-mannoheptose pathway
(GmhA2, HddA and HddC) (Valvano et al., 2002); homo-
logue of the UDP-glucose dehydrogenase, Udg, involved
in the formation of UDP-glucuronic acid (Sieberth et a/.,
1995); and a homologue of the UDP-pyranose mutase,
Glf, predicted to catalyse the reversible conversion of pyr-
anoses to furanoses (Nassau et a/., 1996) and shown to
cause loss of CPS when mutated in NCTC11168 (St
Michael et a/., 2002).
In a series of earlier publications on the structural anal-
ysis of HMW LPSs (now realized as CPSs) of C. jejuni, it
was shown that these molecules are highly heteroge-
neous (Moran et a/., 2000). Microarray hybridization anal-
ysis also demonstrated some differences in the CPS-
related genes between the strains of various serotypes
(Dorrell et al., 2001). However, hybridization analysis does
not allow detailed investigation of gene content. Sequenc-
ing of the C. jejuni NCTC11168 genome revealed that the
guanosine cytosine (GC) content of the cps locus
(cj1415-cj1442) is lower (26.5%) in comparison to that for
the entire genome (30.6%) suggesting that this locus was
acquired through horizontal gene transfer (Parkhill et a/.,
2000). In addition, the biosynthetic region of the cps locus
is also prone to phase variation because of the presence
of six genes with homopolymeric tracts (Parkhill et al.,
2000). It was subsequently shown that CPS from 81-176
undergoes antigenic variation at high frequency (Bacon
et a/., 2001) and that CPS from NCTC11168 can vary in
structure (Szymanski et al., 2003). However, the genetic
mechanisms underlying the structural heterogeneity and
antigenic variation remain unknown.
In the current study, we determined the full nucleotide
sequence of cps regions from six C. jejuni strains of sim-
ilar and different serotypes and compared these with the
sequenced strain NCTC11168 (HS:2). The results dem-
onstrate heterogeneity in the biosynthetic cps genes and
e 2004 Blackwell Publishing Ltd, Molecular Microbiology, 55, 90-103
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suggest widespread genetic exchange. Extensive struc-
tural studies, including high-resolution magic angle spin-
ning (HR-MAS) nuclear magnetic resonance (NMR)
spectroscopy, demonstrated polysaccharide heterogene-
ity in Campy/obacter CPS and solved two new structures
for G1 (HS:1) and 81-176 (HS:23/36). Structural and
sequencing analysis also demonstrated the presence of
additional CPS modifications and a large abundance of
genes potentially involved in heptose biosynthesis in
these clusters. This report describes the first comparative
study of C. jejuni cps loci with structure and demonstrates
the commonality and function of these complex heptose
biosynthetic genes in this organism.
Results
Strains and sequencing strategy
Although C. jejuni is the major bacterial cause of gas-
trointestinal disease in developed countries, infection can
also lead to the development of neuropathies such as
Guillain-Barre syndrome (GBS). Two of the type strains
selected in this study, HS:19 (Aspinall et a/., 1994a) and
HS:41 (Lastovica et a/., 1997), have been isolated from
patients with gastroenteritis, but represent a serotype
commonly associated with GBS, while G1 is a human
GBS isolate belonging to the HS:1 serogroup (Karlyshev
eta/., 2000a). Strain 81-176 is a well-characterized strain
isolated from a human outbreak and is highly virulent in
human challenge studies (Black et a/., 1988). The analy-
sis of CPS-related genes in the latter strain was of partic-
ular interest as it reacts with both HS:23- and HS:36-
specific anti-sera, and the origin for this dual reactivity
remained unclear. The HS:23 and HS:36 serotype refer-
ence strains were also investigated for comparison and
these were all compared with the genome sequenced
strain NCTC11168 (HS:2; Parkhill et a/., 2000).
The strategy used for sequencing the variable cps loci
from the different strains is described in Experimental
procedures. Briefly, conserved internal cps genes in a
particular strain were identified by polymerase chain reac-
tion (PCR) with primers specific to NCTC11168 cps
genes. These primers were then used in long-range PCR
in combination with primers specific to the flanking kps
genes. In some cases, this resulted in overlapping PCR
products, which, after sequencing using a standard shot-
gun procedure, produced a sequence of an entire biosyn-
thetic cps region. When necessary, the gaps were closed
using PCR with primers derived from the sequences of
the long PCR products. Several overlapping reads were
analysed before generating a consensus sequence. The
diagram shown in Fig. S1 demonstrates the general strat-
egy for amplification of cps clusters using long-range
PCR. The overall summary of the cps sequencing results
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Table 1. Biosynthetic cps regions of various strains of C. jejuni.
No. of
Accession different
No. of Sugar sugar
nucleotide No. of Contingency phosphate Putative residues
Strain Serotype sequence Size %GC genes genes nucleotidyltransferases glycosyltransferases found"
NCTC11168 HS:2 AL139078 34180 26.5 28 6 2 8 4
NCTC12517 HS:19 BX545860 16727 26.1 13 2 1 4
2b
G1 HS:1 BX545859 15180 26.8 11 2 2 2
1b
81-176 HS:23/36 BX545858 24625 27.1 21 5 2 7 6
CCUG 10954 HS:23 AY332625 24627 27.0 21 6 2 7 6
ATCC 43456 HS:36 AY332624 24625 26.9 21 6 2 7 6
176.83 HS:41 BX545857 34118 27.2 30 5 2 8 4
a. According to structural analysis.
b. Additional uncharacterized labile substituent present.
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is presented in Table 1. A schematic of the cps loci com-
pared in this study is shown in Fig. 1. The predicted func-
tion of cps genes from strain NCTC11168 (HS:2) based
on the published genome sequence (Parkhill et al., 2000)
and the recently published CPS structure (St Michael
et al., 2002) are presented in Table S1. CPS structures of
NCTC11168 and the representative serostrains used in
this study are shown in Fig. 2.
NCTC12517 (HS:19) CPS
NMR analysis of the HS:19 serostrain used in this study
confirmed that the CPS contained the published disaccha-
ride (Fig.2; data not shown) (Aspinall et al., 1994b) in
addition to two acid-labile functional groups that were not
reported previously. Both the phosphoramide modification
recently described for NCTC11168 (Szymanski et a/.,
2003) and an unknown labile sugar were observed during
the analysis and are currently being characterized. As
expected by the lack of heptose in the structure, the cps
region of the HS:19 serostrain did not contain homologues
of the heptose pathway, but did have the udg homologue
(Table S2) correlating well with the presence of ~-D-
glucuronic acid which is further substituted with 2-amino-
2-deoxyglycerol similar to NCTC11168. The genes respon-
sible for glycerol modification are currently unknown.
G1 (HS:1) CPS
In contrast to NCTC11168 (HS:2) and the HS:19 seros-
train, the biosynthetic region of strain G1 (HS:1) is the
smallest (15 kb) and contains only 11 genes. Organization
of the genes from cj1415 to cj1421 in this strain is similar
to that of serostrain HS:19 and NCTC11168. However, the
remaining genes have no counterparts in the correspond-
ing regions of these strains (Fig. 1;Table S3). In addition,
the cps locus of G1 does not encode homologues of UDP-
glucose 6-dehydrogenase or the heptose pathway
_ CIt"* ...... ** fI"ft--..- -~- ..._ .._ ....."........._
Fig. 1. Graphical representation of the sequenced cps biosynthetic regions. In cases with high level of similarity between putative gene products
(usually with BLAST E-values below 1e-30), the genes were given names of counterparts found in other bacteria. When no such similarity was
found, the genes were assigned the names of respective genes from strain NCTC11168. The genes with no similarity to either NCTC11168 or
other bacteria are given strain-specific systematic names. The cps clusters 01 serostrains HS:23 and HS:36 are almost identical to that of strain
81-176 (see text).
© 2004 Blackwell Publishing Ltd, Molecular Microbiology, 5f7~-103
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Fig. 2. Summary of the representative C. jejuni
capsular polysaccharide structures described
in this study. The CPS structures of the heat-
stable (HS) Penner type strains HS:1, HS:19,
HS:23 and HS:36 have been reviewed by
Moran et al. (2000). The structures of
NCTC11168 (St Michael et al., 2002) and
HS:41 (Hanniffy et al., 1999) CPS have recently
been described. NCTC11168 modifications that
have been demonstrated to be phase-variable
are indicated in curved brackets. Sugars are
shown in pyranose configurations unless other-
wise noted. P, phosphate; Gal, galactose; Gro,
glycerol; Me, methyl; Hep, heptose; Rib, ribose;
GaINAc, N-acetylgalactosamine; GlcA6, glucu-
ronic acid; NGro, aminoglycerol;
OP=O(NH2)OMe, phosphoramide; GlcNAc, N-
acetylglucosamine; Ara, arabinose; Alt, altrose;
Fuc, fucose.
(6-0-Me}-o-glycero-a-L-glc-Hep-l,
3
1-2)-J3-o-Ribf-1-5-J3-o-GalfNAe-1-4-a.-o-GleA6{NGro}-1-)3 n
t
{OP=O(NH2)OMe}
NCTCl1168
(HS:2)
HS:19 1-4)13-o-GleA6(NGro)-1-3-J3-o-GIcNAc-l-)n
1-3)13-o-GleNAe-1-3-a-o-Gal-1-2-6d-a-o-altro-Hep-l-)n
-6d-3Me-a-o-altro-Hep-l-)n
-o-glycero-a.-o-altro-Hep-l-)n
-3Me-o-glycero-a.-o-altro-Hep-l-)n
HS:23IHS:36
HS:41 (-2)-f3-L-Araf-1-2-!3-o-6d-altro-Hepf-1-2-!3-L-6d-Altf-l-)n
-a-o-FueI-1-In
(Table S3) and thus the strain may not have the ability to
synthesize glucuronic acid or heptose unless the genes
are located elsewhere on the chromosome. In contrast,
G1 contains a potential tagO homologue encoding a glyc-
erol-3-phosphate cytidylyltransferase necessary for the
formation of COP-glycerol (Table S3) (Pooley et al., 1991).
The strain also encodes a TagF homologue, which trans-
fers glycerol-phosphate residues from COP-glycerol
(Schertzer and Brown, 2003). Therefore, genetic analysis
suggests that the repeating unit of this CPS may contain
glycerol-phosphate residues.
Indeed, the HS:1 serostrain was reported to contain
glycerol-'-phosphate residues alternating with galactose
in the repeating unit (Fig. 2; MacDonald, 1993). The NMR
spectra of G1 (Fig. S2) revealed that the structure of this
CPS is consistent with the HS:1 structure. However,
extensive NMR analysis by COSY, TOCSY, NOESY and
HMQC detected galactose and two additional acid-labile
groups similar to those observed for HS:19 in both G1 and
HS:1 strains. Again, the phosphoramide was confirmed to
be one of these modifications by the strong correlation
between the OP=O(NH2)OMe 'H resonance at 3.8 p.p.m.
(indicated in Fig. S2) and the phosphoramide 31p reso-
nance at 14 p.p.m., in the 31p HMQC spectra. 31p NMR
experiments for G1 also confirmed the presence of a
phosphate diester linkage, consistent with the reported
glycerol-1-phosphate structure in HS:1 (data not shown).
Note that the additional anomeric proton resonance at
5.44 p.p.m. in the HR-MAS spectrum of G1 was absent in
the partially purified CPS sample suggesting that this
resonance probably came from the medium used.
CCUG 10954 (HS:23), ATCC 43456 (HS:36) and
81-176 (HS:23/36) CPS
The eps loci of the HS:23 and HS:36 serostrains and of
strain 81-176 (which reacts with both HS:23 and HS:36
<Cl2004 Blackwell Publishing Ltd, Molecular Microbiology, SS, 90-103
anti-sera) all have the same gene content and colinear
representation (Fig. 1 and Table 1). Pair-wise alignments
of the CPS biosynthetic regions (24.6 kb) of these strains
show that the HS:23 and HS:36 serostrains share 97.6%
DNA sequence identity while strain 81-176 shares 97.6%
and 98.9% identity with HS:23 and HS:36 respectively. All
pair-wise comparisons showed >93% protein sequence
identity except for HS23.08 (HddC) which shared 87.9%
and 86.6% identity with the corresponding gene products
in HS:36 and 81-176 respectively. Analysis of the pre-
dicted products, encoded by the eps regions of serostrains
HS:23 and HS:36 and of strain 81-176 (Table S4), dem-
onstrate a potential for deoxyheptose biosynthesis
because of the presence of genes cj1423 (hddC), ej1424
(gmhA2), ej1425 (hddA) and the new gene, dmhA,
inserted between genes cj1427 and (el (Fig. 1),The OmhA
homologue is suggested to be involved in conversion of
heptose to deoxyheptose in Yersinia pseudotuberculosis
(Pacinelli et al., 2002).
The published CPS structures of HS:23 and HS:36
were found to contain repeating units of o-o-catactose, 13-
D-GlcNAc and D-glyeererD-altrerheptose or deoxyheptose
variants with and without methyl groups (Fig. 2; Aspinall
et al., 1992). However, it was reported that the D-g/yeerer
D-a/trerheptose variant was not detected in the HS:23
serostrain (Aspinall et al., 1992). In this study, HR-MAS
spectra of cells and NMR spectra of the partially purified
CPS from strain 81-176 demonstrated similar sugar res-
onances with the HS:23 and HS:36 serostrains (Fig.3).
In all the spectra, the characteristic OMe signal at
3.5 p.p.m. and NAc resonance at 2.05 p.p.m. were
observed. In the 'H NMR spectra of the CPS, the ano-
meric region (4.7-5.5 p.p.m.) of the HS:23 serostrain was
the Simplest with three anomeric resonances (Fig.3A).
The anomeric region for HS:36 and 81-176 was more
complex (Fig.38 and C) with the spectrum of 81-176
being the most complex.
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2D-NMR experiments were performed to identify the
sugar resonances (Fig. 3). The HMQC and TOCSY spec-
tra for the HS:23 serostrain (Fig.3A) confirmed that the
anomeric resonances at 5.06, 4.97 and 4.77 p.p.m. cor-
responded to Gal, Hep and GlcNAc respectively (Aspinall
et al., 1992). In the HMQC spectrum, the C-6 cross-peaks
of the 6-deoxy-heptose were observed at 34.8 p.p.m. C3C)
and 2.06 and 1.71 p.p.m. CH).
For the HS:36 serostrain, three anomeric resonances
were also observed by HMQC and TOCSY experiments
on the CPS (Fig. 3B). The 'H resonance at 4.92 p.p.m.
was confirmed to be a non-anomeric resonance using
HMQC. While the anomeric carbon resonances had sim-
ilar chemical shifts, the proton anomeric resonance of the
heptose residue was different, probably because of differ-
ent structural motifs on the heptose residue. In the TOCSY
spectrum, the anomeric resonances at 4.76 and
5.06 p.p.m. exhibited connectivities that were similar to
those observed for the HS:23 serostrain, indicating the
presence of similar sugars in both serostrains. In the
HMQC spectrum, resonances characteristic of a 6-deoxy-
heptose could not be observed, indicating that for this
serostrain this modification was not predominant (see
contingency gene analysis below).
The HMQC and TOCSY spectra for strain 81-176
(Fig. 3C) showed correlation patterns similar to those
observed for the HS:23 serostrain for the Gal, Hep and
G/cNAc anomeric resonances, again indicating similar
sugar structures to those of HS:23 and HS:36. Compari-
son of the NOESY spectra (data not shown) established
that serostrains HS:23 and HS:36 and strain 81-176 exhib-
ited similar NOE patterns for the Gal, Hep and GlcNAc
residues, a result that is consistent with the conclusions
arrived at from the analysis of the TOCSY experiments.
These observations are in agreement with the conserva-
tion of the cps genes for these three strains. However,
structural analysis of 81-176 also demonstrated the pres-
ence of additional resonances indicating the presence of
a more complex repeating unit or the presence of another
polysaccharide structure as was previously suggested
(Bacon et a/., 2001). The phosphoramide modification
observed for NCTC11168 was also observed for strain 81-
176 and serostrain HS:36, but not for serostrain HS:23.
176.83 (HS:41) CPS
The major and minor components of CPS isolated from
the HS:41 serostrain were described to contain ~-L-arabi-
nose, 6-deoxY-~-D-altroheptose, 6-deoxY-~-L-altrose and
c-c-fucose all in the furanose form (Fig. 2, Hanniffy et a/.,
1999; Szymanski et a/., 2003). NMR analysis demon-
strated that the CPS of the sequenced strain used in this
study is consistent with the published structure (data not
shown). Interestingly, sequencing results from this strain
(Table S5) show the cps region to be quite outstanding in
that it lacks the cj141~j1420 genes conserved in the
other strains. However, three heptose-related genes in the
middle of the cps locus (gmhA2, hddA and hddC) are
almost identical to those in NCTC11168 (Fig. 1;Table S5).
The mosaic patterns of similarity and divergence indicate
that these cps regions have a diverse recent ancestry,
suggesting that recombination between different cps clus-
ters has occurred. Sequencing also demonstrated three
UDP-pyranose mutase (g/t) homologues, consistent with
having three of the CPS sugars in the furanose form (note
that arabinose is a pentose and therefore is naturally in
the furanose configuration). The presence of genes
gmhA2, hddA, hddC and dmhA (Fig. 1) is consistent with
the presence of deoxyheptose in the CPS (Fig. 2). Addi-
tional sugar dehydratases will be required for the biosyn-
thesis of fucose and deoxyaltrose and putative
homologues are observed in Table S5.
Variation in the contingency genes
The biosynthetic cps locus of C. jejuni NCTC11168 was
to 2004BlackwellPublishingLtd,Molecular MicrobioIOgY'l~690-103
Table 2. Comparison of the contingency genes in the biosynthetic cps region of serostrains HS:23, HS:36 and strain 81-176.
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Gene
Strain cj1420 HS23136.07 dmhA cj1429 HS23136.17 HS23136.20
81-176 (HS:23/HS:36) G9 G9/G10 (on) G9/G10 G9 G8/G9
CCUG 10954 (HS:23) G8/G9 G8 G9 G8/G9 G9 G8
ATCC 43456 (HS:36) G8/G9 G8/G9 G9/G10 G9/G10 G9 G9/G10
Gene 'ON' G9 G9 G9 G9 G9 G9
The number in bold indicates the most frequent variant. For strains CCUG 10954 (HS:23) and ATCC 43456 (HS:36) the 'most frequent variant'
is defined as the one corresponding to the strongest signal on a DNA sequencing electrophoregram when we sequenced a PCR product using
chromosomal DNA isolated from a confluent plate. For strain 81-176 (HS:23/HS:36) the most frequent variant is determined from sequence
analysis of multiple clones. Gene dmhA is not phase-variable in strain 81-176.
...... D-g{l'('cro-a-L-gluco-heptopyranose + 60Me
... ¢:::J -n-II-Qltro-heptopYrllnosc +/- 3Mc
o-g{l'('ero-a-II-allro-hcplopyranose +/- 31\1c
... ¢::::l -!3-II-uttrQ-heptoruranosc
¢::::I ~-P-IN"QII"q.htplllpyraDosc + ZONAe
found to contain six genes with homopolymeric G tracts
potentially prone to phase variation (Parkhill et al., 2000).
We surveyed the 'ON' and 'OFF' states of these gene
homologues in the other strains and found that most of
the genes tested are predominantly in the 'ON' state,
although many are demonstrated to vary (data not
shown). It is possible that such modulation may explain
the presence of variant structures in the HS:41 serostrain
and in serostrains HS:23 and HS:36 compared with strain
81-176 (HS:23/36). We therefore examined the latter three
strains in more detail because they share the same gene
content (see above), yet produce capsules with slight
differences in CPS structure (Fig.3). As these three
strains share >95% gene identity in their cps biosynthetic
regions, phase-variable genes could be responsible for
the differential expression of deoxyheptose and phos-
phoramide observed in this study, i.e. HS:23 (Gal,
GlcNAc, Hep, deoxyhep), HS:36 (Gal, GlcNAc, Hep, phos-
phoramide) and 81-176 (Gal, GlcNAc, Hep, deoxyhep,
phosphoramide). There are six contingency genes in the
cps cluster of the HS:23 and HS:36 serostrains but only
five in 81-176 as the dmhA homologue (ORF#12) is not
phase-variable (Table 2). DmhA has been shown to be
Cj 11 168
Cj 8t-176
Cj 176_83
Bp/m 'Itnnm
Yp -At «!Jnlln
Ca <t1nnm
involved in deoxyheptose synthesis in Yersinia and inter-
estingly, in this study, the dmhA homologue is functional
in 81-176 and HS:23, but variable in HS:36. This may
correspond to the detection of deoxyheptose in 81-176
and HS:23 and the difficulty in detecting this heptose
variant in HS:36. In the HS:23 serostrain, two 'OFF' genes
(HS:23.07 and HS:23.20) show high sequence similarity
with the putative glycosyltransferase (cj1422c) from
NCTC11168 and may playa role in adding the missing
phosphoramide. However, function of these contingency
genes must be proven experimentally.
Analysis, mutagenesis and complementation of
conserved heptose genes from NCTC11168
The C. jejuni gmhA2 (sedoheptulose-7-phosphate
isomerase), hddA (o,o-heptose-7-phosphate kinase) and
hddC (o,D-heptose-1-phosphate guanosyltransferase)
gene homologues are conserved in ali strains containing
heptose in their CPS and also share similarity and colin-
earity with the respective genes involved in heptose bio-
synthesis in other bacteria (Fig. 4) (DeShazer et al., 1998;
Reckseidler et al., 2001; Pacinelli et al., 2002; Valvano
¢::::l 6 -D-nlumw-heptopyrano e
D-glyaro-a-D-nJalllloheptopyranosc
Currently unknown
Fi.g.4. Evidence for h~rizontal gene transter ot putative GDP-heptose pathways among bacteria. The top four matches for BlastX analysis of 23:
CJ1423 (HddC, nucleotidyltransferase): 24: CJ1424 (GmhA2, isomerase); and 25: Cj1425 (HddA, kinase) were to: Bp/m: Burkholderia pseudoma-
lIeilmall.el; Yp: Yerslnla pseuaotuberculosis; At: Aneurinibacillus theromoaerophilus; and Ca: Clostridium acetobutylicum. A schematic of the
respective heptose gene clusters, shown by grey arrows, adjacent to the configuration of the heptose(s) found in the bacterial polysaccharide
~tructures ISshown. An additional gene shown by.open arrows (DmhA, dehydratase) was not in the C. jejuni NCTC11168 genome but was found
In the cps lOCIof strains 81-176 and 176.83 and IS suggested to be involved in deoxyheptose formation (Pacinelli et al., 2002), which correlates
with the observed deoxy conflgurallons shown by ope~ boxes. Black arrows represent additional gene insertions while hatched arrows represent
the CJ1152c phosphatase homologue that IS located In the LOS heptose cluster in C. jejuni NCTC11168. Note that hddC, gmhA2, hddA and
dmhA correspond to wcbM, gmhA2, wcbL and wcbK in the Burkholderia species.
© 2004 Blackwell Publishing Ltd, MOlecular Microbiology, 55, 90-103
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et al., 2002). We therefore mutated these genes in
NCTC11168 to examine their role in CPS heptose biosyn-
thesis. Genome sequencing of NCTC11168 identified a
second heptose gene cluster (cj1148-cj1152) involved in
lipooligosaccharide (lOS) biosynthesis (Parkhill et et.,
2000; C.M. Szymanski, unpubl. obs.). Thus, for complete-
ness, both heptose gene clusters were compared and
both LOS and CPS were examined for structural changes.
NCTC11168 has two copies of the heptose isomerase
gene, gmhA (cj114910cated in the lOS gene cluster) and
gmhA2 (cj1424 located in the CPS gene cluster). Mutation
of either gene in C. jejuni did not have an effect on lOS
or CPS (data not shown) suggesting that both products
were functional and compensated for each other. To test
this hypothesis, we complemented Escherichia coli X711
lacking gmhA with C. jejuni gmhA or gmhA2. The mass of
the truncated E. coli lOS core [1394 and 1516 amu
(+PEtn)] was restored back to wild type [2970 and 3093
amu (+PEtn); Fig. 53 and Table 56] in the presence of
either C. jejuni isomerase and coincided with a slower
lOS migration on deoxycholate-PAGE (Fig. S3). Mutation
of both gmhA and gmhA2 in C. jejuni resulted in the loss
of CPS 6-0-methylheptose (Fig. 5C) demonstrated by the
disappearance of the heptose anomeric 'a' and methyl
resonance 'x' and the truncation of the lOS core (Fig. 50;
Table 57) compared with wild-type CPS (Fig.5A) and
lOS (Fig. 5B; Table 57). These results confirm that both
isomerases are functional and involved in both the CPS
and lOS heptose pathways.
In contrast, individual mutations of the C. jejuni
NCTC11168 kinase (hddA) and nucleotidyltransferase
(hddC) homologues resulted in loss of the CPS 6-0-meth-
ylheptose (Fig. 5E and I) without altering the lOS mass
(Fig. 5F and J; Table S7) demonstrating their role solely
in CPS heptose biosynthesis. Unlike other bacteria that
contain this alternate heptose pathway, C. jejuni lacks a
phosphatase homologue (GmhB) in its CPS cluster
(Fig.4, hatched arrows). However, a phosphatase homo-
logue exists in the lOS cluster (Cj1152), so we were
interested in determining whether this enzyme could func-
tion for both pathways. As expected, mutagenesis of C.
jejuni NCTC11168 gmhB affected both CPS (Fig. 5G) and
lOS (Fig. 5H; Table 57) demonstrating that this enzyme
is shared by both pathways. Because of the large number
of putative glycosyltransferases in the cps locus of
NCTC11168, we predicted that the heptosyltransferase
for this alternate pathway may exist within this locus. In
order to identify the NCTC 11168 heptosyltransferase, it
was necessary to sequentially inactivate all of the putative
glycosyltransferases in the cps locus (Table 51) as homo-
logues of this enzyme have not been previously
described. The NCTC11168 glycosyltransferase mutants
were examined by HR-MAS NMR for loss of the heptose
anomeric (data not shown). Figure 5K demonstrates that
mutagenesis of the putative glycosyltransferase, cj1431c,
results in loss of CPS 6-0-methylheptose with no change
to LOS (Fig. 5L; Table 57). From this analysis, we dem-
onstrate that cj1431c is the CPS heptosyltransferase
which we have designated hddD. A summary of the initial
steps of heptose biosynthesis in C. jejuni NCTC11168
leading to formation of D-glycero-a-L-glucoheptose is
shown in Fig. 6.
Discussion
In this study, we compared the sequences of capsule
biosynthetic loci from six C. jejuni strains using a PCR
amplification procedure dependent on the presence of
highly conserved genes in this region. Comparison of the
biosynthetic loci with CPS structural analyses demon-
strated a good correlation between gene sequence and
structure. The structural studies also identified additional
CPS modifications, including the recently identified phos-
phoramide, which coincide with the presence of additional
genes in the cps regions potentially involved in biosynthe-
sis of these structures.
As CPSs from strains belonging to serotypes HS:23
and/or HS:36 are closely related in structure, comparative
analysis of the corresponding gene clusters was of par-
ticular interest. Striking similarity between the cps regions
of both the HS:23 and HS:36 serostrains and that of strain
81-176, which is of mixed HS:23/HS:36 serotype (Fig. 2),
indicates their cps loci originated from a common ances-
tor. The variation in the heptoses and phosphoramide in
the respective CPS structures may be attributed to the
presence of phase-variable genes whose expression was
demonstrated to differ between the three strains. Indeed,
phase-variable expression of methyl, ethanolamine, ami-
noglycerol and phosphoramide groups on the CPS of
strain NCTC11168 has recently been described and also
shown to result in changes in antibody reactivity (Szyman-
ski et al., 2003).
The availability of the sequence data allowed further
comparison of the cps regions with that of C. jejuni
NCTC11168. Both highly conserved and variable genes
were found. The biosynthetic genes that are proximal to
the transport-related kps genes were more conserved,
particularly the five to six genes near kpsC. Similarly, the
study of Streptococcus pneumoniae cps loci also revealed
a non-random variation of CPS-related genes, with the
highest difference for those genes closest to the central
region (Jiang et a/., 2001). However, the biosynthetic cps
genes of strains HS:41 and NCTC11168, with the excep-
tion of gmhA2, hddA and hddC, were found to have very
low levels of similarity. This finding indicates that the cps
regions of these two strains are the most distantly related.
An independent analysis of the C. jejuni NCTC11168
genome performed elsewhere (http://www.fut.es/-debb/
C 2004 Blackwell Publishing Ltd, Molecular Microbiology, 551~103
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Fig. 5. HR-MAS NMR analysis of capsule (A, C, E, G, I and K) and CE-MS analysis of LOS (B, 0, F. H, J and L) of C. jejuni NCTClll68 and
heptose mutants. (A and B) C. jejuni NCTCl1168; (C and D) gmhA/gmhA2 mutant; (E and F) hddA mutant; (G and H) gmhB mutant; (I and J)
hddC mutant and (K and L) hddD mutant. The anomeric protons of the capsular polysaccharide correspond to: (a) 6-0-methyl-o-g'ycero-a-L-
glucctJeptose; (b) j3-o-ribose; (c) (l-o-glucuronic acid amldated predominantly with 2-amino-2-deoxyglycerol and (d) j3-o-GaIINAc.Other proton
resonances of note include: (x) methyl group linked to heptose, (y) the phase-variable phosphoramlde and (z) variable ethanolamine replacing
2-amino-2-deoxyglycerol on glucuronic acid. Note that the anomeric resonance 'd' corresponding to GaiINAc shifts due to the relative proportions
of the phase-variable substitutions, aminodeoxyglycerol and ethanolamine, on glucuronic acid.
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D-sedoheptulose-7 -P
GmhA (Cj1149c) I 'and two isomerases used
GmhA2 (Cj1424c) for LOS and CPS pathway
D-glycero-D-mannoheptose-7 -P
HddA (C'1425 )IkinaseJ c + ATP
D-glycero-D-mannoheptose-1, 7-PP
GmhB (CJ'1152c)Ip~osphatase shared
with LOS pathway
D-glycero-D-mannoheptose-1-P
HddC (C'1423 )Inucleotidyltransferase
J c + GTP
GDP-D-glycero-D-mannoheptose
II possible epimerization
at C3, 4, 5
I
GDP-D-glycero-a.-L-glucoheptose
HddD (Cj1431c)Iheptosyltransferase
CPS
Fig. 6. Summary of the capsular heptose biosynthetic pathway in C,
jejuni NCTC11168,
HGT/) also predicted that a number of genes have been
acquired via horizontal gene transfer, including many from
the biosynthetic cps region (e.g. cj 1432-cj 1442). These
data suggest that exchange of the genes present in the
biosynthetic cps regions of different C. jejuni may provide
an efficient mechanism of structural variation in this patho-
gen. Evidence for this was recently shown in the C. jejuni
GBS isolate GB11 (HS:2) which is similar to NCTC11168
(HS:2), but has horizontally acquired the entire LOS locus
from the HS:19 serostrain (Gilbert et al., 2004). Similar
mechanisms of variation in CPS structure via genetic
exchange were suggested for Neisseria meningitidis
(Swartley et al., 1997) and S. pneumoniae where more
than 90 different capsular serotypes have been described
in the latter (Dillard and Yother, 1994; Dillard et a/., 1995;
Kamerling, 1999).
In addition to the mechanisms of variation attributed to
homopolymeric tracts and horizontal gene transfer, exten-
sive intragenomic variation in the cps regions can be
observed. Some genes, e.g. cj1421 and cj1422 in
NCTC11168 share long regions of identity, which may
have resulted from gene duplication while in other strains
only one copy of either of these genes is present. Other
genes may have arisen from deletions resulting in the
formation of hybrid genes. For example, the N-terminal
region of gene H19.11 from serostrain HS:19 is similar to
many C. jejuni glycosyltransferases, with the first 169 aa
residues being almost identical to the N-terminal residues
of the Cj1440 protein of NCTC11168. However, the C-
terminus of HS19.11 has no similarity to the correspond-
ing region of Cj1440, and resembles instead the Cj1438
glycosyltransferase. The finding supports the possibility of
intracistron recombinations between genes performing
a similar function (e.g. encoding glycosyltransferases).
It remains to be determined whether mosaic gene
sequences encode enzymes with altered substrate spec-
ificity and contribute to structural variation of the CPS. It
is interesting to note that there is an extensive duplication
of glycosyltransferase genes in the cps loci resulting in
approximately double the number of transferases pre-
dicted by the structures (Table 1 and Fig. 2).
Strains NCTC11168, HS:23, HS:36, 81-176 and HS:41
were found to contain the following gene homologues:
gmhA2 (sedoheptulose-7-phosphate isomerase), hddA
(D,D-heptose-7-phosphate kinase) and hddC (0,0-
heptose-1-phosphate guanosyltransferase) which have
enzymatically been shown to be involved in the alternate
D-glyeerO-D-manno-heptose biosynthetic pathway in
Aneurinibaeillus thermoaerophilus proceeding through
GDP- rather than ADP-linked intermediates (Kneidinger
et al., 2001). The presence of these genes correlates with
the presence of heptose in the respective CPSs demon-
strated by structural studies. In addition, the C. jejuni
gmhA2, hddA and hddC genes are nearly identical in all
loci, suggesting that recent exchange of these genes
occurred between strains with different cps clusters. The
gmhA2, hddA and hddC genes found in C. jejuni share
similarity with and show colinearity to the respective
genes involved in heptose biosynthesis in other bacteria
(Fig.4) (DeShazer et al., 1998; Reckseidler et al., 2001;
Pacinelli et al., 2002; Valvano et al., 2002), thus support-
ing the possibility of being acquired via horizontal gene
transfer.
In this study, we have demonstrated that the enzymes
encoded by these homologues are also involved in hep-
tose biosynthesis in C. jejuni. Furthermore, we have
shown that C. jejuni has retained two heptose isomerase
enzymes (GmhA and GmhA2; Fig. 6) that are both func-
tional in E. coli and are used for the first step of heptose
biosynthesis in both C. jejuni LOS and CPS. Interestingly,
the genes required for Campylobaeter LOS (cj114B-
cj1152) and CPS (ej1423-cj1425) heptose biosynthesis
are both clustered on the genome (Parkhill et al., 2000).
This is in contrast to most organisms that contain genes
involved in ADP-activated heptose biosynthesis scattered
throughout their genomes. Also, unlike bacteria containing
the alternate GOP-activated pathway, all of the Campy/o-
baeter CPS clusters lack the phosphatase homologue
necessary for the conversion of D,D-heptose-1,7-bisphos-
C 2004 BlackwellPublishing Ltd, Molecular Microbiology, 55,90-103
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176.83 (HS:41 serostrain, enteritis isolate; Hanniffy et al.,
1999), NCTC12517 (HS:19 serostrain, enteritis isolate), G1
(HS:1, GBS isolate; Karlyshev etal., 2000a), 81-176 (HS:23/
36, enteritis isolate used in human challenge studies; Black
etal., 1988), CCUG 10954 (HS:23 serostrain, enteritis iso-
late) and ATCC 43456 (HS:36 serostrain, enteritis isolate)
(Table 1). C. jejuni strains were grown in microaerophilic con-
ditions at 37°C on 7% blood agar plates for 2 days. The E.
coli XL2 Blue MRF' strain (Stratagene), used in cloning
experiments, was grown overnight at 37°C on LB agar plates
supplemented with 100 ~g mr' ampicillin when necessary.
The E. coli X705 parent and X711 gmhA variant were previously
described (Brooke and Valvano, 1996).
Construction and characterization of C. jejuni
NCTC11168 heptose mutants
C. jejuni NCTC 11168 insertional mutants were created and
verified as previously described (St Michael et al., 2002). For
construction of the cj1424c (gmhA2) mutant, genes cj1423c
to cj1425c were cloned using the primers: Cj1423cF651 and
Cj1425cR41 (see Supplementary material; Table S8). The
kanamycin resistance cassette (kan1 from pILL600 (Labigne-
Roussel et al., 1988) was inserted into the Afnl restriction site
in a non-polar orientation generating pCSc24Km. The
chloramphenicol resistance cassette (cam) from pRY109
(Yao et al., 1993) was inserted into the same site in a non-
polar orientation to generate pCSc24Cm. For the cj1425c
(hddA) mutant, genes cj1423e to ej1425e were cloned using
the primers described above and kan' was inserted into the
Ben restriction site generating pCSc25. Although sequencing
results demonstrated that kan' insertion into hddA was in the
polar orientation, the resulting phenotype did not result from
polar effects on adjacent genes as mutagenesis of gmhA2
(this study) or ej1426c (M. Szymanski, unpubl. obs.) does not
alter the CPS heptose. For the cj1152c (gmhB) mutant,
genes cj1148 to cj1152c were cloned using waaFF9 and
Cj1152c_R113 and kan'was inserted into the Sphl restriction
site in a non-polar orientation generating pCS152. For the
cj1423c (hddC) mutant, genes cj1422c to cj1426c were
cloned using Cj1422cF1869 and Cj1426c_R30 and kan'was
inserted into the Bgnl restriction site in a non-polar orienta-
tion. The resultant construct, pCSc23, was truncated by
==2kb. Sequencing demonstrated that the 3' end of pCSc23
lacked cj1425o-cj1426c and the first 84 base pairs of
cj1424c. For the cj1149c (gmhA) mutant, genes cj1148 to
cj1152c were cloned using the primers described above and
the mutant was generated by transposon mutagenesis to
create pCSI49 using the EZ::TNTM<KAN-2> insertion kit (Epi-
centre) according to the instructions of the manufacturer.
Sequencing with the forward and reverse primers provided
with the kit demonstrated that kan' was inserted in a non-
polar orientation after 420 bp in gmhA. The double
gmhA::kan'/gmhA2::carrf mutant was constructed by natu-
rally transforming gmhA2 with gmhA chromosomal DNA
(Guerry et al., 1994) and confirmed by PCR that both antibi-
otic cassettes were retained in the correct genes. The cj1431
(hddD) mutant was made using plasmid cam10ge8 con-
structed as part of the C. jejuni NCTC11168 genome
sequencing project (Parkhill et al., 2000). The plasmid con-
tains a 1.7 kb fragment of NCTC11168 genomic DNA cloned
into pUC18. The kan' cassette from plasmid pJMK30 (van
Vliet et al., 1998) was inserted in a non-polar orientation into
the Swal site of cj1431 contained within the fragment.
Complementation of E. coli X711with C. jejuni isomerase
homologues
Campylobacter jejuni gmhA was amplified using primers con-
structed with forward Ndel and reverse san restriction sites
(FgmhA and BgmhA) while gmhA2 was amplified using
FgmhA2 and BgmhA2 and inserted in frame into the Ndel
and san sites of cloning vector pCW (Karwaski et al., 2002)
to generate CjgmhA and CjgmhA2. The plasm ids were then
inserted into electrocompetent E. coli X711 lacking gmhA
(Brooke and Valvano, 1996).
The strategy of amplification and sequencing
of C. jejuni CPS regions
Short sequences of kpsC and kpsF genes from different
strains were derived using the single-primer PCR procedure
(Karlyshev et al., 2000b). Primer pairs ak176/ak177 and
ak173/ak174 were used for sequencing of the kpsC and kpsF
genes respectively. Alignment of the derived sequences
allowed the design of universal primers suitable for long-
range PCR in various strains: ak186 for kpsFgene and ak188
for kpsC (see below). For serostrain HS:19 a more optimal
kpsC primer ak187 was designed. Long-range PCR with
kpsF and kpsC primers alone failed to produce any product
with the reference strain NCTC11168. This could result from
a relatively large size of the amplicon (over 36 kb). However,
it was possible to amplify the entire cps region as two long-
range PCR products when kpsC and kpsF primers were
combined with primers derived from the internal biosynthetic
genes.
The same strategy was used for amplification of cps
regions from other strains. The sequencing of the cps regions
of serostrains HS:23 and HS:36 was performed after the
sequencing of the cps region of strain 81-176 was complete.
The identical gene content and high sequence identity
between these three strains allowed us to completely
sequence the cps regions of serostrains HS:23 and HS:36
using custom-made oligonucleotides.
The biosynthetic cps region of strain NCTC 11168 contains
28 genes (Karlyshev et al., 2000a). The conserved genes
present in the biosynthetic regions of other strains were iden-
tified using PCR amplification with primers derived from the
sequence of NCTC11168 genome. Primer pairs specific to
the biosynthetic cps genes of strain NCTC11168 are indi-
cated in the Supplementary material (Table S9). The long-
range PCR with the flanking kpsC- and kpsF-specific primers
combined with the primers derived from conserved internal
genes resulted in overlapping products suitable for genera-
tion of complete sequences of the internal biosynthetic
regions. Long-range PCR was performed using the Expand
20 kbPLUS PCR System (Roche) using conditions described
by the manufacturer.
The long-range PCR products were treated with polynucle-
otide kinase, sonicated, and blunt-ended with T4 DNA poly-
merase. Then, 1-2 kb fragments were gel-extracted and
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cloned into alkaline phosphatase-treated pUC18 (Promega)
before sequencing. For closing gaps, primers corresponding
to the ends of the contigs were designed and the regions
were amplified and sequenced either directly or after cloning
into pGEM-T-Easy vector (Promega) using the automatic
sequencer. DNA sequencing was performed on ABI 377 or
ABI 3700 automatic sequencers using an ABI PRISM BigDye
Terminator Cycle Sequencing Kit (Perkin-Eimer). The
sequences generated via shot-gun sequencing were assem-
bled and edited using GAP4 (Bonfield et al., 1995) or Gene-
Tool software, and were deposited at the EMBL database
with the accession numbers listed in Table 1.
Multiple sequence alignment was performed using the
CLUSTALWprogram (http://www2.ebLac.uklclustalw/). The cps
sequences were analysed using Artemis software (Ruther-
ford et al., 2000) and the extracted amino acid sequences
were analysed by similarity searches with the BLASTp pro-
gram against NCTC11168 at http://www.sanger.ac.ukl
Projects/Cjejuni/ and a non-redundant protein database at
http://www.blast.genome.ad.jp/. The entire cps regions were
compared with the cps region of NCTC11168 using BLASTn
and tBLASTXprograms (http://www.hgmp.mrc.ac.ukl) followed
by the analysis using MSPCRUNCH(http://bioweb.pasteur.fr/
seqanal/interfaceslmspcrunch.html) and ACTprograms (http:/
/www.sanger.ac.uk).
Isolation and purification of CPS
The CPS was isolated from dried cell mass (",1 g) by the
hot water/phenol method (Westphal and Jann, 1965). The
aqueous phase was dialysed against water and lyophilized.
The dried sample was then dissolved in water to a 1%
solution (w/v) and subjected to ultracentrifugation to yield a
gel-like pellet containing LOS and supernatant containing
the CPS.
Analytical methods
Sugars were determined by examining their alditol acetate
derivatives (Sawardeker et al., 1965) by GLC-MS. Samples
were hydrolysed for 4 h using 4 M trifluoroacetic acid at
100°C. The sample was reduced in NaB04 overnight in
H20 and acetylated with acetic anhydride at 100°C for 2 h
using residual sodium acetate as the catalyst. The GLC-MS
was equipped with a 30 M OB-17 capillary column (180°C
to 260°C at 3.5°C per minute) and MS was performed in
the electron impact mode on a Varian Saturn II mass
spectrometer.
HR-MAS NMR allows the screening of small amounts of
bacterial cells directly without having to purify surface carbo-
hydrates (Szymanski et al., 2003). HR-MAS experiments
were performed on a Varian Inova 500 and 600 MHz spec-
trometer using a gradient 4 mm indirect detection HR-MAS
nano-NMR probe (Varian) with a broadband decoupling coil
as previously described (St Michael et al., 2002; Young et al.,
2002). Proton spectra of cells were acquired with the Carr-
Purceil-Meiboom-Gill (CPMG) pulse sequence [90-(t-180-
tlo-acquisition] to remove broad lines arising from lipids and
solid-like material. The total duration of the CPMG pulse (n2t)
was 10 ms with t set to (1/spin rate). 1Hchemical shifts were
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referenced relative to that of sodium 3-(trimethylsilyl)propri-
onate-2,2,3,3-d4 at 0.0 p.p.m.
High-resolution NMR experiments on the partially purified
CPS were acquired using a Varian Inova 500 MHz spectrom-
eter equipped with a Z-gradient 3 mm triple resonance CH,
13C, 31P) probe. The experiments were performed at 40°C
with suppression of the water resonance. The methyl reso-
nance of acetone was used as an internal reference at 0.,
2.225 p.p.m. and Be 31.07 p.p.m. Standard pulse sequences
from Varian, COSY, TOCSY, NOESY, HMOC and 31pHMOC
were used.
Preparation of O-deacylated LOS and CE-MS analysis
LOS preparations and CE-MS analyses were performed as
previously described (Szymanski et al., 2003). Briefly, a
Prince CE system (Prince Technologies) was coupled to a 0-
Star quadrupole/time-of-flight mass spectrometer or an API
3000 mass spectrometer (Applied BiosystemslMOS Sciex)
via a microlonspray interface.
Deoxycholate-PAGE of polysaccharides
Proteinase K-treated whole-cell digests of E. coli X705, X711
and X711complements were prepared and analysed on 16.5%
deoxycholate-PAGE as previously described (St Michael
et al., 2002).
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